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ABSTRACT 
Background: Silica is the common name for silicon dioxide (SiO2) materials 
and exists in both crystalline and amorphous forms. While crystalline silica is 
known for its severe health effects, amorphous silica has been considered safe 
and applied in many areas. However, some recent studies have showed 
evidence of their toxicity, raising concerns about its use as nanomaterial for 
biomedical applications. When nanomaterials enter the body, they are 
enveloped in biological fluids rich in biomolecules, which compete for binding to 
the nanomaterial. Such effect could alter their surface chemistry and therefore 
affect their bio-distribution and interaction with cells.   
Aim and objectives: As part of the EU-funded NANODRUG network 
programme, the aim of this project was the in vitro toxicity assessment of 
commercially-sourced fumed and colloidal amorphous silica particles in relation 
to their physico-chemical properties and potential application as carriers for 
drug delivery. The objectives were 1) characterization of  silica particles 
hydrodynamic (Hd) size and dispersity  in different cell culture media; 2) in vitro 
toxicological assessment of silica particles in human skin cells; 3) delineation of 
toxicity mechanisms in relation to their size; 4) assessment of the influence of 
Foetal Bovine Serum (FBS) on particle Hd size and toxicity; and 5) contributing 
to the overall objective of the NANODRUG programme - development of safe 
nanodrugs for skin application - through collaborations with different partners.  
Methods: A group of amorphous silica including fumed silica 7 nm and 14 nm 
(SiNP7 and SiNP14), and colloidal silica nanoparticles of 20 nm and 70 nm 
(SiNP20 and SiNP70) and submicroparticles 200 nm and 500 nm (SMP200 and 
SMP500) were selected for the study. They were dispersed in different media 
(used for culture of different cells) and characterized for size, shape, dispersion 
and zeta potential using Dynamic Light Scattering (DLS), Zeta Potential (ZP), 
Scanning and Transmission Electron Microscopy (SEM and TEM). HaCaT 
keratinocytes were used to assess the toxicity potential of all the silica particles 
after 24 h treatment at 5-200 µg/ml, while K17 keratinocytes, and BJ fibroblasts 
and Human Dermal Fibroblasts (HDF) were also used to assess cell type 
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specific effect.   Toxicity assessment included morphology, cellular uptake, cell 
viability, cell membrane damage, apoptosis, wound healing, and gene 
expression.      
Results: TEM and SEM imaging showed that fumed SiNPs formed irregular 
chain-like aggregates, while all colloidal silica displayed spherical shape apart 
from SiNP20, which also formed chain-like aggregates. DLS assays suggested 
that FBS and some other components of cell culture media could alter the 
hydrodynamic size and dispersity of the particles. Fumed SiNP7 and SiNP14 
induced significant cytotoxicity in the absence of FBS, while the effect was 
diminished in the presence of FBS. Colloidal SiNP20 also induced significant 
toxicity in the absence of FBS, while the effect was attenuated in the presence 
of FBS. For colloidal SiNP70, the toxicity was only detected in the absence of 
FBS. These SiNPs toxicity were detected by assays including cell viability, cell 
membrane leakage and apoptosis, and appeared to be associated with cellular 
internalization. SMP200 and SMP500, on the other hand, appeared to sediment 
during incubation with cells. Although they were readily internalized by the cells 
their toxicity was only detected in the absence of FBS by apoptosis assay. 
Moreover, all the colloidal silica also showed a dose-dependent effect in 
promoting wound healing at 5-25 ug/ml, with SiNP70 being most significant. In 
K17 keratinocytes, cellular internalization occurred to all the silica tested, yet 
only SiNP20 induced a significant toxicity. In BJ fibroblasts and human dermal 
fibroblast cells, silica toxicity appeared not to be associated with their 
internalization.   
Conclusions: This study clearly demonstrated that 1) fumed and colloidal 
SiNPs exhibited different dispersity in cell culture media; 2) silica particles 
exerted toxicity in a size-dependent manner in four human skin cell lines 
including two cell types; 3) SiNPs toxicity involved activation of apoptosis; 4) 
SiNPs dispersity, cellular uptake and toxicity were modulated by FBS; 5) silica 
promoted wound healing in size- and dose-dependent manner.   This in vitro 
study suggests that 1) SiNP7, SiNP14, SiNP20 may not be suitable for 
biomedical applications due to their instability in biological media and toxicity 
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induction respectively; 2) the potential of silica toxicity could be different in vivo 
as components of FBS used in vitro are different from that of human serum; 3) 
there seems to be dose thresholds for colloidal silica to interfere with different 
cellular processes such as toxicity and wound healing. Although this project 
aimed to assess the toxicity silica particles for drug delivery, it has also provides 
new evidence supporting development of new regulations specific for 
nanomaterials.  
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1 LITERATURE REVIEW 
1.1 Introduction 
Nanotechnology is a new scientific research area, which has undergone 
intensive development over the last two decades, bringing new hopes in 
improving human life in many ways, including medicine, transport, clothing and 
food [1]. The purpose of this review is to go through the brief history of 
nanotechnology-enabled materials, nanomaterials, in regards to their definition, 
physico-chemical characteristics and potential toxicity. The status of current EU 
and USA regulation has been included to highlight the need for research. Such 
an overview will help delineate the aims and objectives of this project, which is 
part of NANODRUG, a European Commission-funded project with the aim of 
developing and characterizing a selected set of nanomaterials to study their 
suitability as drug delivery systems targeting inflammatory skin diseases. The 
review was based on literature that was searchable from Cranfield-provided 
Scopus library, National Centre for Biotechnology Information (NCBI) and 
Google Scholar. 
 
1.2 Nanomaterials – An Overview 
1.2.1 History of nanotechnology and nanomaterials 
Nanotechnology can be defined as the manipulation of matter that has at least 
one dimension between 1-100 nm [1]. Even though the most significant 
increase in nanomaterials popularity occurred between the 1990s and 2000s, 
the first observations and size measurements of nanoparticles can be dated 
back to 1914, when Richard Adolf Zsigmondy developed the first system 
classification based on particle size in the nanometre range [1]. Even though 
the idea of nanotechnology was given for the first time in 1959 by Richard 
Feynman, the term was first used in 1974, in a publication by a Japanese 
student named Norio Taniguchi. He stated: “Nanotechnology mainly consists of 
the processing of, separation, consolidation, and deformation of materials by 
one atom or one molecule” [1, 2].  
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Nanotechnology did not start developing into a field of science until the 1980s, 
when MIT scientist Eric Drexler expanded Feynman’s vision by publishing in 
1981 an article entitled “Molecular engineering: An approach to the 
development of general capabilities for molecular manipulation” in the journal 
“Proceedings of the National Academy of Sciences” [3]. The article discussed 
the possibility of molecular manufacturing as a process for the fabrication of 
objects with specific atomic specifications. This concept was further developed 
into a book entitled “Engines of Creation: The Coming Era of Nanotechnology” 
[4]; right after this publication, Drexler founded the Foresight Institute, whose 
stated goal was to “ensure the beneficial implementation of nanotechnology.” 
As a direct result, a lot of publicity was generated on both Drexler’s work and 
the Forsight Institute, prompting scientists from all over the world to begin 
studies in the field of nanotechnology [1]. 
The development of nanotechnology was further driven by the development of 
tools such as the scanning tunnelling microscope (STM) in 1981, which allowed 
the clear identification of individual atoms for the first time. The STM invention 
was followed by the Atomic Force Microscope (AFM) in 1986. AFM proved to be 
quite an important development in materials analysis, as it allowed the imaging 
of non-conducting materials (e.g. organic molecules) for the first time; it 
consequently could be used to study biological macromolecules and living 
organisms. With the development of such microscopic technologies, 
nanotechnology could develop and evolve to include research in several fields, 
including chemistry, materials science, medicine, toxicology, ecotoxicology, and 
industrial hygiene [5].  
There was a significant boost in the popularity of nanotechnology in the 1990s 
and 2000s, with the development of several nanomaterials as well as their 
incorporation in a wide variety of consumer products. In 2001, the National 
Nanotechnology Initiative (NNI), a US federal funding initiative for 
nanotechnology begun under President Clinton, gave the first definition of 
nanoscale technology as “anything with a size between 1 and 100 nm with 
novel properties”. This broad definition was adopted in a range of application 
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areas including cutting-edge semiconductor research, several developing areas 
of chemistry, nanomedicine, and advances in nanomaterials [1].  
In the early 2000s, concerns about the potential human and environmental 
health effects of nanomaterials were also being considered by many scientists, 
regulators, and non-governmental agencies, as particles and materials in the 
nanosize range might pose toxicological hazards due to their enhanced 
reactivity and potential for systemic availability and environmental occurrence. 
Consequently, the term “nanotoxicology” was first used in 2004 in an editorial 
by Donaldson et al [6]. Since then, there has been a significant increase in the 
amount of in vitro and in vivo nanotoxicological research, as well as 
toxicokinetics and toxicodynamics of nanomaterials evaluation. 
 
1.2.2 Nanomaterials’ characteristics and influence upon interaction with biological systems 
Engineered Nanomaterials (ENMs) can be defined as intentionally developed 
nanomaterials that have at least one dimension of 1-100 nm [7]. They can be 
composed of a variety of materials including noble metals (Au, Ag, Pt, Pd), 
semiconductors (CdSe, CdS, ZnS, TiO2, PbS, InP, SiO2), magnetic compounds 
(Fe3O4, CoFe2O4, FePt, CoPt) and their combinations. Their composition is not 
limited to these materials, but also includes non-metallic compounds such as 
silica and carbon, as well as polymers and biologically originated materials 
(phospholipids, lipids, lactic acid and chitosan) [8, 9]. Nanomaterials (NMs) can 
be produced in different formats, such as single particles, aggregates, powders, 
colloids, suspensions, nanolayers, carbon fullerenes, and their derivatives [10]. 
A great number of NMs are available nowadays, thus making a clear 
classification quite challenging (Figure 1.1); moreover, most nanomaterials do 
not consist of only one substance, but typically are hybrid materials, involving 
surface coatings and other modifications. Even NMs formed out of only one 
material will turn effectively into a hybrid NMs upon contact with any biological 
system, as an organic coating of biomolecules will envelope them. 
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Figure 1.1 An overview of some of the different nanomaterials that are available today.  This 
explains how challenging a complete classification of nanomaterials can be (modified from [9] 
Algar et al. (2011)). 
 
Nanomaterials have attracted considerable interest over the years because of 
their unique physico-chemical properties, which greatly differ from their 
corresponding bulk materials. Their main characteristic is size, which falls in the 
transitional zone between individual atoms or molecules and the corresponding 
bulk materials; as a consequence, the electronic, magnetic, optic, catalytic, 
biomedical and thermodynamic properties are affected as well [11]. The 
reasons for this phenomenon lie in the increased surface/volume ratio, which 
can be defined as the amount of surface area per unit volume of an object or 
collection of objects. Surface/volume ratio is an important factor both in 
chemistry, where it influences the reactivity of solid materials, and in biology, 
where it affects the physiology and behaviour of cells and organisms [12].  
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Physico-chemical properties, including size, surface area, surface charge, 
shape, chemical composition, solubility, agglomeration state and surface 
coating, influence not only the nanomaterial itself, but also any biological 
system it might come in contact with depending on the function for which it’s 
designed  [13]. Particle size and surface area are interconnected, as a decrease 
in particle size leads to an exponential increase in surface area. This increase 
consequently makes the nanomaterial surface more reactive on itself and to its 
contiguous environment. Size and surface area both play a major role in the 
interaction of nanomaterials with biological systems. Particle size and surface 
area have a direct influence on how a biological system responds to, distributes, 
and eliminates nanomaterials [13, 14]. It has also been established that various 
biological mechanisms including endocytosis, cellular uptake, and efficiency of 
particle processing in the endocytic pathway are dependent on size. Size also 
dictates nanomaterials’ pharmacological behaviours, as it has been observed 
that NMs smaller than 50 nm administrated by intravenous injection readily 
transverse and impart potentially toxic manifestations in various tissues; on the 
other hand, those bigger than 50 nm are readily taken up by the 
reticuloendothelial system (RES) therefore refraining their path to other tissues 
[15]. Surface charge is important as well, as it is a major determinant of colloidal 
behaviour and therefore particle stability in solution [16]. It plays an important 
role also in the interaction of nanoparticles with biological systems, as it can 
influence the uptake rate depending on the type of charge [17]. Nanomaterials 
come in different shapes, including rings, tubes, spheres, and planes. The 
shape of nanomaterials directly influences the membrane wrapping processes 
in vivo during endocytosis or phagocytosis. It has been observed that 
endocytosis of spherical nanoparticles is easier and faster when compared to 
rod shaped nanoparticles; non-spherical nanomaterials tend to go through 
capillaries, thus causing different biological effects [18]. Surface coatings may 
also be an important factor on the properties of nanomaterials, as it can change 
their magnetic, electric, and optical properties and chemical reactivity [13] and 
alter their pharmacokinetics, distribution, accumulation, and toxicity.  Because 
of these characteristics, nanomaterials behave differently when interacting with 
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biological barriers, especially with proteins, causing modification in both 
themselves and the interacting species. This is very important when NMs are 
designed for nanomedicine applications, as they must satisfy certain criteria. 
For in vitro applications such as ﬂuorescent staining of proteins and 
Transmission Electron Microscopy (TEM) imaging, they must outperform the 
conventional agents while having minimal cytotoxicity. For in vivo applications, 
NMs must avoid non-speciﬁc interactions with plasma proteins (opsonisation) 
and be able to either evade or allow uptake by the reticulo-endothelial system 
(RES), depending on the application, to reach their intended target efﬁciently; 
they must also maintain colloidal stability under physiological conditions. 
Nanomaterials (NMs) carrying a payload, such as drug molecules or DNA for 
gene therapy, must avoid premature release yet speciﬁcally deliver the load to 
the desired site [19]. 
 
1.2.3 Toxicity of nanomaterials 
In the last few years, nanotechnology has provided enormous benefits in areas 
such as materials science, communication, electronics, medicine, energy, and 
environmental sciences. But as manipulation and application of engineered 
nanomaterials is involved, nanotechnology has also become the subject of 
debate regarding its toxicological and environmental impact, considering that 
nanomaterials are not only used for various commercial applications, but also in 
the biomedical field, where their applications involve deliberate ingestion or 
injection into the body [20, 21, 22]. Nanomaterials for imaging and drug delivery 
are often intentionally coated with biomolecules such as DNA, proteins, and 
monoclonal antibodies to target specific cells [23]. Because of the growing 
interest in exploring nanomaterials’ uses for imaging, systemic delivery of drugs, 
target specific killing of cancerous cells, understanding the relationship between 
the physico-chemical properties of nanomaterials and their absorption, 
distribution, metabolism and elimination (ADME) characteristics is critical to 
achieve the desired biological effect . Given these concerns, nanotoxicology 
was proposed as a new branch of toxicology to address the gaps in knowledge 
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and to specifically address the adverse health effects likely to be caused by 
nanomaterials [24]. Nanotoxicology encompasses the physicochemical 
determinants, routes of exposure, bio distribution, molecular determinants, 
genotoxicity, and regulatory aspects, as summarized in Figure 1.2; it is also 
involved in proposing reliable, robust, and data-assured test protocols for 
nanomaterials in human and environmental risk assessment. 
 
 
Figure 1.2 An overview of the factors involved in nanotoxicology (modified from [7] Nel et al. 
2006). 
 
The physico-chemical determinants play an important role in toxicity. Among 
them, size and surface area play the most pivotal role, as the size of 
nanoparticles/aggregates is an essential parameter in determining nanoparticle 
toxicity due to a more effective macrophage clearance for larger particles 
compared to smaller ones, leading to reduced toxicity when nanoparticles 
aggregate at sizes larger than 100–200 nm [25, 26].  Size and surface area also 
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play an important role in the potential dose-dependent increase in oxidation and 
DNA damage, as nanomaterials with smaller size and higher surface area could 
cause much higher damage than larger materials [27, 28]. Among the other 
determinants, NMs chemistry also plays an important part in toxicity, as it can 
influence cellular uptake, subcellular localization, and ability to catalyse the 
production of reactive oxygen species. Moreover, surfactants used in 
nanoparticle synthesis can drastically change the physico-chemical properties 
of nanoparticles, such as magnetic, electric, and optical properties, and 
chemical reactivity, affecting their cytotoxicity.  
The macromolecules most frequently affected by nanomaterial toxicity are those 
genes or proteins with significant roles in oxidative stress, DNA damage, 
inflammation or injury to the immune system. Table 1.1 summarises some of 
the potential pathological effects that nanomaterials can have after contact with 
human cells. 
 
Table 1.1 Possible patho-physiological outcomes due to various nanomaterials (modified from 
[24] Arora et al. 2012). 
Experimental NMs Effects Pathophysiological Outcomes 
ROS generation and Oxidative 
Stress 
Protein, DNA, Membrane Damage 
Mitochondrial Perturbation Cytotoxicity, Inflammation, Energy Failure, 
Apoptosis 
Uptake by Reticulo-Endothelial 
System 
Asymptomatic sequestration and storage in the 
liver, spleen and lymph nodes, possible organ 
enlargement and dysfunction 
Nuclear Uptake and DNA Damage Nucleoprotein Clumping, Mutagenesis, 
Carcinogenesis 
Generation of neo-antigens, 
perturbation of phagocytic function 
Autoimmunity, Chronic Inflammation 
Altered Cell Cycle Regulation Proliferation, Cell Cycle Arrest, Senescence 
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Because nanomaterial size is comparable to that of cellular components, they 
can efficiently enter living cells by exploiting the cellular endocytosis machinery 
[29]. Endocytosis is a mechanism to overcome the barrier function of the cell 
membrane; it can be defined as the uptake of particulate matter (proteins, 
nutrients) inside cells via enclosure by the cell membrane. It is also exploited for 
the clearance of cell debris and foreign cells from the body. Several forms of 
endocytosis can be distinguished based on the substance to be internalized 
(Figure 1.3) [30, 31]. 
 
         
Figure 1.3 Schematics of endocytosis mechanisms. 
 
Opsonin-bound particulates and small solute volumes are internalized by 
phagocytosis. In animals, phagocytosis is part of the immune defense and is 
typically restricted to cells specialized in the uptake and degradation of foreign 
cells as well as cell debris and apoptotic cells belonging to the organism itself 
[30]. Particles in large amounts of solute, on the other hand, are taken up by a 
process termed pinocytosis. Pinocytosis can be further divided into 
macropinocytosis and receptor-mediated endocytosis (RME) [30, 32, 33]. 
Macropinocytosis is a non-specific mechanism in which fluid contents are taken 
up in the same concentration as in the surrounding medium. It is a constitutive 
process occurring continuously in highly ruffled regions of the cell membrane; 
ruffles trap the surrounding medium when their tips bend back toward the cell 
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surface. Materials adsorbed onto the cell membrane can be taken up as well, in 
what is called adsorptive macropinocytosis. Caveolae- and clathrin-mediated 
endocytosis are receptor-mediated endocytosis which allow different types of 
ligand (toxins, cholesterol-carrying proteins, vitamins, and iron transport 
proteins, as well as hormones and growth factors) to enter cells by binding to 
specific receptors localized on the cell membrane [30]. Particle uptake by 
endocytosis is a complex interplay of energy release by several factors, 
including particle size, number of bound receptors, number of vesicles that can 
be formed from the membrane, receptor diffusion toward the attached particle, 
and time to complete this process. For large NPs, only one particle can be 
taken up per vesicle, and attachment occurs to numerous receptors at a time, 
resulting in a major change in free energy. Large particles will also require more 
time to complete wrapping. For small particles, several NPs can be taken up in 
a single vesicle, but energy release is weaker because only single attachment 
sites exist. Because a local decrease in the free energy is required to induce 
membrane wrapping, a minimum size for a single particle at a given ligand 
density must exist; otherwise endocytosis is energetically impossible. Uptake is 
only initiated after a certain number of receptors have been triggered. If the 
change in free energy is too small, membrane wrapping will not be induced [30, 
34, 35, 36]. 
When exposed to molecular determinants such as light or transition metals, 
nanomaterials may also promote the formation of pro-oxidants, which, in turn, 
destabilizes the delicate balance between the biological system's ability to 
produce and detoxify the reactive oxygen species (ROS). ROS include free 
radicals such as singlet oxygen (1O2), the superoxide anion (O2•), hydroxyl 
radicals (•OH) and the non-radical hydrogen peroxide (H2O2); they are 
constantly generated in cells’ mitochondria during normal metabolism, and they 
are involved in enzymatic reactions, mitochondrial electron transport, signal 
transduction, activation of nuclear transcription factors and gene expression. 
When cells are exposed to any chemical or physical damage, it results in the 
production of ROS. However, cells are also endowed with an extensive 
antioxidant defence system to combat them, either directly by interception or 
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indirectly through reversal of oxidative damage. Oxidative stress induced by 
nanomaterials is reported to enhance inflammation through up-regulation of 
redox-sensitive transcription factors. As shown in Figure 1.4, ROS production 
by mitochondria can lead to oxidative damage to mitochondrial proteins, 
membranes and DNA, impairing the ability of mitochondria to synthesize ATP 
and to carry out their wide range of metabolic functions. It also increases the 
tendency of mitochondria to release inter-membrane space proteins such as 
cytochrome c to the cytosol by mitochondrial outer membrane permeabilization 
(MOMP) and thereby activate the cells apoptotic machinery. In addition, 
mitochondrial ROS production leads to induction of the mitochondrial 
permeability transition pore (PTP), which renders the inner membrane 
permeable to small molecules in situations such as ischemia/reperfusion injury. 
Consequently, it is unsurprising that mitochondrial oxidative damage contributes 
to a wide range of pathologies. In addition, mitochondrial ROS may act as a 
mouldable redox signal, reversibly affecting the activity of a range of functions in 
the mitochondria, cytosol and nucleus [24, 37]. 
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Figure 1.4 Impairment in ROS control can give rise to several pathologies (modified from [37] 
Murphy et al., 2009). 
 
Another important process for nanoparticles toxicity assessment inside cells is 
apoptosis. This process, also known as ‘programmed cell death’ is an important 
control mechanism for the total number of cells inside the human body.  During 
apoptosis, the cell shrinks and condenses (blebbing), the cytoskeleton 
collapses, the nuclear envelope disassembles, and the nuclear DNA breaks up 
into fragments. Most importantly, the cell surface undergoes alterations, 
displaying properties that cause the dying cell to be rapidly phagocytosed either 
by a neighboring cell or by a macrophage. The intracellular machinery 
responsible for apoptosis is similar for all animal cells and depends on a family 
of proteases called caspases. Caspases are usually synthesized as inactive 
precursors, called pro-caspases, activated by cleavage at specific aspartic 
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acids by other caspases. Once activated, they cleave and activate other pro-
caspases, resulting in an amplifying proteolytic cascade that induces apoptosis 
[38, 39]. Apoptosis is extremely complex, therefore its full description can be 
extremely challenging. A common activation method is by receptor-mediated 
oligomerization of caspase 8 (Figure 1.5). When the Fas ligand (FasL), a 
transmembrane protein expressed on cytotoxic T lymphocytes, binds to its 
receptor (FasR) on target cells, the new complex binds directly to the adaptor 
protein FADD, activating caspase 8. Caspase 8 in turn activates the Bid protein, 
responsible for the release of cytochrome c from the mitochondria to the 
cytoplasm, therefore activating the caspase cascade [39]. 
 
 
Figure 1.5 The molecular mechanism of apoptosis (modified from [39] Cullen et al. (2009)). 
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The process described above is known as the extrinsic pathway, as activation 
starts outside the cell. An intrinsic pathway is also available, in which an injured 
mitochondrion releases cytochrome c in the cytoplasm activating the caspase 
cascade (Figure 1.6). 
 
 
Figure 1.6 The intrinsic activation pathway (modified from [38] Alberts et al. (2002)). 
 
Apoptosis can be activated not only for normal cell maintenance, but also as a 
direct result of stimuli in the surrounding environment, including nanomaterials. 
Aside from chemical and molecular determinants, another important aspect 
about nanotoxicology is the routes of exposure, as the human body has several 
semi-open interfaces for direct substance exchange with the environment, 
mainly  the skin, respiratory tract and gastrointestinal tract (GIT), as displayed in 
Figure 1.7:  
 
Figure 1.7 Drawing showing the routes of exposure to nanomaterials (modified from [10] Chen 
et al. 2011). 
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Organisms have always faced nanoscale environmental compounds interacting 
with their exterior barrier but a significant interest in the interactions between 
NMs and organisms developed because of the increase in the production of 
engineered nanomaterials. The first step of any interaction between an 
organism and any compound is its uptake from the environment. Several 
pathways of absorption exist for human and most animal organisms of which 
skin is the easiest to reach. Skin absorption of any kind of material can be 
summarized in two general pathways: along the skin appendages or through 
the skin outermost layer, the stratum corneum (SC). Even though the 
appendages present only a small portion of skin surface they are considered to 
contribute and might even be addressed for a directed delivery because of the 
depth they reach; generally, the stratum corneum is assumed to be the main 
barrier for absorption.  Absorption across the SC offers two possible pathways, 
as shown in Figure 1.8: through its cells, known as corneocytes (shown in 
black) or along the intercellular spaces along its lipid matrix (shown in grey). 
The latter pathway seems to be most suited for penetration, offering channel-
like structures providing higher diffusivity, although it takes longer to reach the 
target [19, 40, 41]. 
 
 
Figure 1.8 The stratum corneum and its pathways for molecule diffusion (modified from [19] 
Schneider et al. 2009). 
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The SC can be considered to be a lipoidic compartment whereas the underlying 
living tissue is a more aqueous environment; hence lipophilic molecules can 
distribute more easily in the SC and penetration is facilitated. Furthermore, the 
absorbent needs to fit into the intercellular space and move along the lipid 
phase or the aqueous phase, respectively, restricting the space available and 
therefore the size of penetrating species influences the absorption behaviour 
[42]. As a consequence, the stratum corneum acts as the primary protecting 
layer and may be the rate-limiting barrier to defend against the penetration of 
most micron sized particles and harmful exogenous toxicants.  
Skin exposure to nanomaterials can also occur during the intentional application 
of topical creams and other drug treatments. Besides skin, the respiratory 
system serves as a major portal for ambient particulate materials. Pathologies 
resulting from airborne particle materials have long been researched in 
occupational and environmental medicine; but, being different from micron sized 
particles that are largely trapped and cleared by upper airway mucociliary 
escalator system, nanoparticles can be deposited in the alveoli. After absorption 
across the lung epithelium, nanomaterials can enter the blood and lymph to 
reach cells in the bone marrow, lymph nodes, spleen and heart; other targets 
include the sensory nerve endings embedded in the airway epithelia, followed 
by ganglia and the central nervous system via axons. Nanomaterials can reach 
the gastrointestinal tract (GIT) after mucociliary clearance from the respiratory 
tract through the nasal region, or can be ingested directly in food, water, 
cosmetics, drugs, and drug delivery devices. The utility of biodegradable 
nanoparticles in the delivery of oral vaccines has been proposed for antigens 
known to be susceptible to proteolysis. Apparently studies on toxicity of 
nanomaterials post-oral ingestion are limited [43, 44, 45, 46]. 
 
1.2.4 Current status of nanomaterials regulation 
Because of the concerns over the use of nanotechnology, over the last few 
years there has been significant debate concerning special government 
regulation over nanotechnology-based products. The rapid commercialization of 
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products involving nanotechnology has caught many regulatory agencies off-
guard, mainly because of the lack of funding to properly assess the potential 
toxicity as well as the complete life cycle of nanomaterials. As a consequence, 
many countries do not have regulations specifically designed to address 
nanomaterials toxicity. Comprehensive surveillance and regulations for 
nanomaterials has partially been achieved by the EU and the US [47].  
According to the European Commission Environment webpage, 
“Nanomaterials are chemical substances or materials that are 
manufactured and used at a very small scale (down to 10,000 times 
smaller than the diameter of a human hair). Nanomaterials are developed 
to exhibit novel characteristics (such as increased strength, chemical 
reactivity or conductivity) compared to the same material without 
nanoscale features (…) even though nanomaterials are not per se 
dangerous, there still is scientific uncertainty about the safety of 
nanomaterials in many aspects and therefore the safety assessment of 
the substances must be done on a case-by-case basis.” In terms of 
regulatory aspects, the EU regulatory framework is a shared competence 
between all member states; in this matter the European Commission (EC) and 
its agencies play a central role, as it is in charge of issuing ‘communications’ on 
the subject of nanotechnology. As of 2015, the EC has released two 
documents, one in 2008 and one in 2012. The first one is mostly a legal 
assessment of how nanomaterials are implemented in the current chemical 
environment, Health & Safety and product legislation. It concluded that even 
though nanomaterials were adequately covered, some implementations were 
needed to address the knowledge gap regarding risk assessments and 
management methodologies, the adoption of provisions (ex. specific 
thresholds), better consumer information and increased market surveillance. 
The 2008 communication was criticized for not being empirical enough; 
therefore, in 2012, a second review was issued. The new communication gave 
more attention to the risk and safety assessment issues, addressing the existing 
knowledge gap and lack of reliable data. It also reviewed how nanomaterials 
have been addressed in REACH regulations (Registration, Evaluation, 
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Authorization & Restriction of Chemicals), noticing shortcomings and limitations 
on the clarity of information relevant to nanomaterials. Regarding environmental 
legislation, it acknowledged that many issues still had to be addressed because 
of the significant knowledge gaps. The same report also identified three main 
types of nanomaterials, defined as: A) Commodity materials, such as carbon 
black or synthetic amorphous silica, which constitute more than 95% of market 
and have been extensively used for decades; B) Newly developed medium 
volume substances, including titanium dioxide and carbon nanotubes, which are 
under discussion for safety aspects; C) Newly developed low volume 
substances, most of which are used for technical applications (catalysts, 
batteries, solar cells etc.).  The overall message of this document centered on 
three main objectives: A) the need for more specific risk assessment 
procedures; B) the implementation of nanomaterial definition in an appropriate 
way; C) information-related provisions using REACH as main regulation tool. As 
a follow up for this review, the European Commission has considered the 
modification of some of the technical provisions in the REACH Annexes, with a 
public consultation held until 13 September 2013. Although no amendments 
have been made so far to the legal text of REACH to incorporate nanomaterials, 
the European Chemicals Agency (ECHA) has updated its guidance to include 
nanomaterials. ECHA has also set up a webpage aimed specifically at 
nanomaterials under REACH, and has updated the International Uniform 
Chemical Information Database (IUCLID) user manual "Nanomaterials in 
IUCLID 5" to include instructions on how registrants can report explicitly when a 
nanoform has been used for testing purposes [48, 49]. 
The U.S. Food and Drug Administration (FDA) regulates a wide range of 
products, including foods, cosmetics, drugs, devices, veterinary products, and 
tobacco products some of which may utilize nanotechnology or contain 
nanomaterials.  Consequently, a nanotechnology task force was formed in 
August 2006 to determine regulatory approaches to guarantee the development 
of safe and effective FDA-regulated nanotechnology products. As of 2014, the 
FDA issued one draft and three final guidance documents related to the use of 
nanotechnology in regulated products. These three guidance documents 
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consider A) the application of nanotechnology in FDA-regulated products; B) the 
safety of nanomaterials in cosmetic products; C) the assessment of the effects 
of significant manufacturing process changes, including emerging technologies 
[50]. The first two guidance documents provide an overview of nanomaterials’ 
assessment for industry applications. Guidance document A considers mainly 
the application of two specific points of view. The first is whether a material or 
end product is engineered to have at least one external dimension, or an 
internal or surface structure, in the nanoscale range (approximately 1 nm to 100 
nm), the second is whether a material or end product is engineered to exhibit 
properties, including physical or chemical properties or biological effects, that 
are attributable to its dimension(s), even if these dimensions fall outside the 
nanoscale range, up to one micrometer (1,000 nm). These considerations need 
to be applied not only to new products, but also to manufacturing processes of 
FDA-regulated products that may need to be altered by said technology. 
Guidance document B, on the other hand, considers the safety assessment of 
nanomaterials’ safety, physical and chemical properties, toxicology as well as 
ADME (absorption, distribution, metabolism and excretion) by addressing the 
routes of exposure, the uptake and absorption, and toxicity testing. It also 
considers distinctive properties and biological behavior for toxicity testing of 
cosmetic products containing nanomaterials [51, 52].   
Both these main legislations lack information regarding the pharmaceutical field, 
especially that of drug delivery. While nanomaterials are normally included in 
the chemicals’ legislation in the EU and mostly in the cosmetics assessment in 
the US, no specific regulations regarding their size-related effects have been 
considered, even though size is probably the most important in NMs behaviour, 
as it has direct influence on several other characteristics.  
Despite these regulation gaps, as of 2014 nanoformulations have been 
approved by the FDA, as shown in Table 1.2 [53, 54, 55]: 
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Table 1.2 FDA-approved nanoformulations in the last 15 years (modified from [53] Tinkle et al 
(2014)). 
Tradename Therapeutic agent Targeted disease Manufacturer FDA Approval Date 
PEGASYS® Peginterferon alfa-2a (polymer–protein conjugate) 
Hepatitis B and C Genentech 2002 
Neulasta® PEG-G-CSF or pegfilgrastim and monomethoxypolyethyleneglycol) (polymer–protein conjugate) 
Chemotherapy-associated neutropenia 
Amgen 2002 
Eligard® Leuprolide acetate and PLGH polymer formulation Advanced prostate cancer Sanofi 2002 
Somavert® Pegvisomant (PEG-hGH) (polymer–protein) Acromegaly Pfizer 2003 
Emend® Aprepitant nanocrystal particles Chemotherapy-related nausea and vomiting 
Merck 2003 
Alimta® Pemetrexed Non-squamous NSCLC, malignant pleural mesothelioma 
Lilly 2004 
Macugen® Pegaptanib (PEG-anti-VEGF aptamer) Wet age–related macular degeneration 
Eyetech 2004 
Tricor® Fenofibrate Hypercholesterolemia, mixed dyslipidemia, hypertriglyceridemia 
Abbott 2004 
Abraxane® Albumin protein-bound paclitaxel Metastatic breast cancer Calgene 2005 
Elestrin® Estradiol gel (0.06%) incorporating calcium phosphate nanoparticles 
Moderate to severe hot flashes in menopausal women 
Biosanté 2006 
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Mircera® Methoxy PEG-epoetin beta Symptomatic anemia associated with CKD 
Hoffman La Roche 2007 
Cimzia® Pegylated Fab′ fragment of a humanized anti–TNF-alpha antibody 
Crohn’s disease, rheumatoid arthritis UCB 2008 
Marqibo® Vincristine Philadelphia  chromosome-negative lymphoblastic leukemia 
Talon Therapeutics 2012 
 
1.3 Silica Nanomaterials 
1.3.1 Synthesis methods and characteristics 
Silica is the common name for materials composed of silicon dioxide (SiO2) and 
exists in different forms: crystalline and amorphous, porous and non-porous, 
anhydrous and hydroxylated. Quartz is the most common natural crystalline 
silica compound, but manufactured silica porous crystalline compounds are also 
available.  
Regarding the amorphous forms, silica glass represents the most famous 
natural type, but many manufactured forms are also available, having attracted 
interest for applications in a variety of industries.  As a bulk material, amorphous 
silica finds applications as additive to cosmetics, drugs, printer toners, 
varnishes, and food. As nanosized material, silica nanoparticles have been 
attracting interest for several biomedical applications (cancer therapy, DNA 
transfection, drug delivery, and enzyme immobilization) due to their 
biocompatibility, low toxicity and scalable synthetic availability. Their size, 
porosity, crystallinity and shape can be finely tuned for diverse applications; 
their surface can also be easily modified and controlled to achieve specific drug 
or chemical loading, as well as site-specific targeting. The possibility to combine 
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these properties makes silica nanoparticles a desirable platform for biomedical 
imaging, assaying, therapeutic delivery, monitoring and ablative therapies [56, 
57]. To meet the demand of these applications, several synthesis techniques 
have been developed; most of them exploit sol–gel processing at 25°C with 
careful control of the reactant to solvent ratios or the use of templates to control 
particles size. The main silica synthesis techniques are described in Table 1.3: 
 
Table 1.3 The different types of silica nanoparticles that can be obtained by reaction in 
aqueous solution (modified from [56] Napierska et al (2010)). 
Silica particle type Synthesis method 
Stöber/ Colloidal silica Prepared by controlled hydrolysis and 
condensation of tetraethylorthosilicate (TEOS) in 
ethanol with catalytic amounts of water and 
ammonia. This procedure can be used to obtain 
monodisperse spherical amorphous silica 
particles with tuneable size and porosity 
Silica gel Obtained by destabilisation of a silica sol, it’s an 
open 3-D network of aggregated sol particles. 
Precipitated silica Formed by destabilization and precipitation of a 
silica gel 
Mesoporous silica Obtained by a supramolecular assembly of silica 
around surfactant micelles, amphiphilic polymers 
such as triblock- copolymers or quaternary alkyl 
ammonium compounds. These organic 
supramolecular templates are evacuated from the 
mesopores by calcination, a controlled 
combustion process leading to oxidation and 
decomposition of the template molecules into 
small volatile products such as NOx, CO2 and 
H2O, which can leave the pores. 
 
The Stöber method was first developed in 1968, when Werner Stöber prepared 
silica particles in the range of 0.05–2 μm through the hydrolysis and 
condensation of alkyl silicates under alkaline conditions in alcoholic solutions 
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[58]. It continues to be a widely employed method for synthesizing silica 
nanoparticles, as it avoids the use of templates to form solid particles [59]. To 
synthetize Stöber silica, tetraethylorthosilicate (TEOS) or other silicates are 
combined in a water/alcohol/ammonia solution and agitated to form particles, 
whose size depends on the concentration of the solvents and silicate additives 
(Equation 1.1). 
1) ܵ݅ − (ܱܧݐ)ସ + ܪଶ0 ேுయሱۛሮ  ܵ݅(ܱܪ)ସ + 4ܧݐܱܪ 
2) ܵ݅(ܱܪ)ସ + 4ܧݐܱܪ ேுయሱۛሮ  2ܵ݅ − ܱ − ܵ݅ + 4ܪଶ0 
Equation 1.1 The two-step process (1) hydrolysis and (2) condensation to form colloidal silica. 
 
There have been many investigations of the kinetics and characterization of 
Stöber process generated particles in order to precisely control their size, 
shape, and uniformity. For example, Nozawa et al. (2005) studied the rate of 
addition of TEOS vs. the resulting size of synthesized particles [60]. The particle 
size decreased with an increase in the rate of addition of the TEOS, and 
precisely controlling the rate of addition produced uniform particles. Further 
experiments with Stöber type processes have demonstrated that controlling the 
ratio of solvent/TEOS permits fine control of particle size [61].  A completely 
different synthesis route of amorphous silica involves the use of silicon 
tetrachloride (SiCl4) in vapour phase. Silicon tetra- chloride is oxidized in a 
hydrogen flame at temperatures above 1000°C and polymerized into an 
amorphous non-porous nanopowder with very low bulk density and high specific 
surface area, typically 200 to 300 m2/g. This material is called pyrogenic or 
fumed silica, referring to the special synthesis conditions (Figure 1.9). 
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Figure 1.9 Schematics of the reaction used to obtain fumed silica. 
 
Both fumed and colloidal silica are produced in tonnage quantities, arguably 
making them the most abundant synthetic nanoparticles on Earth. 
 
1.3.2 Relationship between characteristics and toxicity 
Amorphous silica is generally considered ‘safe’ by the FDA, and amorphous 
silica nanoparticles are often used as negative controls in toxicity studies of 
nanocrystalline quartz. However, depending on the manufacturing process, 
amorphous silica has a wide range of physico-chemical properties that 
determine its industrial applications. These properties also determine silica 
interaction with and within cells, therefore even subtle differences can modulate 
the toxicity and modes of action, thus making the results difficult to interpret and 
compare. In the case of amorphous silica nanoparticles, establishing a reliable 
toxicological pathway is challenging. While crystalline silica is well-deﬁned 
structurally, amorphous silica lacks long-range order, with its structures strongly 
dependent on kinetic and environmental factors. These factors are manifested 
principally as diﬀerences in the siloxane framework architecture, which consists 
of combinations of closed siloxane rings, shown in Figure 1.10 [56, 62]. 
 
SiO2 + 4HCl 
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Figure 1.10 Siloxane rings that constitute the architecture of amorphous silica (modified from 
[62] Zhang et al. 2012). 
 
The diversity of possible structures and toxicological behaviours, in tandem with 
their unique physico-chemical properties, makes amorphous silica particles a 
target for toxicological studies, as to date knowledge about the potential hazard 
they represent for human health is still limited. Searching through the literature, 
it is clear that, until recent years, toxicological research into silica particles 
focused mainly on crystalline silica, especially natural forms such as quartz, 
cristobalite and tridymite, and the particulate matter generated through industrial 
exposure (sandblasting, ceramics, cement manufacture, construction). This 
trend is directly connected to silicosis and other detrimental respiratory effects 
that crystalline silica causes when inhaled in excessive amounts, causing lung 
inflammatory diseases, increased susceptibility to infection, as well as lung 
cancers. Silicosis, in particular, is a generally progressive fibrotic lung disease, 
exemplified by the development of nodules composed of silica particles 
surrounded by whorled collagen in concentric layers, with macrophages, 
lymphocytes, and fibroblasts in the periphery. As comparison, amorphous silica 
has been far less studied than the crystalline form; consequently, the 
mechanisms of amorphous silica toxicity at the cellular and molecular levels are 
still unclear. However, the growing abundance and industrial applications of 
nanotechnology has resulted in a recent shift of toxicological research towards 
amorphous silica nanoparticles [62, 63]. Following this new trend, different in 
vitro and in vivo studies on amorphous silica NPs have been published.  
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Relevant in vitro and in vivo studies are summarized in Table 1.4 and Table 1.5 
respectively. 
 
Table 1.4 Summary of relevant in vitro studies regarding silica particles. 
Research group Published study 
Rancan et al. (2012) [64] Investigated skin penetration and cellular uptake of 40-
200 nm amorphous silica particles with positive and 
negative surface charge. Partial particle aggregation 
was observed upon NPs transfer in physiological 
media, as well as size-dependent uptake inside 
HaCaT skin cells. Functionalization of the particle 
surface with positively charged groups enhanced in 
vitro cellular uptake as well as tendency of particles to 
form aggregates, leading to lower internalization 
ratios. 
Kato et al (2013) [65] Investigated the effect of amorphous silica particles of 
50, 100, and 200 nm on the Caco-2 intestinal cell line. 
Particles were incubated in fasted-state and fed-state 
gastric and intestinal fluids; size, intracellular transport, 
membrane permeability, and cytotoxicity were 
evaluated. Silica particles were shown to agglomerate 
in fed-state intestinal fluids, inhibiting particles 
absorption and transport; however, they did not 
observe any cytotoxicity when the average size was 
larger than 100 nm, independent of the fluid and the 
concentration. 
Park et al. (2013) [66] Negatively charged [NC] and weakly negatively 
charged [WNC] silica NPs of 20 nm and 100 nm size 
were used to investigate cytotoxicity and reactive 
oxygen species (ROS) generation on keratinocytes, as 
well as skin irritation and skin sensitization on HSEM 
(Human Skin Equivalent Model) and mouse skin. 
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Smaller size (20 nm) NC silica NPs proved to be more 
toxic than the larger size particle (100 nm). They also 
observed an effect of surface charge in cytotoxicity 
and ROS generation, by showing that the NC silica 
NPs (20 nm) were more toxic than the WNC silica NPs 
(20 nm), suggesting the importance of surface charge 
in silica NPs-induced toxicity. 
Kim et al. (2015) [67] Employed 20–200 nm monodisperse spherical silica 
nanoparticles to study size, dose, and cell-type 
dependent cytotoxicity in A549 human lung carcinoma 
cells, HepG2 human hepatocarcinoma cells and 
NIH/3T3 mouse embryo fibroblasts. Cytotoxicity were 
found to be size-, dose- and  cell type dependent; 60 
nm particles were preferentially endocytosed by cells 
and, at high doses, caused a disproportionate 
decrease in cell viability. 
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Table 1.5 Summary of relevant in vivo studies regarding silica particles. 
Research group Published study 
Yoshida et al. (2015) [68] Observed that in mice silica nanoparticles with sizes 
smaller than 100 nm were more likely to cause 
consumptive coagulopathy, pregnancy complications 
and immune-modulating effects in mice compared to 
silica particles with sizes larger than 100 nm. 
Consequently, they examined the relationship between 
the surface properties of 70 nm amorphous silica 
nanoparticles with and without amino surface 
modification and their interactions with proteins in 
biological fluids as well as their toxicity by mice 
intravenous administration of 2 mg/mouse for up to 24 
hours. They concluded that surface modification with 
amino groups prevented toxicity compared to the non-
modified particles, as no effect could be detected by 
assays of platelet counting, clotting time assessment 
and activated partial thromboplastin Time (APTT) in 
mice. 
Kim et al. (2015) [69] Investigated the potential toxicity and the No Observed 
Adverse Effect Level (NOAEL) and target organ(s) of 
negatively charged 20-100 nm colloidal silica particles 
after 90 day-oral administration in rats at 500 mg/kg, 
1,000 mg/kg and 2,000 mg/kg. Up to the highest tested 
concentration, no animal deaths were observed, and no 
treatment-related clinical changes or histopathological 
findings were observed in any of the experimental 
groups. Moreover, no difference in toxic effects from 
chronic exposure to 20 or 100 nm silica NPs was 
observed, indicating that the NOAEL would most likely 
be 2,000 mg/kg without any identifiable target organ in 
rats of either sex. 
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Despite these various in vitro and in vivo nanotoxicity studies in the assessment 
of silica particles toxic effects, there is still a substantial lack of available 
investigations, as well as a full understanding of the cellular and molecular toxic 
property of these particle, prompting more work to be done on the matter. 
 
1.4 Skin – A Major Target of Nanomaterials 
1.4.1 Structure and function 
Skin is the largest organ of the human body, and can be described as a 
complex, inhomogeneous laminate composite material that is often subjected to 
large deformations. Skin is organized in three different layers, as illustrated in 
Figure 1.11. The most external one is the epidermis, which serves as a barrier 
between the external environment and the internal parts of the human body. 
Under the epidermis is located the dermis, which confers flexibility and is 
responsible for skin’s mechanical behaviour. The inner layer is the hypodermis, 
which acts as an energy reserve and has a role in skin plasticity [70, 71]. 
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Figure 1.11 Drawing of the skin tissue and main components of cells. At the bottom is the 
hypodermis, consisting of adipose cells; the next layer up is the dermis, consisting of fibroblasts; 
at the top is the epidermis consisting of viable and nonviable keratinocytes and melanocyte 
(from [70] Brohem et al. 2011). 
 
Each skin layer has diversified functions mediated by different types of cells. 
Epidermis is formed mainly by keratinocytes, organized in multiple layers. 
These cells are generated from the stratum basale, the innermost part of 
epidermis, and move upwards through the different strata while enduring 
defined stages of differentiation. They will eventually fully differentiate into 
keratinocytes and die on the outermost layer of the epidermis, the stratum 
corneum [70], which is mainly responsible for the barrier function of the skin. 
Epidermis also contains other types of cells, namely: melanocytes, which confer 
skin its pigmentation by transferring melanin to the keratinocytes in the final 
sublayer of the stratum lucidum; Merkel cells, which are thought to play a 
sensory role [72, 73]; Langerhans cells, which play an important role in the skin 
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immune response [74, 75]. Between the epidermis and the underlying dermis 
lies the basement membrane, formed by collagen IV, glycosamminoglycans and 
proteoglycans. The basement membrane has three primary functions:  
 it anchors the two layers to each other;  
 it controls molecules’ traffic in both directions;  
 it is able to bind numerous cytokines and growth factors [76]. 
The dermis, located under the basement membrane, is formed by collagenous 
materials, such as elastin fibres, fibronectin and hyaluronic acid, all known as 
the ECM (extracellular matrix), mixed together with dermal fibroblasts (which 
are responsible for the production of the ECM), immune system cells, nerve 
endings, hair follicles, blood vessels and endothelial cells [77, 78]. Associated 
with the dermis and the epidermis are skin appendages, serving different 
functions. The sweat glands regulate body temperature by secreting sweat on 
the skin surface, while the sebaceous glands keep skin and hair moisturized by 
secreting sebum; hair follicles are important in re-epithelialization during wound 
healing, nails protect the distal phalanx and the fingertips [79]. Figure 1.11 
represents only a schematic overview of skin structure. In reality, the three 
layers are connected to each other by complex interactions between individual 
cells with the neighbour cells and the ECM. The connections between layers of 
the skin can be maintained partially by different mechanical forces applied to 
the epidermis, which are transmitted to the dermis through the basement 
membrane [70, 71]. 
 
1.4.2 The stratum corneum, its composition and barrier function 
As said before, the skin permeation barrier is localized in the outermost layer of 
epidermis, the stratum corneum (SC). It was not too long ago that the SC was 
considered just a ‘graveyard of insoluble keratin fibrils’, a lifeless skeleton of 
what were previously keratinocytes that had completed the upward journey 
through the layers of the epidermis prior to their shedding by desquamation. 
Only the ability to harvest the SC intact and separate it from the rest of 
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epidermis led to the belief that it was a wrap-like film structure important for 
barrier function.  The subsequent investigations based on this principle helped 
the progressive recognition of the many physiological functions that occur in this 
particular layer [77]. 
The SC is made up of a collection of cellular-like structures, with an individual 
structure being named corneocyte, which originates during the upward 
migration of a keratinocyte. A stepwise sequence of active biological processes 
occurs that involves synthesis and activation of specific structural proteins, 
lipids and enzymes, and formation of structures all of which impact directly upon 
SC health and functional integrity [77]. The real differentiation process begins in 
the stratum granulosum, where keratinocytes become flattened and gradually 
differentiate into corneocytes. Corneocytes contain certain types of organelles, 
namely keratohyalin granules, which stock proflaggarin, and lamellar bodies 
(LBs), which transport precursor lipids, protease enzymes, and cAMP. These 
organelles undergo lysozomial degradation, and the lipid precursors in the LBs, 
shown in Table 1.6, are released in the lipid phase of the SC by exocytosis and 
subsequently transformed into fatty acids, cholesterol and ceramides, which will 
form a bilayer that will comprise the intercellular lipid membrane [77]. 
 
Table 1.6 Lipid conversion in the stratum corneum. The table summarizes the precursor lipids 
present in the lamellar bodies, which undergo lysozomial degradation, thus freeing the 
precursors in the lipid phase of the SC. From there, they are enzymatically converted in 
ceramides, fatty acids and cholesterol (edited from [77] Del Rosso et al. 2011). 
Precursor Lipid Enzymatic Conversion Final Stratum Corneum 
Lipid 
Glucosylceramide Β-glucosylcerebrosidase Ceramides 
Phospholipid Phospholipase Fatty Acids 
Cholesterol Sulfate Steroid Sulfatase Cholesterol 
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These three types of lipids are really important, because their properties are 
directly related to the stratum corneum barrier function. Ceramides are the most 
abundant class, and are structurally heterogeneous, as shown in Figure 1.12. 
Ceramide 1 consists of 30- to 34-carbon ω-hydroxyacids amide-linked to 
sphingosine bases with linoleic acid ester-linked to the ω-hydroxyl group; 
Ceramide 2 consists of long, mostly 24-, 26- and 28-carbon, normal fatty acids 
amide-linked to sphingosine and dihydrosphingosine bases; Ceramide 3 
contains the same long-chain normal fatty acids, but they are linked to 
phytosphingosine bases. Ceramides 4 and 5 both contain α-hydroxyacids 
amide linked to sphingosines and dihydrosphingosines; the main difference is 
that Ceramide 4 contains predominantly 24- through 28-carbon hydroxyacids, 
whereas Ceramide 5 contains predominantly α-hydroxypalmitic acid [78]. 
 
 
Figure 1.12 The structure of ceramides, fatty acids and cholesterol (modified from [78] Lee et 
al. 2006). 
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Fatty acids are almost entirely saturated, straight-chained and longer than 18 
carbons, with the most abundant ones being 22-24 carbon length. Together with 
ceramides, they confer the stratum corneum its rigidity [79, 80]. To plasticize 
these otherwise rigid membranes, cholesterol plays a fundamental role, as it 
can increase or decrease fluidity, based on its proportion and the nature of the 
other components.  Figure 1.13 displays a schematic distribution of ceramides, 
fatty acids and cholesterol inside the stratum corneum. 
 
 
Figure 1.13 Major SC lipid content by weight. Ceramides are the most abundant lipids, being 
approximately 40-50% of total, followed by cholesterol and fatty acids. 
 
During the differentiation process, inside the corneocytes proflaggarin is 
converted into the protein flaggarin, which subsequently migrates at the 
periphery of the corneocyte and intermingles with keratin filaments to form 
filament-matrix complex.  This matrix is cross-linked by the action of calcium-
dependent transglutaminases to: a) the extracellular cornified envelope (CE), a 
15-20 nm thick structure composed of structural proteins and a covalently 
bound lipid monolayer made of long-chain ceramides, that provides external 
protection for the corneocytes;  b) the corneodesmosomes , formed by proteins, 
especially desmocollins and desmoglein, that anchor the corneocytes within the 
stratum corneum and that are directly related to the desquamation process. The 
whole differentiation process is schematized in Figure 1.14. 
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Figure 1.14 Steps in the formation of the stratum corneum. Starting from the stratum basale, 
keratinocytes undergo a stepwise differentiation process that ends with corneocyte 
desquamation on the stratum corneum. (Skin Image from 
http://php.med.unsw.edu.au/embryology/index.php?title=File:Adult_epidermis_histology_01.jpg) 
 
The process described above can be viewed as a ‘bricks and mortar’ model, 
where the flattened corneocytes represent the bricks, while the lamellar lipid 
membrane represents the mortar between the bricks [77].  
In addition to the permeability barrier function, it is important to remember that 
the stratum corneum also plays fundamental roles in other critical functions 
such as antimicrobial defence, hydration of viable epidermis, UV defence, 
antioxidant defence and the formation of a mechanical barrier, as shown in 
Figure 1.15 [78]. Due to structural heterogeneity, both corneocytes and the lipid 
membranes contribute to the defence functions. Extracellular lipids usually act 
as permeability, antioxidant and microbial barrier, while corneocytes act as UV 
and mechanical barriers [78].  Despite this division, all of these functions are 
 36 
closely interrelated, so if there’s any change in one, all the others could undergo 
some modifications as well. 
 
 
Figure 1.15 The bricks and mortar model with the various functions of the SC (modified from 
[78] Lee et al. 2006). 
 
As skin is the major site for NMs exposure, in vitro and in vivo skin models have 
been used to assess NPs toxicity. In vitro models include classic 2D cell culture, 
ex vivo tissues and 3D culture, while in vivo refers to the use of animal models. 
Each of these techniques have their own advantages and disadvantages, 
therefore must be chosen carefully depending on the intended study purpose. 
2D cell culture, also known as monolayer culture, is conventionally used for 
drug testing; it consists of cell lines grown on a flat surface in medium 
supplemented with growth stimulating compounds. 2D culture is a well-
established method that has been in use since the beginning of the 20th century. 
It also has limitations, such as lack of cell–cell and cell–extracellular matrix 
(ECM) signalling that occurs in the in vivo environment [81]. Ex vivo tissues 
consist of excised specimens of animal and human skins. Such models have 
been widely used to test drug permeation in the skin. Despite being full 
thickness skin, they have their own limitations, as animal ex vivo tissues present 
difference compared with human ex vivo tissues; nude mouse skin, for 
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example, is too leaky to be a reliable substitute of the human skin. Even human 
ex vivo tissues can cause practical problems, especially in terms of availability, 
variability and quality. Furthermore, the excised pieces of human skin represent 
dead tissue that is not suitable for toxicity evaluation of drug delivery systems 
[82].  3D models of skin epidermis are a promising alternative to the animal 
experiments and ex vivo human skin samples. Unlike excised skin samples, the 
cell models are viable and they can be used to study specific biological 
responses to the treatments [82]. However, most of the currently commercially 
available skin equivalents are based on static culture systems emulating human 
epidermis only, or combining epidermis and dermis in full-thickness skin 
equivalents. None of the existing systems comprises functional and 
physiologically important elements, such as an immune system, vasculature or 
skin appendices. Such incorporation needs to be implemented in an appropriate 
culture system with a constant oxygen and nutrient supply and with controlled 
levels of toxic metabolites [83]. Because of their complexity, long periods of time 
are necessary for full model growth; such models may also present practical 
difficulties when the intended use is the toxicological assessment of particle 
behavior, as using assays such as MTT or LDH might prove challenging. In vivo 
models remains the best in terms of complexity compared to the human body, 
but ethical and practical reasons call for the constant diminishment on the use 
of such models. Despite their advantages and disadvantages, all these models 
are of major importance in several fields of study, including nanomaterials 
testing.  
Murray et al. (2013)  [84] for example, used human epidermal keratinocytes 
(HEK) and murine epidermal cells (JB6 P+) for in vitro testing of dextran-coated 
super-magnetic iron oxide nanoparticles (SPIONs) of different sizes (15–50 nm) 
and manufacturers in relation to their cytotoxicity and internalization. By using 
this method, they found that HEK cells exposed to 20 nm particles resulted in a 
decrease of viability, while the 15 and 50 nm particles were not cytotoxic. They 
also showed that HEK cells were capable of internalizing the 15 and 20 nm but 
not 50 nm. Cohen et al. (2013) [85] used skin explants cultivated on 
polycarbonate slides to assess the biological effects of topically applied copper 
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oxide (CuO) nanoparticles by assays of light and electron microscopy, as well 
as biochemical tests including MTT, ELISA and caspase 3 assays. With this 
method, they showed that nanoparticles were more toxic than micro sized 
particles, and their effects were stronger when supplied in growth medium than 
in topical application. They also found that topically applied CuO nanoparticles 
induced inflammatory cytokine secretion and necrosis, especially in epidermis 
deprived of its protective cornea. Choi et al. (2014) [86] used the commercially 
available 3D human skin model KeraSkinTM to assess skin corrosion and 
irritation upon treatment with zinc and titanium oxide nanoparticles by assay of 
cytotoxicity and cytokine release. They found no decrease of viability after 
exposure to nanomaterial for pre-determined threshold level, which was 15% 
after 60 minutes exposure in corrosion test and 50% after 45 minutes exposure 
in the irritation test. Korani et al. (2013) [87] used guinea pigs to determine the 
morphological changes and pathological abnormalities on the tissues following 
dermal treatment with silver nanoparticles (AgNPs). They showed a close 
correlation between dermal exposure and tissue levels of Ag NPs; they also 
demonstrated that tissue uptakes happened in dose dependent manner with 
ranking kidney>muscle>bone>skin>liver>heart >spleen. 
 
1.4.3 Basic principles of in vitro tissue culture 
Tissue culture was first established in the last years of XIX century, when 
Wilhelm Roux, a German zoologist working in Innsbruck (Austria), first removed 
a section of the medullary plate of an embryonic chicken and maintained it in a 
warm saline solution for several days [88]. From there, tissue and cell culture 
has matured from a simple and microscope-driven observational science to an 
indispensable technology in many branches of the life sciences, with roots set 
deep in both industry and academia. They provide the basis for studying the 
regulation of cell proliferation, differentiation and product formation in carefully 
controlled conditions. They have also provided the means to define almost the 
entire human genome, and to dissect the pathways of intracellular and 
intercellular signalling [89].  
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Originally, tissue culture was regarded as the culture of whole fragments of 
explanted tissue, which was considered to maintain at least part of its 
histological integrity. Now the term includes organ culture as well, but also, and 
most importantly, cell culture, where tissue is dispersed mechanically or 
enzymatically and the resulting cells are propagated as a suspension or 
attached monolayer [56]. Literally thousands of different cell lines have been 
derived from human tissues. Many of these originate from normal tissues and 
exhibit a definable, limited doubling potential; others may be propagated 
continuously, either having gone through an engineered or spontaneous genetic 
change, or having been developed from tumour tissue [90]. 
Cell cultures have lost their histotypic architecture, and often the associated 
biochemical properties; consequently, they are not only devoid of structural 
organisation, but also do not reach a steady state unless specific conditions are 
achieved. These specific conditions mainly involve: 
 Substratum: a surface where cells can attach and spread; the type used 
depends on the cell type, with optically clear negatively charged 
polystyrene being the one almost universally used by research labs. 
 
 Medium: represents the diffuse environment, and is often chosen 
empirically, especially for primary cell lines. 
Culture medium comprises all types of soluble molecules - nutrients and salts, 
hormones and growth factors; it must supply all essential nutrients for cell 
metabolism, proliferation and growth [91]. These include 1) biosynthetic 
precursors for cell anabolism, 2) catabolic substrates for energy metabolism, 3) 
vitamins and trace elements for catalytic function, 4) electrolytes for catalytic 
and physiological functions. An example of such catalytic and physiological 
functions is the maintenance of pH and osmolarity within acceptable limits. In 
addition to those components, animal serum, such as Foetal Bovine Serum 
(FBS) is frequently added. FBS and related sera, in general, are an extremely 
complex mixture of low and high molecular weight biomolecules with different, 
physiologically balanced growth-promoting and growth-inhibiting activities. The 
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main components and major functions of FBS in culture media are summarized 
in Table 1.7: 
 
Table 1.7 Main components and properties of FBS (modified from [91] Gstraunthaler et al., 
2003). 
Main Components Biological functions 
Albumin Providing hormonal factors 
stimulating cell growth and 
proliferation Cholesterol 
Cortisone Providing stabilizing and 
detoxifying agents to 
maintain pH and inhibit 
proteases 
Glucose 
Haemoglobin Transport proteins 
Thyroxine, trijodo-thyronine Providing attachment and 
spreading factor 
 
FBS has become the standard supplement of cell culture media; in most cases, 
it is used at concentrations of 10% (v/v), although this may vary for specific 
applications. 
 
1.4.4 Interaction of culture medium and biological fluids with nanomaterials 
When NMs enter a biological fluid, for example blood, proteins and other 
biomolecules rapidly compete for binding to the NMs surface, leading to a 
formation of a dynamic protein layer, called protein corona (PC). This layer 
critically defines the biological identity of the particle, as cells interact with the 
entire nanoparticle–protein corona complexes rather than with the bare entity of 
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nanoparticle (Figure 1.16). Protein coronas have been experimentally identified 
and characterised using a range of techniques, which include polyacrylamide 
gel electrophoresis (SDS-PAGE), tandem liquid chromatography-mass 
spectrometry (LC-MS/MS), proteomics, differential centrifugal sedimentation 
and Western blotting. These research efforts have revealed differential aﬃnity 
or binding strength of each protein member of the plasma, serum or other body 
fluids onto specific type of nanoparticle surface, leading to the formation of 
‘hard’ and ‘soft’ corona proteins. From these studies, it is believed that within 
the first seconds or minutes after immersion of NPs into biological fluids a soft 
protein corona is formed. This corona dynamically evolves over time due to the 
Vroman effect [92]: mobile and abundant proteins first interact with the surface 
of the particle, but over time they are replaced with less mobile proteins that 
have a higher affinity for the surface and subsequently evolve into a hard PC. 
That may consequently change the NPs properties, affecting biological 
responses and NPs bio-distribution [92, 93, 94]. 
 
 
Figure 1.16 The principle behind protein corona formation (Modified from [88] Aggarwal et al., 
2009). 
 
Not surprisingly, protein corona has been found not only to change its 
composition, but also its physical character over time, being loosely bound at 
first and gradually transitioning into a more tightly bound protein layer over the 
course of several days. Changes in composition are influenced by NPs 
properties such as size, hydrophobicity, charge and surface chemistry, as 
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reported in Table 1.8. The composition of the protein corona has been studied 
in an attempt to elucidate its role in governing NP interactions with, and their 
biological impact on mammalian cells.  
 
Table 1.8 Major effect of NPs properties on corona formation (from [95] Aggarwal et al. 2009). 
NPs Properties that 
influence protein binding 
Effect 
Surface Charge Neutral particles have slower 
opsonisation than charged 
particles 
Hydrophobicity Hydrophobic particles are 
opsonised more quickly than 
hydrophilic particles 
Size Influences the amount of 
bound proteins 
 
The majority of studies examining the influence of protein binding on uptake 
have been conducted either by pre-incubating particles with bulk serum/plasma, 
or by pre-incubating particles with individual proteins or attaching individual 
proteins to the surface of the particles, and by evaluating uptake by 
macrophages. This research has showed that neutrally charged particles have 
a distinctively slower opsonization rate than charged particles, demonstrating a 
direct correlation between surface charge and protein binding [95]. Formation of 
the protein corona on NPs in mammalian growth media also leads to changes in 
hydrodynamic diameter and zeta potential. Lundqvist et al. analyzed the protein 
corona composition on polystyrene (PS) NPs incubated in human serum for one 
hour, and found that the native size and surface chemistry of NPs affected the 
nature of the resulting corona. A detailed analysis of the protein corona 
composition is necessary for evaluating changes in surface properties and the 
putative presence of opsonization candidates that could affect NPs uptake and 
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toxicity in mammalian cells [93]. Mortensen et al. (2013) [93] results indicate 
that in vitro each protein corona comprised more than 30 detectable proteins 
confirming the complex and dynamic nature of the NPs protein corona, and 
illustrating that the original surface chemistry of the NPs composition 
significantly impacts the resulting protein corona. 
Aggarwal et al. (2009) [95] reported that in current preclinical testing of 
pharmaceutical molecules, evaluation of plasma protein binding is recognized 
as an important element in an assessment of drug efficacy, safety, and 
disposition, as well as pharmacokinetics and pharmacodynamics of the drug 
inside the body. The composition of the protein corona on a given particle, at a 
given time, depends on the concentrations and kinetic properties of the proteins 
found in plasma. Therefore, it is important to not only determine which proteins 
are adsorbed onto the surface of the nanoparticle, but also understand the 
binding affinities and stoichiometry. They reported that kinetic studies on solid 
lipid nanoparticles (SLNs) showed that initial protein binding was predominated 
by albumin, replaced over time by fibrinogen, which was then replaced by IHRP 
(inter-α- trypsin inhibitor family heavy chain-related protein) and apolipoproteins. 
They have also reported that with increasing plasma concentrations, the 
amount of fibrinogen on the SLNs surface decreased while the amount of 
apolipoproteins steadily increased. At high concentrations of plasma, fibrinogen 
can be displaced within seconds, if not fractions of a second, by 
apolipoproteins.  
Just as the properties of a nanoparticle influence the protein binding profile, the 
binding profile influences biodistribution, as it can cause, for example, a change 
in nanoparticle size and surface charge. These changes affect the 
internalization process of these nanoparticles into macrophages and the overall 
distribution throughout the body [95]. The presence of protein corona affects 
cellular responses toward the particles in a complex manner. Aggarwal et al. 
(2009) [95] reported that binding of opsonins such as IgG, complement factors, 
and fibrinogen are said to promote phagocytosis and the eventual removal of 
the particles from systemic circulation via cells of the RES, whereas 
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dysopsonins such as albumin are said to promote prolonged circulation times in 
the blood. Lesniak et al. (2012) [96] used 50 nm SiO2 NPs to observe how the 
absence and presence of preformed protein corona change their biological fate. 
To do so, they used NPs in the presence and absence of serum to perform cell 
uptake studies.  ‘Bare’ NPs were internalised at higher extent by human cells 
and more strongly adhered to the cell membrane compared to those with 
presence of pre-formed corona. ‘Bare’ NPs were found engulfed in vesicles and 
lysosomes, and also as free particles in the cytosol and as aggregates in the 
proximity of the plasma membrane. The particles with pre-formed corona on the 
other hand, were enclosed in vesicles along the endolysosomal pathway. The 
work further revealed that the protein identity of the corona is determined by the 
environment in which the NPs were found. Investigations of the post-cell 
exposure protein corona of the recovered particles revealed a very different 
protein composition. For the NPs exposed to cells in the serum-containing 
medium (presence of pre-formed corona), the major members of the corona 
were the serum proteins immunoglobulins, complement proteins and 
apolipoproteins, while in the serum-free medium (‘bare’ NPs) the most abundant 
proteins were cytosolic proteins, components of cytoskeleton and membrane-
associated proteins. The protein composition of the corona governs the 
nanoparticle - cell interactions and in turn, the biological fates and potential in 
vivo roles of the particles. Adsorption of a particular protein identity in relatively 
high abundance on the particle surface could trigger key biological processes in 
the forms of cell uptake, activation of unique cellular signalling pathways as well 
as scavenging of biomolecules. Kinetics of nanoparticle – protein association 
and dissociation, along with the simultaneous exchange of the bound proteins 
with ‘free’ proteins in the surrounding fluid, may also influence the nanoparticle 
interactions with biological surfaces and receptors. In unique cases, proteins 
can undergo conformational and/ or orientation changes upon particle binding, 
which could result in the presentation of a new epitope, thus modifying the 
biological functions of the nanoparticles and in a number of circumstances lead 
to disease pathogenesis [92]. 
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1.5 Conclusions 
As described in this literature review, there has been a great development in 
NMs applications and toxicity assessment over the last few years. Despite 
these advancements, more research is needed to further understand the 
relation between nanomaterials characteristics in biological media and toxicity 
upon contact with cells, tissues and organs. To achieve such knowledge, the 
study of molecular mechanisms of uptake and toxicity, the improvement of in 
vitro models, as well as studying the toxicity in relation to the NMs 
characteristics will be fundamental in the next few years. Providing further 
evidence supporting in vivo studies will also contribute to fill the gaps in 
nanomaterials’ regulation, thus leading to even better development on safe 
nanoformulations. 
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2 AIMS AND OBJECTIVES 
2.1 Aims 
This project is part of NANODRUG, a research consortium funded by the 
European Commission, Marie Curie Actions, Seventh Framework Programme, 
Initial Training Network (grant agreement number: 289454). The scientific aim of 
the NANODRUG consortium was to develop and characterize a selected set of 
nanomaterials and to study their suitability as drug delivery systems targeting 
inflammatory skin diseases. As part of the NANODRUG consortium, the main 
aim of this project was the toxicity assessment of nanoparticles in relation to 
their physico-chemical properties, with focus on fumed and colloidal amorphous 
silica particles because of their unique physical and chemical properties and 
potential application as carrier for drug delivery through topical route. 
 
2.1.1 Research hypothesis 
Size and characteristics influence nanoparticles and submicroparticles toxic 
potential. 
 
2.2 Objectives 
2.2.1 Objective 1: Characterization of silica particles behaviour in cell culture medium 
The availability of studies focusing on amorphous silica is still limited, due to the 
variable synthesis methods used by different laboratories as well as their 
mouldable physical and chemical properties. For this study, amorphous fumed 
and colloidal silica nanoparticles of different size were sourced from commercial 
suppliers without further treatment and characterized, in order to make the 
results more reproducible and easy for comparison across different laboratories. 
Because all nanomaterials interact with biomolecules in biological fluids upon 
contact with them, undergoing changes in their surface structure as well as their 
biological interaction, in vitro study of interaction between silica particles and 
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biomolecules was investigated. Silica particles were tested in different media 
used for culturing of different cells in order to gain information regarding media 
composition effect on particle behaviour, focusing on the effect of Foetal Bovine 
Serum (FBS) as this is widely used in cell culture in vitro. Further information 
was also gathered regarding particle shape and stability in biological media. 
The results obtained were assessed for relationship between characteristics 
and toxicity of the silica particles. 
 
2.2.2 Objective 2: Toxicological assessment of silica particles in vitro in human skin cells 
As the focus for the use of silica nanoparticles in this project is for drug delivery 
through topical application, particle behaviour upon contact with skin cells was 
investigated in vitro by toxicological assessment of fumed and colloidal silica 
particles on four different types of human skin cells: HaCaT and K17 
keratinocytes, BJ fibroblasts and Human Dermal Fibroblasts (HDF). Multi-
parameter assays were performed on each cell type to establish the toxicity 
potential of the silica particles in relation to their size, dose and the sensitivity of 
different cell types. 
 
2.2.3 Objective 3: Delineation of toxicity mechanisms in relation to silica particle size 
Because of its variable structure, establishing a reliable toxicity pathway for 
amorphous silica has proven to be challenging. The assessment of silica toxicity 
via multi-assays proved necessary in delineate the mechanisms of cell-type, 
particle size- and dose-dependent toxicity. These assays included cell viability, 
cell membrane damage, morphology changes, cellular uptake and induction of 
apoptosis, and cell death gene expression. 
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2.2.4 Objective 4: Assessment of the effect of serum on silica particle behaviour in cell culture medium and toxicity potential 
As introduced before, animal serum, such as Foetal Bovine Serum (FBS) is 
frequently added to cell culture media in in vitro cell culture to mimic in vivo 
conditions. As in in vivo conditions any type of nanoscale material that enters in 
contact with biological fluids is quickly enveloped in biomolecules competing for 
binding on the nanomaterial surface, in in vitro conditions a similar effect occurs 
for nanomaterials dispersed in serum-rich culture media. The adsorption of such 
biomolecules on the surface of nanomaterials can alter their surface reactivity, 
thus influencing their size, stability in suspension and, most importantly, their 
interaction with cells. Consequently, in this study the effect of FBS on silica 
particle behaviour in cell culture media and on their toxicity potential upon 
treatment of skin cell lines has been investigated. 
 
2.2.5 Collaboration with partners to achieve the overall objectives of the NANODRUG consortium  
The NANODRUG consortium brings together six academic groups and two 
industrial teams as full partners, distributed over a total of six European Union 
member states. The consortium brings together groups with a very 
interdisciplinary expertise ranging from polymer synthesis and characterisation, 
computational modelling and physicochemical characterisation of materials to 
bioavailability, nanoparticles formulation, drug distribution and nanotoxicity, 
genetics, drug delivery and clinical dermatology. As part of researcher 
development, collaborations with consortium and external partners were one of 
the most important overall objectives of the programme, as a means to develop 
awareness of value of working together to benefit research and to maximise the 
potential for impact (i.e. publications). 
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2.3 Research Approach 
The research approach taken for implementing the aims and objectives of the 
project is illustrated in Figure 2.1. 
 
 
Figure 2.1 An overview of the research approach used in this study. 
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3 MATERIALS AND METHODS 
3.1 Materials 
In this section, a list of the materials used in this study is provided for further 
reference. Each table summarises a specific materials category: nanomaterials, 
cell lines and related media/supplements, cell-based assay reagents. Table 3.1 
reports amorphous and colloidal silica particles purchased and used for this 
study. 
 
Table 3.1 Nanomaterials used in this study. 
Material name Supplier Catalogue Number 
SiNP7 (amorphous) Sigma Aldrich S5130 
SiNP14 (amorphous) Sigma Aldrich S5505 
SiNP20 (colloidal) Sigma Aldrich 420875 
SiNP70 (colloidal) Postnova Analytics Z-PS-SIL-GFP-0,07 
SMP200 (colloidal) Postnova Analytics Z-PS-SIL-GFP-0,2 
SMP500 (colloidal) Postnova Analytics Z-PS-SIL-GFP-0,5 
 
Table 3.2, on the other hand, reports all the information regarding the cell lines 
used for the cell-based experiments, including the media and the supplements 
used for cell growth. 
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Table 3.2 Cell lines, media and supplements. 
Material name Supplier Catalogue Number 
HaCaT cells CLS (Germany) CLS 300493 
BJ Fibroblasts ATCC (American Type 
Culture Collection) 
BJ (ATCC® CRL-2522™) 
HDF (Human Dermal 
Fibroblasts) 
Gibco® C-013-5C 
K17 Queen Mary University  N/A 
Phosphate Buffered Saline Sigma Aldrich P4417-100TAB 
DMEM/F-12 medium Gibco® 31330-038 
Medium 106 (for HDF) Gibco ® M-106-500 
EpiLife™ Medium (for K17) Gibco® M-EPI-500-CA 
Fetal Bovine Serum  Gibco® VX10108165 
LSGS (supplement for Medium 
106) 
Gibco ® S-003-10 
HKGS (supplement for EpiLife 
Medium) 
Gibco ® S-001-5 
Penicillin/Streptomycin 
100UI/ml 
Gibco® 15070-063 
Trypsin/EDTA 10X Gibco® 15400-054 
Trypsin-EDTA 0.05% Gibco ® 25300-054 
Trypsin Neutralizer Solution 
(TNS) 
Gibco® R-002-100 
 
Table 3.3 reports the reagents used for the cell-based assays, such as cell 
viability, membrane damage, apoptotic cell death and fluorescent staining, as 
well as those used for molecular biology experiments. 
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Table 3.3 Cell-based and molecular biology assay reagents. 
Material name Supplier Catalogue Number 
MTT reagent (3-(4,5-
dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide) 
Sigma Aldrich M2128-500MG 
Dimethyl Sulfoxide Sigma Aldrich D5879-500ML 
LDH assay kit Sigma Aldrich TOX7-1KT 
Annexin V/FITC conjugate Gibco® APOAF-50TST 
Propidium Iodide Sigma Aldrich P4170-10MG 
RNeasy Mini Kit QIAGEN 74104 
QIAshredder QIAGEN 79654 
RT2 First Strand Kit (12) QIAGEN 330401 
RT² SYBR Green ROX FAST 
Mastermix (12) 
QIAGEN 330622 
RT² Profiler™ PCR Array QIAGEN   PAHS-212Z 
PFA Stock Solution (10 ml, 
16% in water) 
Alfa-Aesar  43368 
Draq7TM CST  #7406 
Hoechst 33342 Invitrogen  H3570 
ActinRedTM 555 Invitrogen  R37112 
Vybrant AlexaFluor 594 Lipid 
Raft Labelling Kit 
Invitrogen  V34405 
Cell Proliferation Reagent 
(WST-1) 
Roche  11-644-807-001 
Apo-ONE Homogeneous 
Caspase 3-7 Assay 
Promega  G7792 
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3.2 Characterization of Nanoparticles 
Due to the importance and relevance of NMs characteristics in biological 
studies, they need to be subjected to physico-chemical characterization. 
Several techniques have been developed in order to analyze particle shape and 
size as well as size distribution and stability in solution. The most commonly 
used techniques include Dynamic Light Scattering (DLS), Zeta-Potential (ZP) 
and Electron Microscopy (EM) [97]. DLS is the most widespread light scattering 
technique, performing nano-scale characterization by analyzing patterns 
resulting from light scattered by particles moving under Brownian motion. ZP 
measures the relation between charge and flocculation for particles in a 
solution.  EM, on the other hand, offers high resolution images of the particles 
within a sample, gathering information on both size and morphology [97, 98]. 
All these techniques have limitations and disadvantages: DLS has limited 
capability to analyze particles in polydisperse or heterogeneous systems; ZP 
results tend to be biased towards larger, higher scattering particles; EM requires 
time-consuming sample preparation. Consequently, in order for the data to be 
validated, these techniques should be used together when characterizing 
nanoparticles. 
 
3.2.1 Dynamic light scattering (DLS) 
Dynamic Light Scattering (DLS) has been a well-established method for the last 
40 years. In monodispersed systems, it measures Brownian motion and relates 
it to the size of particles in a sample suspension. Brownian motion can be 
defined as the random motion of particles suspended in a fluid resulting from 
their collision with the quick-moving atoms and molecules in the gas or liquid 
which constitutes the sample fluid.  Brownian motion is fundamental for DLS 
analysis because it allows the use of the Stokes-Einstein equation (Equation 
3.1), which relates the velocity of a particle in solution to its hydrodynamic 
radius.  
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ܦ =  ݇ܶ6ߨߟߙ 
 D:  Diffusion velocity 
 k:  Boltzmann constant 
 T: Temperature 
 η:  Viscosity 
 α: Hydrodynamic radius 
Equation 3.1 The Stokes-Einstein equation. 
 
The diffusion velocity in the Stokes-Einstein relation is inversely proportional to 
the radius of the particle; the random movement of the particles and the related 
movement speed are used to determine particle size. Larger particles move 
slower than smaller particles, therefore minimal movement and particle 
positions should be very similar. For smaller particles, on the other hand, the 
amount of movement and particle positions are very variable. Through analysis 
of the resultant exponential correlation function, particle size as well as 
dispersion index can be calculated [97, 98]. 
DLS systems are typically composed of six components (Figure 3.1) including 
laser, cell, detector, attenuator, correlator and computer.  A laser (1) is used as 
the light source to illuminate the sample solution; while most of the laser beam 
will pass straight through the sample, a small portion is scattered by the 
particles in the solution. A cell (2) is used to allocate the sample inside the 
system. It can be made of different materials (plastic, glass, quartz) depending 
on the type of sample and the analysis to be performed. A detector (3) is used 
to measure the intensity of the scattered light. Even though it could be placed 
theoretically in every available position, as light from the sample scatters in all 
directions, detectors in DLS systems are normally positioned at either 173° or 
90°. Moreover, for the detector to make a successful measurement, light must 
be within a specific energy range, in order to avoid overloading. Because of this, 
an attenuator (4) is used to regulate the intensity of the laser and therefore the 
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intensity of the scattering. A correlator (5) then translates the scattering intensity 
signal to a digital signal, which is then passed to a computer (6) where 
dedicated software will analyze the data and derive size information.  
 
 
Figure 3.1 The DLS measuring system has six components: a laser (1), a cell (2), a detector 
(3), an attenuator (4) a correlator (5) and a computer (6) (modified from [98] Malvern Zetasizer 
User Guide). 
 
Within the instrument, the correlator plays the most pivotal role. It measures the 
degree of similarity between two signals over very short periods of time 
(microseconds and nanoseconds). Based on the values obtained, a correlation 
function of signals over time can be drawn, in which 1 = perfect correlation and 
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0 = no correlation. The measured intensity fluctuations are directly related to the 
movement of particles in solution, and are therefore directly related to the 
Stoke-Einstein equation described before. Consequently, the correlation 
function is directly related to particle size, as the intensity signal for smaller 
particles fluctuates more rapidly than for larger particles and as a result, the 
correlation decreases at a faster rate (Figure 3.2) [98]. 
 
 
Figure 3.2 The correlation function measures the similarity between signals over very short 
periods of time; the decay rate is directly related to particle size (modified from [98] Zetasizer 
User Guide). 
 
After correlation function has been measured, algorithms inside the DLS system 
software will extract the decay rates for a number of size classes to produce a 
size distribution graph (Figure 3.3). 
 
Figure 3.3 Size distribution graph derived from the correlation function (modified from [98] 
Zetasizer User Guide). 
 57 
Dynamic Light Scattering (DLS) was used to determine the particles size 
distribution and their dispersion pattern in DMEM/F-12, EpiLife™ and 106 
media, which were used to culture different types of cells. The particles were 
diluted in the media at concentrations relevant to the study of nanoparticles 
effect on cells (10-200 µg/ml). To study the stability of the particles over time 
during incubation at temperatures relevant to cell culture and sample storage, 
only the top part of the nanoparticle solution was taken for DLS assay. Three or 
five measurements were made for each sample using Zetasizer (Malvern, 
Worcestershire, UK) at 25 °C with 173° detector. Before particle analysis, the 
DLS profiles of cell culture media were acquired for the presence of background 
molecule clusters, which could interfere with the samples measurement.   
 
3.2.2 Zeta potential 
Zeta Potential (ZP) is a technique that determines whether the particles 
contained in a liquid tend to flocculate (agglomerate) or not. It is measured by 
performing an electrophoresis experiment and measuring the velocity of particle 
movement using Laser Doppler Velocity (LSV) in a sample when an electrical 
field is applied. The basic principle behind ZP can be viewed in Figure 3.4. The 
development of a net charge at the particle surface affects the distribution of 
ions in the surrounding interfacial region, resulting in an increased concentration 
of counter-ions close to the surface. This phenomenon can be described as 
electrical double layer, and exists around each particle inside the sample. The 
liquid layer surrounding the particles exists as two parts: an inner region (Stern 
layer), where ions are strongly bound, and an outer region (diffuse layer), where 
ions are much less attached. Part of the diffuse layer exists as a boundary (the 
surface of hydrodynamic shear or slipping plane) where ions and particles form 
a stable identity. As a direct consequence, when a particle moves, the ions 
within the boundary move with it, whereas ions outside the boundary do not 
travel with the particle. The potential inside the boundary is known as Zeta 
Potential [98]. 
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Figure 3.4 The basic principle of zeta potential (modified from [98] Zetasizer User Guide). 
 
Zeta potential (ZP) is particularly useful to get information on the potential 
stability of a colloidal system. A colloidal system can be defined as the fine 
dispersion of one of the three state of the matter (gas, liquid, solid) in one of the 
others. For ZP the two colloidal systems that can be measured are solid 
dispersed in liquid and liquid dispersed in liquid (emulsions). If all the particles in 
suspension have large negative or positive ZP they will repel each other, and 
therefore there will be no tendency to flocculate. However, if ZP levels are low, 
it means that there is no force to prevent the particles from coming together and 
flocculate. The general dividing line between stable and unstable suspensions 
is generally taken at either +30 mV or -30 mV; particles more positive than +30 
mV or more negative than -30mV are generally considered stable [98]. 
An important consequence of the existence of electrical charges on the surface 
of particles is that they will exhibit electro-kinetic effects under the influence of 
an applied electrical field. Four different effects can be described depending on 
the way motion is induced: 
1) Electrophoresis: movement of charged particles relative to their 
suspension liquid under the influence of an electrical field; 
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2) Electro-osmosis: movement of a liquid relative to a stationary charged 
surface under the influence of an electric field; 
3) Streaming potential: electric field generated when a liquid is forced to 
flow past a stationary charged surface; 
4) Sedimentation potential: electric field generated when charged particles 
move relatively to a stationary field. 
As said before, for ZP measurements electrophoretic mobility is measured. To 
do so, a micro-electrophoresis system consisting of a cell equipped with a 
positive and negative electrode, where potential is applied, is used to load the 
sample inside the ZP system (Figure 3.5).  
 
 
Figure 3.5 The cell system used to measure zeta potential is equipped with a positive and 
negative electrode, where potential is applied (modified from [98] Zetasizer User Guide). 
 
When an electric field is applied across an electrolyte, charged particles 
suspended in the electrolyte are attracted towards the electrode of opposite 
charge. Viscous forces acting on the particles tend to oppose this movement. 
When equilibrium is reached between these two opposing forces, the particles 
move with constant velocity [98]. 
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The velocity of the particle is dependent on the following factors:  
 Strength of electric field or voltage gradient; 
 The dielectric constant of the medium; 
 The viscosity of the medium; 
 The zeta potential. 
With this knowledge zeta potential of the particle can be obtained by application 
of the Henry equation (Equation 3.2), which is: 
ܷா = 2ߝ ݖ ݂(ܭܽ)3ߟ  
 z : Zeta potential; 
 UE : Electrophoretic mobility; 
 ε: Dielectric constant; 
 η: viscosity; 
 f(Ka) : Henrys function. Two values are generally used as approximations for the f(Ka) determination - either 1.5 or 1.0. 
Equation 3.2 The Henry equation. 
 
Because electrophoretic determinations of zeta potential are commonly made in 
aqueous media and moderate electrolyte concentration, f(Ka) approximation of 
1.5 is normally used. This is referred as the Smoluchowski approximation; zeta 
potential calculations for systems that fit the Smoluchowski model is 
straightforward [98].  
The system used to measure ZP is in practice very similar to the one used by 
DLS systems, and consists of seven components (Figure 3.6): a laser (1), used 
to provide the light source to illuminate the particles within the sample. For ZP 
measurements the light source is split, in order to provide an incident and a 
reference beam. A cell (2) holds the sample solution. When an electric field is 
applied to it, any particles moving will cause the intensity of the light detected to 
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fluctuate with a frequency proportional to the particle speed. A detector (3) 
sends the information to a digital signal processor (4) and then to a computer 
(5), where the system software produces a frequency spectrum from which ZP 
is calculated. As for the DLS system measurement, the scattered light must be 
in a specific range for the detector to make a successful measurement, 
therefore an attenuator (6) is used to regulate the intensity of the laser and the 
scattering. In order to compensate and correct any variations in the cell wall 
thickness and the dispersant refraction compensation optics (7) are installed 
within the scattering beam path in order to guarantee the alignment of the 
beams. 
 
 
Figure 3.6 A schematic version of the ZP measurement system including a laser (1), a cell (2), 
a detector (3), a digital signal processor (4), a computer (5), an attenuator (6) and compensation 
optics (7) (modified from [98] Zetasizer User Guide). 
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Zeta Potential was used to determine surface charge for colloidal silica 
particles. Each sample was dispersed in DMEM/F-12 medium with 10% FBS 
(CM-10%) and 0% FBS (CM) at 100 µg/ml for 24 h at 4oC (storage conditions) 
and analyzed with Zetasizer (Malvern, Worcestershire, UK). Five cycles of 
measurements were taken to derive an average zeta potential for each sample. 
 
3.2.3 Electron microscopy (scanning electron microscopy and transmission electron microscopy) 
Electron microscopy (EM) over the years has proven an extremely valuable tool 
for several research applications, including nanomaterials analysis. It involves 
the use of a beam of electrons and a series of electric or electromagnetic fields 
to achieve higher resolution imaging compared to light or optical microscopes. 
Visible light, used by optical and light microscopes, makes it impossible to 
resolve points in an object closer together than a few hundred nanometers. 
Electrons, on the other hand, exhibit similar, albeit shorter wavelengths than 
those found in light. The various forms of electron microscopy have several 
areas of application [99, 100].  
Transmission electron microscopy (TEM) is a stationary beam method applied 
to a wide range of materials (Figure 3.7). It is composed of an electron optical 
column, a vacuum system, lens for focusing and deflecting the beam, a high 
voltage generator for electron source, and control software. It typically 
comprises an operating console placed for the operator; the microscope may 
also be fully enclosed to reduce interference from environmental sources or 
operated remotely [100].  
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Figure 3.7 The basics of TEM (from 
http://www.nobelprize.org/educational/physics/microscopes/tem/). 
 
The electron column includes elements analogous to those of a light 
microscope. The light source is an electron gun built into the column. The 
lenses used are electromagnetic lenses, which allow the focal length to be 
changed by changing the current through the lens coil. Instead of the eyepiece 
or ocular, a fluorescent screen and/or a digital camera are used by the operator. 
The electron beam emerges from the electron gun, and passes through the 
sample, transmitting electrons that are collected, focused, and projected onto 
the viewing device at the bottom of the column. The entire electron path from 
gun to camera must be under vacuum. As the electron beam emerges (on the 
downward side of the specimen), two other electronic lenses (electromagnetic 
fields) influence its path. First, a minutely focused objective lens spreads the 
concentrated beam created by the condenser lens. Then, a projector lens 
“captures” the resultant image, which is recorded on the fluorescent screen as a 
picture [100, 101]. TEM has proved invaluable to examine the ultrastructure of 
metals, as it is able to detect dislocations in the crystal lattice fairly easily; it’s 
been equally useful in life sciences applications, for examining plant, bacteria or 
animal tissue. One limitation of the TEM is that samples need to be very thin, 
otherwise electrons are scattered or absorbed rather than transmitted. In order 
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to be able to examine relatively thick samples, scanning electron microscope 
(SEM) was developed [100, 101, 102].  
SEM (Figure 3.8) is the most popular of the microscopic techniques due to the 
simplicity of interpretation of most of the images and the ease of specimen 
preparation. In SEM, electrons are focused in a small-diameter spot on the 
sample surface; said focused spot is then used to scan in two perpendicular 
directions, thus covering a specific area. The intensities of the signals created 
by the interactions between the beam electrons and the sample are measured 
and then mapped as variations in brightness on the image display. The 
secondary electron (SE) signal is the most frequently used signal. It varies with 
the topography of the sample surface much like an aerial photograph: edges 
are bright while recesses are dark. The ratio of the size of the displayed image 
to the size of the area scanned on the specimen gives the magnification [100, 
101].  In SEM, the optical column is shorter than TEM, as the only lenses 
needed are those above the sample used to focus the electrons into a fine spot 
on the sample surface. The sample chamber, however, is larger because the 
SEM technique does not impose any restriction on specimen size other than 
chamber size. The electron gun and lenses are similar to those of a 
transmission electron microscope [100, 102].  
 
 
Figure 3.8 The difference between SEM and TEM (from 
http://bsp.med.harvard.edu/node/221). 
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To summarize, the most important differences between a transmission electron 
microscope and a scanning electron microscope are: 
 While TEM uses a broad static beam, the SEM beam is focused to a fine 
point and scans line by line over the sample surface in a rectangular 
pattern; 
 Voltages are much lower in SEM than in TEM because sample 
penetration is not necessary;  
 In SEM, the sample does not need to be thin, thus simplifying specimen 
preparation. 
Scanning Electron Microscopy (SEM) and Transmission Electron Microscopy 
(TEM) were used to establish silica particles morphology structure and 
distribution in water. Each sample was dispersed in deionized water at a 
concentration of 10-25 µg/ml. For SEM imaging, a drop of each sample 
suspension was placed on a silicon chip, dried in air, and coated with Au/Pd or 
carbon. For TEM imaging, a drop of the sample suspension was placed on a 
carbon-formvar coated grid and dried in air. Each sample was then analyzed at 
different magnifications using Philips XL30 SFEG SEM and Philips CM20 TEM 
(Philips, Netherlands). 
 
3.3 Cytotoxicity Assessment 
3.3.1 Cell lines used for the assays 
Thousands of different cell lines, either primary or immortalized, have been 
derived from human tissues throughout the years depending on the intended 
use. Whereas primary cells are normally isolated from tissue and then 
proliferated and sub-cultured for a specific amount of time, immortalized cells 
can proliferate indefinitely. Immortalized cells are generally obtained by virus-
mediated genome modification or by isolation of cells from tumorigenic tissue, 
which makes them more prone to malignancy and related problems [103].  
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An exception is represented by HaCaT cells, a line developed at the end of the 
Eighties by the Cancer Research Center in Heidelberg. Instead of using viruses 
such as SV40 for immortalization, Petra Boukamp and her research group used 
a method based on temperature and calcium levels to achieve immortalization 
without inducing tumorigenic effects. Full thickness human body skin was 
obtained from the distant periphery of a melanoma located on the upper half of 
the back of a 62-year old male patient. Cells were then isolated from tissue, 
suspended in MEM medium with low levels of Ca2+ and sub-cultured at 38.5 o C 
in order to increase cell proliferation. The first subculture, after reaching 
confluency, was split with a high cell density ratio (1:2) for the following three 
passages. By the fourth passage, density was no longer critical and the 
resulting cell line was designated ‘HaCaT’ to denote its origin from human 
keratinocytes and the growth conditions used to establish it.  After the fourth 
passage, proliferation continued steadily, allowing the researchers to passage 
the cells for over 140 times, becoming completely independent from Ca2+ and 
temperature levels after the tenth passage [104].  Because they are 
characterized by an altered phenotype, though without tumorigenic effects, after 
their development HaCaT cells have been used for different applications, from 
3D skin grafting to in vitro toxicity evaluation. 
Because of their properties, as well as being an established model for in vitro 
keratinocyte studying, HaCaT cells were chosen as the main cell line to use for 
this study.  In order to gain additional information on comparison between other 
skin cell lines, three additional lines were chosen to perform experiments on cell 
viability, apoptosis and morphology studies: BJ fibroblasts, Human Dermal 
Fibroblasts (HDF) and K17 keratinocytes. The BJ cell line was first obtained in 
the Nineties from the foreskin of a healthy new-born male. They have a normal 
diploid karyotype, and can be cultured up to 70 passages. They are not 
immortalized, and are telomerase negative. BJ cells have been used for 
different studies in cellular and molecular biology, especially for telomerase 
studies as well as transfection host [105, 106].  Human Dermal Fibroblasts 
(HDF) is a primary cell line purchased from Gibco© derived from adult skin 
(single donor), capable of at least 12 doublings [107]. K17 keratinocytes were 
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kindly provided by Prof. David Kelsell (Queen Mary University of London –
Centre for Cell Biology and Cutaneous Research). The cells were prepared 
following the protocol by Storey et al. [108]. 
 
3.3.2 Cell culture 
As said before (see Introduction) cell culture can be defined as the mechanical 
or enzymatic dispersion of tissue followed by the propagation of the resulting 
cells as a suspension or attached monolayer. Cell cultures have lost their 
histotypic architecture, and often the associated biochemical properties; 
therefore, they do not reach a steady state unless specific conditions are 
achieved. These specific conditions mainly involve a surface where cells can 
attach and spread (the substratum) and, most importantly, a diffuse 
environment that must supply all the essential nutrients for cell metabolism, 
proliferation and cell growth (the medium). To mimic in vivo conditions and 
achieve physiologically balanced growth-promoting and growth-inhibiting 
activities, animal serum is frequently added, as it contains low and high 
molecular weight compounds such as albumin, cholesterol, cortisone, 
endotoxin, glucose, thyroxine, haemoglobin, insulin, and triiodothyronine.  
For HaCaT cells and BJ fibroblasts, cells were suspended in DMEM/F-12 
culture medium supplemented with 10% FBS and antibiotics (penicillin 100 
units/ml, streptomycin 100 μg/ml), then seeded at a density of 5 × 105 cells/cm2 
in flasks and incubated at 37°C in a humidified atmosphere with 5% CO2 and 
95% air. The cells were sub-cultured every 3 days by trypsinisation with trypsin 
coupled with ethylene diamine tetra acetic acid (trypsin-EDTA).   
For K17 keratinocytes, cells were suspended in EpilifeTM culture medium 
supplemented with antibiotics (penicillin/streptomycin 5000U/ml) and HKGS 
(Human Keratinocyte Growth Supplement), an ionically-balanced supplement 
containing bovine pituitary extract (BPE), recombinant human insulin-like growth 
factor-I, hydrocortisone, bovine transferrin, and human epidermal growth factor. 
Cells were then seeded at a density of 5 × 105 cells/cm2 in flasks and incubated 
 68 
at 37°C in a humidified atmosphere with 5% CO2 and 95% air. The cells were 
sub-cultured every 4-5 days by trypsinisation with trypsin coupled with ethylene 
diamine tetracetic acid (trypsin-EDTA).   
For HDF fibroblasts, cells were suspended in Medium 106 culture medium 
supplemented with antibiotics (penicillin/streptomycin 5000U/ml) and LSGS 
(Low Serum Growth Supplement), a solution containing foetal bovine serum, 
basic fibroblast growth factor, heparin, hydrocortisone, and epidermal growth 
factor. Cells were then seeded at a density of 3 × 105 cells/cm2 in flasks and 
incubated at 37°C in a humidified atmosphere with 5% CO2 and 95% air. The 
cells were sub-cultured every 4-5 days by trypsinisation with trypsin coupled 
with ethylene diamine tetra acetic acid (trypsin-EDTA).  
 
3.3.3 Cell viability and membrane damage assays 
The reduction of tetrazolium salts from weakly colored aqueous solutions to 
brightly colored derivates known as formazans has been the basis of many 
biochemistry applications for more than half a century. This widespread 
application is due to the unique physico-chemical properties of these 
compounds, which depends on the positively charged quaternary tetrazole ring 
core containing four nitrogen atoms surrounded by three variable aromatic 
structures usually containing phenyl groups (Figure 3.9). This variability has 
generated several tetrazolium compounds with different properties, which have 
been used both qualitatively and quantitatively for many biological 
measurement systems. All these compounds have a common chemistry 
principle, which involves a mild reduction reaction; as a direct consequence, the 
tetrazole ring inside the compound is displaced, prompting the transformation 
into colored formazan salts [109]. 
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Figure 3.9 The general structure of the tetrazolium dyes and the formazan salts. 
 
There are two categories of tetrazolium salts. The first one, which includes 3-
(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), forms 
insoluble formazan salts  upon reduction by NAD(P)H-dependent 
oxidoreductases and hydrogenases of metabolically active cells. In order for the 
assay to be measurable, the salts must be solubilized using solvents such as 
DMSO or acidified isopropanol. The second one, which comprises WST-1, does 
not require any kind of stabilization of the medium in the sample, as the 
formazan salt that is formed is soluble. This difference in the two categories is 
given by the aromatic variable groups in each compound: whereas MTT has a 
positively charged moiety, which improves lipophilicity and gives it the ability to 
form large needle-like structures inside the cell/tissue, WST-1 and the related 
compound have their phenyl moieties capped with negatively charged sulfonate 
groups, which improves solubility but also hinders movement ability of these 
compounds across cell membranes (Figure 3.10) [110]. 
 
                
Figure 3.10 The structures of MTT (A) and WST-1 (B). 
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Because of this difference, MTT and WST-1 reaction location inside cells is 
different; whereas MTT is readily internalized by exploiting the plasma 
membrane potential and reduced intracellularly, WST-1 is reduced at the cell 
surface because of its poor penetration capability. Figure 3.11 shows a 
schematic representation of the two different mechanisms of action: whereas 
MTT is reduced intracellularly by NADH, WST-1 is reduced by trans-plasma 
membrane electron transport (via electron carrier 1-methoxyPMS) using NADH 
derived from the TCA cycle as a reducing agent.  
 
 
Figure 3.11 The mechanism behind MTT and WST-1 reduction by cells (modified from [109] 
Berridge et al., 2005). 
 
In practice, both assays involve the use of microplates, where cell proliferation 
is measured under the assumption that dye reduction will be proportional to the 
number of viable cells in the exponential growth phase [109]. The general 
purpose of these assays is to measure viable cells in a relatively high-
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throughput way (96-well plates) without the need for elaborate cell counting. 
The most common use is the measurement of the cytotoxicity of drug at several 
concentrations, with the results expressed against IC50, the concentration 
needed to inhibit growth in 50% of cell population, or LD50, (LD stands for lethal 
dose), the amount of a material needed to kill 50% of the cell population [110, 
111].  
For this work, MTT has been used to measure viability in HaCaT keratinocytes 
and BJ fibroblasts, while WST-1 has been used on K17 keratinocytes and HDF 
fibroblasts. For MTT assay cells were seeded at a density of 1 × 104 cells/well in 
96-well plates and cultured in full medium until 70% confluency was reached. 
The medium was then replaced with 200 µl of silica particle suspension at 10-
200 µg/ml. Cells incubated with particle-free culture medium were used as 
control. After 24 h treatment, cells were washed twice with PBS. The plate was 
then incubated with 100 µl of MTT [3-(4, 5-Dimethylthiazol-2-yl)-2, 5-
diphenyltetrazolium bromide] solution (1 mg/ml) for 2 h at room temperature in 
the dark. The formazan salt crystals were solubilised with 100 µl of DMSO. After 
20 minutes further incubation at room temperature, the absorption was recorded 
using a Thermo Scientific Varioskan  plate reader (Thermo Fisher Scientific, 
US) at a wavelength of 570 nm. For WST-1, cells were seeded at a density of 2 
× 104 cells/well in 96-well plates and cultured in full medium until 70-80% 
confluency was reached. The medium was then replaced with 100 µl of silica 
particle suspension at 10-200 µg/ml. Cells incubated with particle-free culture 
medium were used as control. After 24 h treatment, the plate was treated with 
10 µl of WST-1 for 4 h at 37 °C, then read using a Thermo Scientific Varioskan 
plate reader (Thermo Fisher Scientific, US)  at 450 nm (sample reading) and 
600 nm (background reading). 
Another important assay for studying the interaction between nanomaterials and 
cells is the LDH assay. Lactate dehydrogenase, also known as LDH, is an 
oxidoreductase enzyme found extensively in body tissues that catalyzes the 
interconversion of lactate and pyruvate (Figure 3.12). 
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Figure 3.12 The LDH enzyme catalyzes the interconversion between pyruvate (left) and 
lactate (right). 
 
When cells are lethally injured, LDH is released in the surrounding external 
medium. Because LDH is a fairly stable enzyme, its release can be measured 
as a marker for necrotic cell death by using NAD, which is reduced to NADH by 
LDH in a reaction that can be detected colorimetrically (450 nm) [112]. 
For this study, HaCaT cells were prepared and treated as descripted for MTT 
assay. After treatment, 50% of supernatant from each well was transferred from 
each well to a new plate, where it was treated with 100 µl LDH reagent for 20 
minutes at room temperature. LDH release was then detected using Thermo 
Scientific Varioskan plate reader (Thermo Fisher Scientific, US) at 490 nm. A 
background reading was taken at 690 nm as instructed by the manufacturer; the 
final value was obtained by subtracting the reading at 690 nm from the reading 
at 490 nm. The cells remained attached and were used for MTT assay as 
described above.   
Beside LDH release, membrane damage can be assessed by using propidium 
iodide (PI). Propidium iodide has the ability to stain the nucleus of membrane-
compromised cells only, as it is membrane-impervious and generally excluded 
from viable cells. After treatment of both K17 keratinocytes and HDF with 
colloidal silica 10-200 µg/ml for 24 hours, PI at 5 µg/ml was added to the wells 
and incubated for 20 minutes at room temperature. Untreated cells were used 
as negative control, while cells incubated with Triton X-100 0.025% for 15 
minutes were used as positive control. Triton X-100 was chosen as positive 
control because it is widely used to lyse cells or to permeabilize the membranes 
of living cells.  After treatment with PI, cells were washed with PBS and fixed 
using a solution of paraformaldehyde 4%. The nuclei were then stained with 
LDH 
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Hoechst 33342 at 0.1 mg/ml for 10 minutes at room temperature. For cell 
counting, a wide field fluorescence microscope (Zeiss Axiovert; Jena, Germany) 
was used. Image acquisition and post-acquisition analysis were performed 
using Morphostrider software (Exploranova; La Rochelle, France). Using an 
objective 10x, images were acquired using the adequate filter cubes for 
Hoechst and PI. Sixteen fields (840.4 x 640.3 µm) per well were acquired in 
order to image a large surface of the well. In the post-analysis process, both 
Hoechst- and PI-labeled cells were counted and the ratio of the number of PI-
labeled cells versus the number of Hoechst-labeled cells was calculated. 
 
3.3.4 Phase contrast microscopy for cell imaging 
Phase contrast is an optical contrast technique for making unstained phase 
objects visible under an optical microscope. Cells that appear inconspicuous 
and transparent in bright field can be viewed in high contrast and rich detail 
using a phase contrast microscope. This technique finds several applications, 
the main one consisting of producing high-contrast images of transparent 
samples, such as living cells (usually in culture), microorganisms, thin tissue 
slices, lithographic patterns, fibers, latex dispersions, glass fragments, and 
subcellular particles (including nuclei and other organelles). The technique of 
phase contrast microscopy was developed in the 1930s by the Dutch physicist 
Frits Zernike. After the technique was brought into use in 1942, Zernike was 
awarded the Nobel Prize in Physics in 1953 [113, 114]. 
The phase contrast microscope (Figure 3.13) uses the fact that the light passing 
through a transparent part of the sample travels slower and therefore is shifted 
compared to the uninfluenced light. This difference in phase is not visible to the 
human eye; however, the change in phase can be increased to half a 
wavelength by a transparent phase-plate in the microscope, thereby causing a 
difference in brightness making the transparent object shine out in contrast to its 
surroundings [115]. 
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Figure 3.13 The structure of a phase contrast microscope and its phase ring. The portion of 
light that passed the specimen without experiencing diffraction passes the phase ring (A), 
whereas the retention plate retards the phase of the non-diffracted light to allow interference 
with the light waves that experienced phase shift and diffraction by passing the sample (B) (from 
[113] http://www.leica-microsystems.com/science-lab/phase-contrast/). 
 
The key elements of a phase contrast microscope are the condenser annulus 
(1) and the phase plate (2). The condenser annulus is placed in the front focal 
plane of the condenser and limits the angle of the penetrating light waves. The 
phase plate lies in the back focal plane of the objective and has a phase ring 
made of a material that dims the light passing through it and changes its phase 
by modifying the light’s wavelength (λ) by λ/4. The ring shaped light that passes 
the condenser annulus is focused on the specimen by the condenser. Portions 
of the ring shaped light are diffracted by optically dense structures of the 
specimen (e.g. plasma membranes, organelles etc.) and experiences a phase 
shift of approximately ¼ λ (usual for biological specimen). This phase 
shifted/diffracted light bypasses the phase ring and is hardly affected by it. The 
phase ring is a central component of a phase contrast microscope, usually 
located in the rear focal plane of the objective. Composed of a grey filter and a 
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retention plate; the grey filter dims the light to avoid irradiation, the retention 
plate retards the phase of the non-diffracted light to allow interference with the 
light waves that experienced phase shift and diffraction by passing the 
specimen. The portion of light that passes the sample without experiencing 
diffraction passes the phase ring. In contrast, the direct ring shaped light from 
the condenser annulus will hit the phase ring, which will dim the direct light and 
cause a phase shift (usually advanced by ¼ λ or retarded by ¾ λ for positive 
phase contrast). As the total phase shift between the light refracted by the 
sample and the light that passed the phase ring will be up to ½ λ, destructive 
interference will occur. Optically dense structures will consequently appear 
darker (in positive phase contrast) [113, 114, 115]. 
Cell morphology was examined before and after treatment with colloidal silica 
particles 25-100 µg/ml in medium with 10% FBS (CM-10%) and 0% FBS (CM) 
at 24 hours. Phase contrast cell images were taken at 20X magnification using 
Leica DFC 295. 
 
3.3.5 Flow cytometry assays for cell uptake of particles and apoptosis assay 
Flow cytometry is a technology that simultaneously measures and analyzes 
multiple physical characteristics of single particles (cells) as they flow in a fluid 
stream through a collimated beam of light, usually a laser. The measured 
properties include size, granularity (internal complexity), and relative 
fluorescence intensity. A flow cytometer is made up of three main systems: 
fluidics, optics, and electronics. The fluidics system transports particles in a 
stream to the laser beam for interrogation; the optics system consists of lasers, 
which illuminate the particles in the sample stream, and optical filters, which 
direct the resulting light signals to the appropriate detectors; the electronics 
system converts the detected light signals into electronic signals that can be 
processed by the computer [116]. In the flow cytometer, particles carried 
through the laser intercept scatter laser light. The extent of light scatter depends 
on the physical properties of the particle measured, namely its size and internal 
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complexity. For cellular samples, affecting factors are also the cell membrane, 
the nucleus, and any granular material inside the cell. Cell shape and surface 
topography also contribute to the total light scatter. Forward-scattered light 
(FSC) is proportional to cell-surface area or size. FSC is a measurement of 
mostly diffracted light and is detected just off the axis of the incident laser beam 
in the forward direction. FSC provides a suitable method of detecting particles 
greater than a given size independent of their fluorescence. Side-scattered light 
(SSC), on the other hand, is proportional to cell granularity or internal 
complexity. SSC is a measurement of mostly refracted and reflected light that 
occurs at any interface within the cell where there is a change in refractive 
index. SSC is collected at approximately 90 degrees to the laser beam by a 
collection lens and then redirected by a beam splitter to the appropriate 
detector. Correlated measurements of FSC and SSC can allow for 
differentiation of cell types in a heterogeneous cell population [116]. 
Flow cytometry was used to detect cellular uptake of particles and study cell 
necrosis and apoptosis.  Measurement of nanomaterials cell uptake by flow 
cytometry is relatively easy, as the only requirement is the use of fluorescent 
labeled samples. The particles inside of cells will react with the lasers inside the 
cytometer system; however, no quantitative or uptake mechanism information 
can be gained using this technique.  
This technique could also provide information on cell death mechanisms, such 
as necrotic or apoptotic cell death.  Whereas apoptosis is accompanied by 
water loss, cell shrinkage, and nuclear fragmentation, necrosis is characterized 
by rapid cytoplasmic swelling, plasma membrane rupture and organelle 
breakdown. Consequently, apoptotic and necrotic cells differ in light scatter 
patterns; apoptotic cells give lower forward scatter and higher side scatter 
values than viable cells, reflecting the smaller size and different 
nucleus/cytoplasm consistency. Apoptosis has been characterized by different 
criteria, such as caspase activation and, most importantly, different kinetics of 
phosphatidylserine (PS) exposure on the plasma membrane [117]. PS is an 
important component of the cell membrane; normally restricted to the inner 
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leaflet of the membrane, it moves transversely across the bilayer to the outer 
leaflet of the plasma membrane. Phosphatidylserine exposure has several 
potential biological consequences, most importantly as the basis to detect 
apoptotic cell death. Annexin V is a Ca2+ dependent phospholipid-binding 
protein with high affinity for PS; as a direct consequence, this protein can be 
used as a sensitive probe for apoptotic cell death. As translocation of PS to the 
external cell surface is not unique to apoptosis, but occurs also during necrosis, 
analysis has to be performed in conjunction with a dye to establish integrity of 
the cell membrane. To do so, Annexin V, properly conjugated with FITC for cell 
staining evaluation, is used to treat cells together with Propidium Iodide. 
Whereas Annexin V binds to phosphatidylserine in the membrane of cells, PI 
binds to the cellular DNA in cells where the cell membrane has been 
compromised, thus providing discrimination between apoptosis and necrosis 
[116, 117, 118]. 
To measure particle uptake, HaCaT cells were seeded in 24-well plates at 5 x 
104 cells/well overnight, then incubated with FITC-labelled SiNP7, SiNP14, 
SiNP70, SMP200, SMP500 in CM-10% and CM for 24 h, then collected by 
trypsinization and centrifugation.  The data containing 10000 events were 
acquired and displayed as side scattering (SSC) vs forward scattering (FSC) to 
distinguish intact cells from debris, using BD Accuri C6 Flow Cytometer (BD, 
San Jose, CA, USA). The intact cells were then analyzed for FITC intensity 
using the Accuri C6 software.  The difference of FITC intensity between cells 
indicates the difference in silica particles uptake. 
For necrosis and apoptosis detection, cells were seeded and treated in the 
same conditions as for particle uptake. The cells were then re-suspended in 
PBS containing Annexin V-FITC (0.025 mg/ml) and propidium iodide (0.01 
mg/ml), and incubated at room temperature for 10 minutes in dark. Cell viability 
and apoptosis were quantified using the BD Accuri TM C6 Flow Cytometer (BD, 
San Jose, CA, USA). The data containing at least 10000 events were acquired 
and displayed as SSC vs FSC to distinguish intact cells from debris. The intact 
cells were then further analyzed for FITC and PI intensity, respectively, to 
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quantify apoptotic and necrotic cell death. The maximum intensity of PI and 
FITC obtained from 90% of cells without particle treatment were set to 
distinguish PI positive, FITC positive and PI/FITC double positive cells. Cells 
with FITC and PI double negative staining were designated as healthy cells, PI 
positive and FTIC negative as necrotic cells, PI negative and FTIC positive as 
early apoptotic cells, PI and FITC double positive as late apoptotic cells. 
 
3.3.6 TEM imaging for cellular uptake 
As described before, the size of nanoparticles allows them to pass through 
biological barriers and enter cells. As this may result in permanent cell damage, 
the quantitative study of the relationship of NPs internalization, cellular location 
and cytotoxicity is crucially important and can be achieved by utilization of 
Transmission Electron Microscopy (TEM). In vitro, the results of cell imaging are 
often qualitatively compared to cell line responses measured by standard 
viability and genotoxicity assays. However, effective quantification of the real 
number of particles internalized by the cells remains quite challenging, as well 
as time and cost consuming [119, 120].  For sample preparation, employing 
resin embedding with only chemical fixation (including osmium tetroxide) 
enables visualization of the main cellular structures without contrast from the 
NPs themselves being obscured by heavy metal stains, allowing easy NPs 
localization. Quantification of NP uptake within thin sections of cells is also 
possible, however random sampling procedures or correlation to higher 
throughout techniques are required to measure a population of whole cells 
[121]. 
For this study, HaCaT cells were seeded in a 6-well plate at 3x105 cells/well, 
cultured overnight and then treated with colloidal silica at 25 µg/ml for 24 h. 
Each sample was then scraped from the plate, fixed with 2% glutaraldehyde in 
0.1 M sodium cacodylate buffer (pH 7.4), and kept at 4oC for 24 h. Cells were 
then postfixed with 1% osmium tetroxide /1% potassium ferrocyanide for 1 hour 
at room temperature and stained en bloc with 5% aqueous uranyl acetate 
overnight at room temperature, dehydrated, and embedded in Taab epoxy resin 
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(Taab Laboratories Equipment Ltd., Aldermaston, UK).  Ultrathin sections were 
stained with lead citrate and recorded using a Megaview 3 digital camera and 
iTEM software (Olympus Soft Imaging Solutions GmbH, Münster, Germany) in 
a Jeol 100-CXII electron microscope (Jeol UK Ltd., Welwyn Garden City, UK). 
 
3.3.7 Confocal microscopy 
Confocal microscopy has proved to be a quite popular technique in recent 
years, as it allows getting high-quality images from samples prepared for 
conventional fluorescence microscopy. It is proving to be one of the most 
important advances ever achieved, with a growing number of applications in cell 
biology for both fixed and living cells and tissues. Compared with conventional 
optical microscopy, confocal microscopy offers several advantages: 
• Ability to control depth of field; 
• Elimination or reduction of background information away from the 
focal plane (that leads to image degradation); 
• Capability to collect serial optical sections from thick specimens.  
The basic key is the use of spatial filtering techniques to eliminate out-of-focus 
light or glare in samples whose thickness exceeds the immediate plane of focus 
[122]. In a confocal microscope, light emitted by an excitation source, usually a 
laser system, passes through a pinhole and an excitation filter before being 
reflected by a dichromatic mirror and scanned across the sample. As a 
consequence, secondary fluorescence is emitted from points on the sample (in 
the same focal plane) and passed back through the dichromatic mirror; the 
fluorescence then passes through a second pinhole aperture positioned in front 
of the detector (a photomultiplier tube) (Figure 3.14). 
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Figure 3.14 The basic structure of a confocal microscope (modified from [122] 
http://www.olympusfluoview.com/theory/confocalintro.html). 
 
The significant amount of fluorescence emission that occurs at points above 
and below the objective focal plane is not confocal with the pinhole and forms 
extended airy disks in the aperture plane. Because only a small fraction of the 
out-of-focus fluorescence emission is delivered through the pinhole aperture, 
most of this extraneous light is not detected by the photomultiplier and does not 
contribute to the resulting image [122, 123]. 
The primary advantage of laser scanning confocal microscopy is the ability to 
produce serially thin optical sections through fluorescent sample restricted to a 
well-defined plane. Contrast and definition are dramatically improved due to the 
reduction in background fluorescence.  With most modern confocal 
microscopies, sections are not restricted to the x-y plane, but can also be 
collected in vertical sections in the x-z and y-z planes (parallel to the 
microscope optical axis). In practice, vertical sections are obtained by 
combining a series of x-y scans taken along the z-axis, and then projected in a 
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view of fluorescence intensity, as it would appear should the microscope 
hardware have been capable of physically performing a vertical section. In 
complex samples, interconnected structural elements can be difficult to discern; 
however, once a sufficient number of sections has been gathered, they can be 
further processed into a three-dimensional representation using computational 
techniques. This approach is now in common use to help elucidate the 
numerous interrelationships between structure and function of cells and tissues 
in biological investigations [122, 123].  
In order to gain additional information on particle localization inside different cell 
lines, 2x104 HDF fibroblasts and K17 keratinocytes were seeded in 8-well 
chamber slides (Ibidi, Germany) and cultured until confluency at 37 oC. 
Treatment with SiNP70, SMP200 and 500 at 10 µg/ml was then carried out for 2 
and 24 h at 37 oC. After incubation the particles were removed and the cells first 
fixed with 4% PFA (Alfa-Aesar, Germany) for 15 minutes, than stained with 
ActinRed and Hoechst 33342 by incubating the cells for 30 minutes and 10 
minutes respectively. Visualization of the samples was performed using Zeiss 
LSM510 laser scanning confocal microscope equipped with 4 lasers (405 nm 
violet diode; 458/477/488/514 nm 4-line Argon; 543 nm HeNe; 633 nm HeNe). 
Images were acquired using the objective Plan Apochromat 63x/1.4 Oil DIC and 
the following laser excitation and emission filters settings (Table 3.4):  
 
Table 3.4 Excitation/Emission outputs of the fluorescent dyes and silica particles. 
 Excitation laser 
(power output) 
Emission filters 
Hoechst 405 nm (10%) BP 420-450 
FITC-NPs 488 nm (10%) BP 520-550 
Alexa 555 543 nm (100%) BP 560-620 
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3.3.8 Wound healing assay 
Cell migration plays an essential role in a variety of biological processes, 
including embryonic development, homeostasis, immune responses, wound 
healing and cancer metastasis; it is a complex process that in recent years has 
attracted the interest of researchers from diverse disciplines in biology. This 
interest is due different factors, such as: 
 The consistent amount of knowledge that has been gathered on the 
components and interactions of the macromolecular machinery of cell 
movement, as well as its related signaling pathways; 
 The use of efficient model organisms for in vivo studies on cell migration 
biology; 
 The use of sophisticated imaging and genetic approaches. 
Wound healing is a dynamic and complex process involving a series of 
coordinated events, including bleeding, coagulation, initiation of an acute 
inflammatory response to the initial injury, regeneration, migration, proliferation 
and remodeling.  The repair process usually begins immediately after injury and 
goes through similar phases of healing in all tissues; however, specialized 
tissues (e.g. liver, skeletal tissue and the eye) have their own distinctive forms 
and follow separate pathways. As most of the repair processes are common for 
all tissues, the related pathways are very similar. They usually involve a 
carefully and precisely regulated cascade that correlates with the appearance of 
different cell types in the wound during distinct phases of the healing process. 
Timing and interactions between the components taking part in the wound 
healing process are different for acute and chronic wounds; the main phases 
remain nevertheless the same. Acute tissue repair, which is triggered by tissue 
injury, can be describes as four time-dependent phases:  
1. Coagulation and hemostasis, beginning immediately after injury;  
2. Inflammation, which begins shortly after the first step;  
3. Proliferation, which includes the major healing processes;  
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4. Wound remodeling, in which scar tissue is formed. 
Wound treatment and its medical complications remain one of the most 
prevalent and economically challenging healthcare issues in the world, 
therefore development of appropriate therapeutics, such as wound healing-
enhancing nanomaterials, is necessary to satisfy the unmet clinical need. [124, 
125, 126]. 
The wound-healing assay is one of the earliest developed methods to study cell 
migration in vitro. It’s a method based on observation of cell migration into an 
artificial wound created on a cell monolayer. Although not an exact duplication 
of in vivo cell migration, this method mimics to some extent migration of cells in 
wound healing. In comparison with other popular in vitro methods, the wound-
healing assay is particularly suitable for studies of directional cell migration and 
its regulation. Migration of the cells is regulated by both the extracellular matrix 
(ECM) surrounding the cells as well as intercellular interactions in the case of 
epithelial and endothelial cells. The effects of each of these factors on 
directional cell migration can be studied using the wound healing method.  The 
wound-healing assay is probably the simplest method to study cell migration in 
vitro, as it only requires common and inexpensive supplies found in most cell 
culture labs. It involves the creation of an artificial wound on a properly 
confluent monolayer of cells, followed by the capture of images at the beginning 
and regular intervals during cell migration. The images acquired will then be 
compared in order to determine the different rate of wound closure across 
different samples.  There are a number of disadvantages and limitations of the 
in vitro scratch assay compared to other available methods. It takes a relatively 
longer time to perform than some other methods, as one to two days are 
needed for the formation of cell monolayer and then up to several days for cell 
migration to close the scratch. Moreover, relatively large amount of cells and 
chemicals will be required for the assay if performed in a tissue culture dish. 
Despite these limitations, the wound-healing assay is still often the method of 
choice to analyze cell migration [124, 127]. 
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To analyze cellular migration following treatment with colloidal silica in vitro, 
HaCaT cells were seeded at a density of 2x104 cells/well in fibronectin-coated 
96-well plates, supplemented with 1% (v/v) penicillin, 1% (v/v) streptomycin and 
10% (v/v) FBS and cultured for 48 h at 37 °C to achieve confluent monolayer.  
Culture medium was then replaced with starvation medium (0.5% FBS) to 
incubate overnight. Each well was then treated with particle suspension or 
particle-free starvation medium for 5 h at 37 °C. After incubation, particles were 
removed and the wells were washed twice with PBS.  Wounds were created by 
cutting through the center of the cell monolayer in the well with a pipette tip.  
The detached cells were washed away using PBS and the wells were re-coated 
with fibronectin (10µg/mL in starvation medium) for 1 hour at 37 °C. At this point 
(t=0), the first images were taken on In Cell Microscope 2000 (GE Healthcare) 
(objective 2x), then cells were washed and maintained in starvation medium for 
cell migration monitoring up to 72h. Scratch areas were quantified using the 
AxioVision software (Carl Zeiss). Wound areas were normalized by the initial 
area (n= 8 images). 
 
3.3.9 Western blot 
Western Blot is an important technique in cell and molecular biology, as it 
allows the identification of specific proteins from a complex mixture extracted 
from cells. To do so, it exploits four elements: 1) separation by size, 2) transfer 
to a solid support, 3) marking of the target protein using a proper primary 
antibody, 4) use of a secondary antibody that binds to the primary antibody to 
visualize the target protein. In Western Blot the mixture of proteins is separated 
based on molecular weight through gel electrophoresis. These results are then 
transferred to a membrane, producing a band for each protein. The membrane 
is then incubated with labeled antibodies specific to the protein of interest. The 
unbound antibody is washed off leaving only the bound antibody to the protein 
of interest. The bound antibodies are then detected by developing the film. As 
the antibodies only bind to the protein of interest, only one band should be 
 85 
visible. The thickness of the band corresponds to the amount of protein present; 
therefore doing a standard can indicate the amount of protein present [128].  
Cell lysates are the most common form of sample used for Western blot. After 
protein extraction, its concentration is measured using a spectrophotometer, 
thus allowing the measurement of the mass that is being loaded into each well 
by the relationship between concentration, mass, and volume. Western blot 
uses two different types of agarose gel: a stacking gel and a separating (or 
resolving) gel. The stacking gel is slightly acidic (pH 6.8) and has a lower 
acrylamide concentration, which has poor separation properties but allows 
proteins to form thin, sharply defined bands. The separating gel is basic (pH 
8.8) with higher polyacrylamide content, thus making its pores narrower and 
causing protein separation by their size, as smaller proteins travel faster than 
larger proteins. After electrophoresis, the separated proteins are transferred to a 
membrane. The transfer is performed using an electric field oriented 
perpendicular to the surface of the gel, causing proteins to move out of the gel 
and onto the membrane. The membrane, the solid support, is an essential part 
of this process. Two types of membrane are commonly used: nitrocellulose and 
polyvinylidene fluoride (PVDF). Nitrocellulose has retention as well as high 
protein affinity, but does not allow the membrane to be used for re-probing. 
PVDF membranes, on the other hand, provide better mechanical support and 
allow the blot to be re-probed and stored. However, they produce higher 
background and therefore must be washed carefully. After blocking of non-
specific binding by treatment with Bovine Serum Albumin (BSA), the primary 
antibody is added to the membrane to bind the target protein. The membrane is 
then detected using the label antibody, which is detected by the signal it 
produces corresponding to the position of the target protein (Figure 3.15). This 
signal is captured on a film which is usually developed in a dark room [128]. 
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Figure 3.15 The detection mechanisms in western blot (from 
http://www.leinco.com/general_wb). 
 
It is very important to remember that Western blot is typically considered a 
semi-quantitative technique, as it provides a relative comparison of protein 
levels, but not an absolute measure of quantity. This is due to two factors: 1) the 
variations in loading and transfer rates between the samples in separate lanes 
as well as separate blots. These differences will need to be standardized before 
a more precise comparison can be made. 2) The detection signal is not linear 
across the concentration range of samples [128].  
To study the effect of colloidal silica on caspase 3, which is involved in apoptotic 
cell death regulation, HaCaT cells were seeded at 7x105 cells/well in 6-well 
plates overnight, and then treated with SiNP20-70 and SMP200-500 at 10-100 
µg/ml in CM-10% for 24 hours. After treatment, cells were washed with PBS, 
collected by centrifugation and shock-frozen by immersion in liquid nitrogen for 
two minutes. The samples were kept at -80oC until needed. Following cell lysis, 
a 4% stacking gel and a 13% resolving gel were prepared (BioRad Mini-
PROTEAN Tetra cell kit, BioRad, US), and Cellular proteins from each sample 
were then loaded into the wells. Protein standard was loaded into the first and 
last wells. The gel was run at 90 V until the bottom of the gel was reached. The 
proteins separated on the gel were then transferred overnight to Hybond C 
(Hybond-C extra, Amersham, Bucks, UK) at 25 V. Subsequently, the membrane 
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was stained with Ponceau S (Sigma Aldrich, US) to confirm transfer of proteins 
and standards.  Membrane were then rinsed twice in Tris-Buffered Saline and 
Tween 20 solution (TBS-T), then blocked for 1 h in blocking buffer. The 
membrane was then incubated for 2 h with in house-raised rabbit anti-human 
caspase-3 primary antibody. After careful rinsing and blocking, incubation for 1 
hour with HRP-conjugated Goat anti-rabbit IgG secondary antibody (DAKO, 
Sigma) was performed. Antibody bound proteins were visualised using the ECL 
analysis system (Amersham, UK) using Kodak Biomax XAR film. Films were 
developed on a Compact X4 Xograph Imaging System. 
Despite being one of the most common procedures in biochemical labs, 
Western blotting has several disadvantages. Besides being semi-quantitative, 
Western blot can only be performed if primary antibodies against the protein of 
interest are available. Western blot can also be challenging to perform without 
proper training, and is time-consuming.  An alternative to this technique is 
represented by direct measurement of caspase3/7 using fluorescence-based 
kits such as the Apo-ONE® Homogeneous Caspase-3/7 Assay (Promega, UK). 
Following rapid and efficient lysis/permeabilization of cultured mammalian cells, 
pro-fluorescent substrate rhodamine 110, bis-N-CBZ- L-aspartyl-L-glutamyl-L-
valyl-L-aspartic acid amide (Z-DEVD-R110), is cleaved as a direct consequence 
of caspase-3/7 activity. Subsequent excitation at 499nm makes the rhodamine 
110 leaving group intensely fluorescent. The emission maximum is 521nm. In 
this study, the Apo-ONE® Homogeneous Caspase-3/7 Assay was used to 
detect caspase activity in K17 keratinocytes and HDF following treatment with 
colloidal silica 10-200 µg/ml. Staurosporine, an anti-cancer drug routinely used 
in apoptosis assays, was used at 1-100 µM as positive control. Fluorescence 
intensity and optical density were measured using Gemini EM Microplate 
Reader (Molecular Devices, US). 
 
3.3.10 Molecular pathway analysis 
Study of cellular response to external stimuli at molecular levels, such as 
protein and gene expression, have provided important advances in many areas 
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of fundamental and applied biology. The latest technique development in gene 
expression profiling allows studying specific subset of target genes, or 
thousands of genes at once, thus creating a global picture of gene expression 
of an organism under a given condition. There are several techniques available 
to evaluate gene expression, such as Northern Blot, ribonuclease protection 
assay (RPA), serial analysis of gene expression (SAGE), reverse transcription-
polymerase chain reaction (RT-PCR), quantitative real-time polymerase chain 
reaction (qRT-PCR), PCR arrays, and microarrays. Among these techniques, 
Northern blot analysis remains a standard method for detection and quantitation 
of mRNA levels despite the advent of more robust techniques [129].  
In the last two decades, real-time PCR has become widely used in biomedical 
science research, and a reliable method to determine the expression level of 
target genes. It is a highly sensitive and quantitative method for the 
determination of copy number of PCR templates, such as DNA or cDNA. Its 
wide dynamic range makes real-time PCR the preferred choice for the 
simultaneous quantification of both rare and abundant genes in the same 
sample. Although a number of kits and reagents for real-time PCR are 
commercially available, the basic principle behind the technique is relatively 
simple and the same for all [130, 131]. There are two types of real-time PCR, a 
probe-based one and intercalator-based one. Probe-based real-time PCR, also 
known as TaqManTM PCR (Figure 3.16), requires a pair of specific primers and 
a fluorogenic probe complementary to the target sequence. The probe is an 
oligonucleotide with a reporter dye attached to the 5' end and a quencher dye 
attached to the 3' end. Until it is hydrolyzed, the quencher and the fluorophore 
remain separated by the probe itself; consequently, the reported dye is partially 
quenched and emits only background fluorescence. During PCR, the probe 
anneals specifically between the primers to an internal region of the PCR 
product. When the polymerase carries out the extension of the primer and 
replicates the template to which the TaqManTM is bound, the probe is cleaved, 
releasing the reporter molecule away from the close vicinity of the quencher 
thus increasing the fluorescence. This process repeats in every cycle and does 
not interfere with the accumulation of PCR product [132]. 
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Figure 3.16 The principle for TaqmanTM RT-PCR (modified from 
http://www.nature.com/nrd/journal/v3/n9/fig_tab/nrd1496_F1.html). 
 
The intercalator-based method requires the use of a dye such as SYBR Green 
(Figure 3.17), which binds to newly synthesized double-stranded DNA by 
intercalating between base pairs and generates fluorescence only when bound 
to DNA. Detection of the fluorescent signal occurs during the PCR cycle at the 
end of either the annealing or the extension step when the greatest amount of 
double-stranded DNA product is present. SYBR Green-based detection is the 
least expensive and easiest method available for real-time PCR; however, as 
SYBR Green detects any double-stranded DNA non-specifically, the reaction 
must contain a combination of primers and master mix that generates a single 
gene-specific amplicon without producing any non-specific secondary products. 
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Figure 3.17 SYBR Green and its intercalation inside dsDNA (modified from 
http://img.guidechem.com/pic/image/163795-75-3.png and 
http://eng.bioneer.com/products/geneexpression/qPCRArrayService-detection.aspx ). 
 
Both methods require the same equipment: a thermal cycler, equipped with a 
sensitive camera that monitors the fluorescence in each sample at frequent 
intervals during the PCR, as well as software for data collection and analysis. 
The principle behind real-time PCR consists of three steps (Figure 3.18): 1) 
total RNA isolation, 2) reverse transcription to cDNA, and 3) PCR [131, 133]. 
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Figure 3.18 The three steps involved in real-time PCR (modified from QIAGEN RT-PCR 
Handbook). 
 
Total RNA isolation refers to the extraction of RNA from biological samples. 
Extracting high-quality RNA might prove challenging, as this nucleic acid is 
labile and is rapidly degraded by ubiquitous RNases which occur naturally in all 
cells and are released following cell lysis, the first essential step of RNA 
extraction. To avoid this problem, modern day kits include buffers containing 
specific molecules, such as the highly denaturing guanidine-thiocyanate, which 
immediately inactivates RNases to ensure purification of intact RNA. Following 
lysis and proper homogenization of the sample, a number of approaches to 
RNA extraction are available, although the most commonly used are based on a 
solid phase approach such as column-binding purification combined with 
microspin technology. Reverse transcription involves the use of the enzyme 
reverse transcriptase to generate single-stranded complementary DNA (cDNA) 
from the extracted RNA. Reverse transcriptases (RTs) use an RNA template 
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and a short primer complementary to the 3' end of the RNA to direct the 
synthesis of the first strand cDNA which can be used directly as a template for 
real-time PCR. Alternatively, the first-strand cDNA can be made double-
stranded using DNA Polymerase I and DNA Ligase [134, 135]. 
To understand the molecular pathway of silica-induced apoptotic cell death, 
6x105 HaCaT cells/well were seeded in 6-well plates and cultured until 70% 
confluence was reached. Each well was then treated with SiNP20 10-50 µg/ml 
in CM-10% for 24 h. After incubation, particles were removed and cells 
harvested by trypsinization and centrifugation. The resulting pellets were 
allowed to completely dry, then dislodged and treated with 350-700 µl RLT 
Buffer (RNeasy Total RNA Extraction Kit, QIAGEN, UK). The lysate was then 
centrifuged 2 minutes into a QIAshredder spin column (QIAGEN, UK), and 
resuspended in 1 volume of 70% ethanol. The mix was then transferred in an 
RNeasy spin column and centrifuged 15 s at ≥8000 x g (≥10,000 rpm). After 
centrifugation, the flow-through was discarded, then 700 µl Buffer RW1 
(RNeasy Total RNA Extraction Kit, QIAGEN, UK) was added to the spin 
column, then centrifuged for 15 s at ≥8000 x g (≥10,000 rpm). This step was 
repeated again twice using 500 µl Buffer RPE (RNeasy Total RNA Extraction 
Kit, QIAGEN, UK); after that, 30-50 µl of RNase free water were added and the 
samples were centrifuged at full speed for 1 min to collect the purified RNA. 
RNA purity and concentration was verified by using Pico100TM (Picodrop, UK).  
After verification, approximately 0.8 µg RNA/sample were mixed with RNase-
free water and Buffer GE (RT2 First Strand Kit, QIAGEN, UK) and put in 
Techne TC-512 thermocycler (Bibby Scientific, UK) for 5 min at 42oC. After that, 
samples were placed in ice for 1 minute, and then mixed with 5x Buffer BC3, 
Control P2, RE3 Reverse Transcriptase, RNase-free water (RT2 First Strand 
Kit, QIAGEN, UK); the mix was incubated at 42°C for exactly 15 min, then 
immediately at 95°C for 5 min. In the end, 91 µl of RNase-free water were 
added to each sample. The samples were then mixed with 2x RT2 SYBR Green 
ROX FAST Mastermix (QIAGEN, UK) and RNase-free water, and loaded in 
Cell-Death Pathway-Finder RT2 Profiler PCR Array (QIAGEN, UK) using 
QIAgility automated sample loading (QIAGEN, UK) to minimize operator-related 
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loading errors. The loaded ring was then sealed with Rotor-Disc Heat-Sealing 
Film (QIAGEN, UK) and placed inside Rotorgene Q100 (QIAGEN, UK). The 
samples were run for 10 minutes at 95oC, then for 40 cycles of 15s/95oC – 
30s/60oC. The collected data were then analyzed using the Rotorgene 
Software. 
 
3.3.11 Statistics 
All experiments were performed at least three times and one of the 
representative experiment data was presented. For MTT and LDH assays, the 
mean values of three replicates were expressed as percentage of negative 
control (cells without treatment) with standard deviation (mean ± SD). Two-
tailed unpaired t-test and one-way ANOVA were used for comparison of 
differences between samples and the control. The differences were considered 
significant when p ≤ 0.05. 
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4 RESULTS 
4.1 Fumed Amorphous Silica 
4.1.1 Characteristics in suspension 
In order to determine the particles’ size, solubility and stability in cell culture 
media, fumed silica particles suspended in media with 10% FBS (CM-10%) and 
0% FBS (CM) were characterized by Dynamic Light Scattering (DLS) at 0 and 
24 h after incubation at 4oC (storage conditions). The resultant hydrodynamic 
(Hd) size of the particles in the suspensions was compared with the given size 
of the respective silica particles (Table 4.1) while their dispersion properties 
were assessed by observation of their polydispersion index (PDI). Particle-free 
CM-10% and CM were used as background controls (Table 4.2).  The particles 
average size in CM-10% was larger than that in CM, suggesting that the 
presence of larger clusters was attributable to FBS proteins. 24 h incubation 
resulted in an increase in average size and PDI.   
 
Table 4.1 Characteristics of fumed silica (see Appendices for full Sigma Aldrich specification 
sheets). 
 SiNP7 SiNP14 
Given size (nm) 7 14 
Surface area (m2/g) 390±40 200±25 
 
The DLS assay of fumed silica 7 (SiNP7) and 14 nm (SiNP14) at 25-100 µg/ml 
suspended in CM-10% and CM was performed. In CM-10% both SiNP7 and 
SiNP14 showed an Hd size around 20 nm and PDI 0.4 and 0.3 respectively, 
when measured at 25 µg/ml 0 h (Table 4.3).  The increase of incubation time to 
24 h had little effect while increasing particle concentration to 100 µg/ml 
resulted in an increase in PDI, indicating the tendency of particle aggregation. In 
CM (Table 4.4), on the other hand, the Hd size/PDI increased to 677 nm/0.6 
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and 375 nm/0.7 for SiNP7 and SiNP14 respectively when measured at 0 h, 
while the particles Hd size and PDI became much smaller with extension of 
incubation time to 24 h and increase of concentration to 100 µg/ml, suggesting 
that these particles were unstable when suspended in CM due to formation of 
aggregates, which appeared larger for SINP7 than SiNP14.  
 
Table 4.2 DLS assay of particle-free CM-10% and CM. Particle-free media was measured in 
order to detected background molecule clusters after 0 and 24 h incubation at 4 °C (storage 
conditions). Results are expressed as Average size (Average (nm)), to indicate the size of 
measured clusters, and polydispersion index (PDI) to indicate stability of the clusters in solution. 
Average size was measured lower in CM due to the different amount of proteins and other 
serum components. Five measurements were performed for each sample using Malvern 
Zetasizer. 
Culture 
Media 
0 h 24 h 
Average 
(nm) 
PDI Average 
(nm) 
PDI 
CM-10% 19 0.4 26.4 0.6 
CM 4.4 0.3 9.3 0.5 
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Table 4.3 DLS assay of fumed silica in CM-10%. SiNP7 and SiNP14 were analysed at 25 and 
100 µg/ml after 0 and 24 h incubation at 4 °C (storage conditions). Results are expressed as 
Average size (Ave. (nm)), to indicate the size of measured clusters, and polydispersion index 
(PDI) to indicate stability of the clusters in solution. Five measurements were performed for 
each sample using Malvern Zetasizer. 
NPs in 
CM-10% 
25 µg/ml 100 µg/ml 
0 h 24 h 0 h 24 h 
Ave. 
(nm) 
PDI Ave. 
(nm) 
PDI Ave. 
(nm) 
PDI Ave. 
(nm) 
PDI 
SiNP7 20 0.4 19 0.4 20 0.4 24.4 0.4 
SiNP14 20.2 0.3 19.4 0.4 20.4 0.4 19.3 0.4 
 
Table 4.4 DLS assay of fumed silica in CM. SiNP7 and SiNP14 were analysed at 25 and 100 
µg/ml after 0 and 24 h incubation at 4 °C (storage conditions). Results are expressed as 
Average size (Ave. (nm)), to indicate the size of measured clusters, and polydispersion index 
(PDI) to indicate stability of the clusters in solution. Five measurements were performed for 
each sample using Malvern Zetasizer. 
 
NPs in CM 25 µg/ml 100 µg/ml 
0H 24H 0H 24H 
Ave. 
(nm) 
PDI Ave. 
(nm) 
PDI Ave. 
(nm) 
PDI Ave. 
(nm) 
PDI 
SiNP7 677 0.6 543 0.3 325.4 0.5 500.1 0.4 
SiNP14 375 0.4 259 0.1 276.2 0.3 304 0.2 
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The dispersion behavior of the particles in cell culture media could be better 
demonstrated by showing the DLS profile (Figure 4.1 a-l). The dispersion 
patterns for SiNP7 and SiNP14 in CM-10% were very different from that of the 
background particles, although they shared a similar average particles size 
(Table 4.1 and 4.2).  The difference in the dispersion profiles of silica particles 
in CM-10% and CM indicated the interaction of the particles with FBS 
components, whereas the wider size distribution after 24 h incubation presented 
evidence of instability of the particles in the suspensions (compare black with 
red line for each particle profile). 
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Figure 4.1 DLS profiling of particle dispersion patterns in CM-10% and CM. a, f: culture media 
presenting background particles; b, c, d and e: dispersion patterns of SiNP7 and SiNP14 in CM-
10%; g, h, i and l: dispersion patterns of SiNP7 and SiNP14 in CM. 
 
To get confirmation of DLS analysis and gain information on particle shape, 
SEM imaging of SiNP7 at 10 µg/ml in water was performed (Figure 4.2). The 
particles were shown as round-shaped,  forming chain-like structures  with size 
far beyond the given size, confirming formation of aggregates consistent with 
the DLS measurement for particles suspended in CM (Figure 4.1, d-f).    
 
 
Figure 4.2 SEM Imaging of SiNP7. SEM imaging in water at 10 µg/ml was performed using 
Philips XL30 SFEG. Scale bar: 1 µm. 
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4.1.2 In vitro cytotoxicity assessment and induction of apoptotic cell death   
Human skin HaCaT cells were used to examine the cytotoxic potential of fumed 
silica nanoparticles by assays of cell viability (MTT) and flow cytometry 
detection of necrotic and apoptotic cell death. Cellular uptake was also 
examined to provide insights into the relationship between particle 
internalization/subcellular location and cytotoxicity. All the assays were 
performed on particle-free cultures as reference and cells treated with SiNP7 
and SiNP14 at 10-200 µg/ml in CM-10% or CM. After 24 h treatment, a 
significant effect of both SiNP7 and SiNP14 on cell viability could only be 
detected in the absence of FBS at concentrations ≥50 µg/ml (Figure 4.3).   
  
 
      
 
  
Figure 4.3 Effect of fumed silica nanoparticles on cell viability in HaCaT cells assessed by 
MTT assay. HaCaT cells were treated with SiNP7 and SiNP14 in CM-10% and CM and cell 
viability was assessed at 24 h treatment. Results were expressed as percentage of negative 
control, indicating increase/decrease of cellular metabolism in particle-treated samples 
compared with cellular metabolism in particle-free control. Black line serves as reference for 
normal cellular activity. Each particle concentration was tested in triplicates and the results 
analysed by one-way ANOVA and Student’s t-test. Statistically significant results (p<0.05) are 
marked with an asterisk (*) on top of the corresponding bar. 
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To assess whether the cytotoxicity of SiNP7 and SiNP14 was due to the 
particles’ cellular uptake, HaCaT cells were treated for 24 h and then subjected 
to flow cytometry for semi-quantification of silica NPs cellular uptake. The 
profiles of cellular uptake of silica nanoparticles are displayed in Figure 4. The 
shift of peaks to the right indicated cellular uptake of the fluorescent particles. A 
weak concentration-dependent increase of cellular uptake of both SiNP7 and 
SiNP14 was detected when tested in CM-10%, while the uptake was much 
greater when tested at ≥50 µg/ml in CM (Figure 4.4 and Table 4.5). These data 
suggested that the cytotoxicity of SiNP7 and SiNP14 was correlated with their 
cellular uptake.    
 
 
Figure 4.4 Flow cytometry assay of cellular uptake of fumed silica nanoparticles. HaCaT cells 
were treated with the particles at 10-200 µg/ml in CM-10% and CM for 24 h. Results are 
expressed as number of cells vs. detected fluorescence. The red line separates the left part of 
the graph, which indicates non-fluorescent cells associated with particle-free cells, from the right 
part of the graph, which shows fluorescence positive cells associated with silica particles 
uptake. 
 Control  10 µg/ml  25 µg/ml  50 µg/ml  100 µg/ml  200 µg/ml 
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Table 4.5 Flow cytometry quantification of silica nanoparticles’ cellular uptake. The results as 
shown in Figure 4.4 were qualitatively analyzed using BD CSampler software as described in 
the methods section. Each value of the table corresponds to the percentage of fluorescence 
detected by the flow cytometer and previously expressed as cell count vs. fluorescence. 
 Uptake in CM-10% Uptake in CM 
SiNP7 SiNP14 SiNP7 SiNP14 
Negative Control N/A N/A N/A N/A 
10 µg/ml 0.5% 0.5% 0.2% 0.1% 
25 µg/ml 0.8% 0.6% 0.6% 0.2% 
50 µg/ml 4.8% 5.2% 5.1% 1.7% 
100 µg/ml 14.3% 9% 24.3% 32.5% 
200 µg/ml 39.6% 29.5% 97.6% 93.6% 
 
The results of cellular uptake obtained by flow cytometry were partially 
confirmed by TEM imaging on HaCaT cells, in collaboration with Dr. David 
Dinsdale and Prof. Marion MacFarlane, MRC toxicology unit, Leicester (UK). 
Cells were treated with Silica 7 25 µg/ml in CM-10%, fixed and analyzed by 
TEM at different magnifications. The TEM images showed no evidence of 
cellular uptake at this concentration (data not shown), consistent with the data 
from the flow cytometry assay.  
To investigate the toxicity mechanism of fumed silica nanoparticles on HaCaT 
cells, Annexin V/FITC and Propidium Iodide (PI) double staining and 
subsequent flow cytometry were employed to detect necrotic and apoptotic cell 
death. As shown in Figure 4.5, approximately 90% of untreated cells were not 
stained with PI and Annexin V/FITC when cultured in particle-free CM-10% and 
CM. In CM-10% both SiNP7 and SiNP14 at 5-25 µg/ml induced a slight 
increase in FITC-positive and PI/FITC double positive staining cells in a 
concentration-dependent manner. In contrast, when tested in CM, both SiNP7 
and SiNP14 induced a great increase of FITC positive and PI/FITC double 
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positive staining cells (Figure 4.6), indicative of apoptotic cell death.  The 
induction of apoptotic cell death by the silica nanoparticles was detected at the 
lowest concentration and reached more than 90% at the highest concentration 
tested. These results suggested that in HaCaT cells the toxicity of fumed silica 
NPs, as detected by the MTT assay, was via induction of apoptosis.  
 
 
 
Figure 4.5 Apoptosis assay of fumed silica in CM-10%. HaCaT cells were treated with SiNP7 
and SiNP14 at 5-25 µg/ml in CM-10% for 24 h. Following treatment, double staining with 
propidium iodide (PI) and Annexin V/FITC was performed and using BD Accuri C6 flow 
cytometer. For each sample 10.000 events were recorded, and the results expressed as PI 
fluorescence vs. Annexin V/FITC fluorescence. In each quadrant, quantification is reported as 
percentage of detected fluorescence. 
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Figure 4.6 Apoptosis assay of fumed silica in CM. HaCaT cells were treated with SiNP7 and 
SiNP14 at 5-25 µg/ml in CM for 24 h. Following treatment, double staining with propidium iodide 
(PI) and Annexin V/FITC was performed and using BD Accuri C6 flow cytometer. For each 
sample 10.000 events were recorded, and the results expressed as PI fluorescence vs. Annexin 
V/FITC fluorescence. In each quadrant, quantification is reported as percentage of detected 
fluorescence. 
 
4.2 Colloidal Amorphous Silica  
4.2.1 Characteristics in suspension  
In order to determine particles’ size and behaviour in different media, Dynamic 
Light Scattering (DLS) was performed to determine their hydrodynamic (Hd) size 
and their dispersion properties, indicated by the polydispersion index (PDI). As 
silica particles may behave diversely in different testing media, in this study 
colloidal amorphous silica particles were characterized in five different cell 
culture media at concentrations that were used for assessing their cellular 
effects. The tested media included DMEM/F-12 with 10% (CM-10%), 0.5% (CM-
0.5%) and 0% (CM) FBS, plus EpiLife™ medium and Medium 106, as these 
media were used for culturing different types of cells in this research. Particle-
free media were analysed as background controls for pre-existing clusters of 
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biomolecules such as sugars, aminoacids and proteins that might interfere with 
the measurement of added particles. As shown in Table 4.6, pre-existing 
clusters were detected in all the tested media. The clusters appeared to be 
similar in size in CM-10%, CM-0.5% and Medium 106, while they appeared 
smaller in CM and larger in EpiLife™ Medium. The difference in size of the 
particles detected in the culture media reflects the difference of their 
composition.  
 
Table 4.6 DLS assay of cell culture media. Five different types of media were used for particle 
dispersion: CM-10% (DMEM/F-12 + 10% FBS), CM-0.5% (DMEM/F-12 + 0.5% FBS), CM 
(DMEM/F-12 + 0%FBS), EpiLife™ Medium, and Medium 106. Particle free media were 
analysed as background controls after 0 and 24 h incubation at 4 °C (storage conditions). 
Results are expressed as Average size (Average (nm)), to indicate the size of measured 
clusters, and polydispersion index (PDI) to indicate stability of the clusters in solution. Five 
measurements were performed for each sample using Malvern Zetasizer. 
Neg. Contr. 0 h 24 h 
Average 
(nm) 
PDI Average 
(nm) 
PDI 
CM-10% 19 0.4 26 0.6 
CM-0.5% 18 0.4 26 0.2 
CM 4 0.3 9 0.5 
EpiLife™  71 0.5 119 0.3 
Medium 106 17 0.4 17 0.4 
 
SiNP20, SiNP70, SMP200 and SMP500 at 25-100 µg/ml were suspended in 
cell culture media and analysed at 0 and 24 h after incubation at 4°C (storage 
conditions).  To gain insights into the stability of the particles in the suspensions 
over time, the size of the particles detected by the DLS were compared with 
their given size by the material supplier (Table 4.7).  
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Table 4.7 Characteristics of colloidal silica (see Appendices for full Sigma Aldrich and 
Postnova Analytics specification sheets). 
 SiNP20 SiNP70 SMP200 SMP500 
Manufacturer Sigma-Aldrich Postnova 
Analytics 
Postnova 
Analytics 
Postnova 
Analytics 
Given size (nm) 20 nm 70 nm 200 nm 500 nm 
Surface area 
(m2/g) 
198-258 43 15 6 
 
When suspended in CM-10% at 25, 50, 100 µg/ml (Table 4.8), all the 4 particles 
showed an average Hd size different from their given one. For SiNP20, the Hd 
size was 3-5 times larger with PDI 0.3-0.5, depending on the concentration. The 
increase in size suggested that SiNP20 might either form aggregates or adsorb 
proteins in the culture medium. For SiNP70, SMP200 and SMP500, their Hd 
size was smaller than their given one when measured at 25 µg/ml, whereas 
when measured at higher concentrations, SINP70 became slightly larger with 
SMP200 unchanged and SMP500 smaller as compared with their given size.  
The big size decrease of SMP500 when measured at 24 h after suspension was 
associated particle sedimentation, which was readily visualized.  According to 
the consistency between the DLS data and their given size, SiNP70 and 
SMP200 have better colloidal stability than SiNP20 and SMP500.   
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Table 4.8 DLS assay of colloidal silica in CM-10%. SiNP20, SiNP70, SMP200 and SMP500 
were analysed at 25, 50 and 100 µg/ml after 0 and 24 h incubation at 4 °C (storage conditions). 
Results are expressed as Average size (Ave. (nm)), to indicate the size of measured clusters, 
and polydispersion index (PDI) to indicate stability of the clusters in solution. Five 
measurements were performed for each sample using Malvern Zetasizer. 
CM-
10% 
25 µg/ml 50 µg/ml 100 µg/ml 
0H 24H 0H 24H 0H 24H 
Ave. 
(nm) 
PDI Ave. 
(nm) 
PDI Ave. 
(nm) 
PDI Ave. 
(nm) 
PDI Ave. 
(nm) 
PDI Ave. 
(nm) 
PDI 
SiNP20 61 0.5 91 0.5 145 0.3 131 0.3 96 0.4 119 0.3 
SiNP70 38 0.5 35 0.6 90 0.3 88 0.3 96 0.3 93 0.3 
SMP200 128 0.7 93 0.7 197 0.3 195 0.2 208 0.2 202 0.2 
SMP500 50 1.00 48 1.00 312 0.8 147 0.7 426 0.4 216 0.7 
 
When suspended in CM-0.5%, SiNP20, SiNP70 and SMP200 were all larger 
than their given size (Table 4.9). The size increase was more than 5 folds for 
SiNP20 and just over 1 fold for SiNP70 and SMP200. These data suggested 
that the size increase could be either due to particle aggregation for the small 
SiNPs or adsorption of proteins for the larger particles. For SMP500, the Hd size 
was very close to its given size.  
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Table 4.9 DLS assay of colloidal silica in CM-0.5%. Particles were analyzed at 25, 50 and 100 
µg/ml after 0 and 24 h incubation at 4 °C (storage conditions). Results are expressed as 
Average size (Ave. (nm)), to indicate the size of measured clusters, and polydispersion index 
(PDI) to indicate stability of the clusters in solution. Five measurements were performed for 
each sample using Malvern Zetasizer. 
CM-
0.5% 
25 µg/ml 50 µg/ml 100 µg/ml 
0H 24H 0H 24H 0H 24H 
Ave. 
(nm) 
PDI Ave. 
(nm) 
PDI Ave. 
(nm) 
PDI Ave. 
(nm) 
PDI Ave. 
(nm) 
PDI Ave. 
(nm) 
PDI 
SiNP20 122 0.2 148 0.2 92 0.2 98 0.2 155 0.3 159 0.3 
SiNP70 121 0.2 119 0.2 112 0.1 112 0.11 201 0.3 127 0.1 
SMP200 287 0.01 266 0.08 221 0.2 216 0.3 264 0.01 255 0.03 
SMP500 491 0.1 511 0.3 320 0.6 241 0.7 499 0.06 455 0.1 
 
Moreover, when suspended in CM, all the particles exhibited Hd size very close 
to their given size (Table 4.10), suggesting no particle aggregation and 
biomolecule adsorption.   It could be seen from Table 4.9 and 4.10 that the PDI 
was ≤0.2 for SiNP70, SMP200 and SMP500, while it was higher for SiNP20, 
suggesting lower colloidal stability in culture medium for the smallest 
nanoparticles.  
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Table 4.10 DLS assay of colloidal silica in CM. Particles were analyzed at 25, 50 and 100 
µg/ml after 0 and 24 h incubation at 4 °C (storage conditions). Results are expressed as 
Average size (Ave. (nm)), to indicate the size of measured clusters, and polydispersion index 
(PDI) to indicate stability of the clusters in solution. Five measurements were performed for 
each sample using Malvern Zetasizer. 
CM 25 µg/ml 50 µg/ml 100 µg/ml 
0H 24H 0H 24H 0H 24H 
Ave. (nm) PDI Ave. (nm) PDI Ave. (nm) PDI Ave. (nm) PDI Ave. (nm) PDI Ave. (nm) PDI 
SiNP20 19 0.4 19 0.5 20 0.4 20 0.5 29 0.5 22 0.4 
SiNP70 73 0.07 73 0.07 75 0.02 81 0.07 71 0.05 72 0.03 
SMP200 193 0.08 190 0.04 244 0.15 343 0.17 183 0.02 184 0.01 
SMP500 527 0.23 498 0.02 505 0.01 478 0.05 492 0.03 473 0.02 
 
In EpiLife™ Medium (Table 4.11), the Hd size of SiNP20, SiNP70 and SMP200 
increased in the order of SiNP70>SiNP20>SMP200, while the Hd size of 
SMP500 showed little difference from its given size. Particle agglomeration and 
sedimentation could be detected for SiNP20 and SiNP70; SMP200 showed a 
Hd size more than 1 fold larger than its given size, while SMP500 showed a Hd 
size (530/488) compatible with the one given by the manufacturer and good 
dispersion (0.2). This sharp difference in particle behaviour was associated with 
different media composition, as shown in the negative control DLS 
measurement, where size average and PDI were higher compared with other 
media (71/119, 0.5-0.3).  
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Table 4.11 DLS assay of colloidal silica in EpiLife™ Medium. Particles were analyzed at 50 
µg/ml after 0 and 24 h incubation at 4 °C (storage conditions). Results are expressed as 
Average size (Ave. (nm)), to indicate the size of measured clusters, and polydispersion index 
(PDI) to indicate stability of the clusters in solution. Three measurements were performed for 
each sample using Malvern Zetasizer. 
Epilife™ 
Medium 
50 µg/ml 
0H 24H 
Ave. 
(nm) 
PDI Ave. 
(nm) 
PDI 
SiNP20 123 0.6 130 0.9 
SiNP70 1215 0.3 3688 1.0 
SMP200 314 0.1 362 0.2 
SMP500 530 0.1 488 0.2 
 
The particles Hd size in Medium 106 were displayed in Table 4.12. SiNP20 
again showed Hd size more than 4 folds larger than it given size, while SiNP70 
retained its given size.  The Hd size of the two SMPs was much smaller than 
expected with high PDIs, indicating unstable colloidal status.  
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Table 4.12 DLS assay of colloidal silica in Medium 106. Particles were analyzed at 50 µg/ml 
after 0 and 24 h incubation at 4 °C (storage conditions). Results are expressed as Average size 
(Ave. (nm)), to indicate the size of measured clusters, and polydispersion index (PDI) to indicate 
stability of the clusters in solution. Three measurements were performed for each sample using 
Malvern Zetasizer. 
Medium 
106 
50 µg/ml 
0H 24H 
Ave. 
(nm) 
PDI Ave. 
(nm) 
PDI 
SiNP20 109 0.3 119 0.2 
SiNP70 97 0.2 100 0.2 
SMP200 188 0.4 166 0.6 
SMP500 87 1.0 48 1.0 
 
Further analysis was performed after 24 h incubation at 37oC (Table 4.13) for 
CM-10% and CM in order to mimic cellular growth conditions. Such analysis 
showed similar data compared with CM, but high aggregation in CM-10%.  
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Table 4.13 DLS assay of colloidal silica in CM-10% and CM after 24 h at 37oC. Results are 
expressed as Average size (Ave. (nm)), to indicate the size of measured clusters, and 
polydispersion index (PDI) to indicate stability of the clusters in solution. Five measurements 
were performed for each sample using Malvern Zetasizer. 
37oC 
24H 
50 µg/ml 
CM-10% CM 
Ave. 
(nm) 
PDI Ave. 
(nm) 
PDI 
SiNP20 813 0.6 28 1.0 
SiNP70 69 0.6 87 0.2 
SMP200 135 0.6 213 0.04 
SMP500 54 1.0 468 0.1 
 
Additional information on particle stability in solution was sought by Zeta 
Potential (ZP) analysis of particles at 100 µg/ml. All particles exhibited a weak 
negative zeta potential (Table 4.14) in CM.  When suspended in CM-10%, a 
slight decrease in ZP was detected for the particles ≥70 nm. These results 
suggested that due to the weak zeta potential, these particles could be unstable 
in CM-10% and CM, which could have implications in the mechanism of their 
cytotoxicity.  
 
Table 4.14 Zeta potential assay of colloidal silica in CM-10% and CM. Particles were 
examined at 100 µg/ml using Malvern Zetasizer. Three measurements were performed for each 
sample using Malvern Zetasizer. 
 CM-10% CM SiNP20 SiNP70 SMP200 SMP500 
CM-10% -10 N/A -13 -14 -10 -12 
CM N/A -11 -13 -18 -19 -14 
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SEM and TEM were employed to gain information on the shape of particles and 
to confirm their size as measured by DLS. Initial imaging of particles in CM and 
CM-10% proved difficult in determination of particle size, due to intrinsic 
problems during sample preparation linked to the sugars inside the media (data 
not shown). Subsequently, all the particles were analysed by SEM (Figure 4.7) 
and TEM (Figure 4.8) in deionized water at 25 µg/ml to avoid any more 
background noise. Both imaging studies highlighted the differences in shape 
between SiNP20, SiNP70, SMP200 and SMP500. In  the SEM images, it was 
observed that  SiNP70, SMP200 and SMP500 all retained a perfect spherical 
shape and size consistent with their given size, while SiNP20 appeared rod 
shaped and larger than its given size, suggesting the formation of aggregates 
that was further confirmed by the TEM imaging. In TEM images, SiNP20 
showed very distinct signs of agglomeration, making particle size measurement 
challenging. The rest of the images confirmed that the spherical shape and size 
of SiNP70, SMP200 and SMP500 were correlated with their given size. 
   
   
Figure 4.7 SEM imaging of colloidal silica particles. a: SiNP20; b: SiNP70; c: SMP200; 
d:SMP500. Particles were analysed in deionized water at 25 µg/ml using Philips XL30 SFEG. 
Scale bar: 1 µm. 
a b 
c d 
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Figure 4.8 TEM imaging of colloidal silica particle in water. a: SiNP20; b: SiNP70; c: SMP200; 
d:SMP500. Particles were analysed in deionized water at 25 µg/ml using Philips CM20 TEM 
(Philips, Netherlands). Scale Bar: 100 nm.  
 
4.2.2 In vitro cytotoxicity assessment and wound healing induction on HaCaT cells 
(a) Effects on Cell Viability and Membrane Damage. In order to assess the 
cytotoxic potential of colloidal silica particles in vitro, human skin HaCaT cells 
were initially employed. The cells were treated with colloidal silica at 25-100 
µg/ml in CM-10%, CM-0.5% and CM, then analysed for cell viability, membrane 
damage and morphology changes using MTT, LDH and phase contrast 
microscopy assays. When tested in CM-10%, SiNP20 induced a dose-
dependent (15-60%) reduction in cell viability at ≥ 25 µg/ml (Figure 4.9, blue 
a b 
c d 
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bars in a), which was accompanied with a notable increase in LDH release 
(Figure 4.9, blue bars in b), suggesting that cytotoxicity was due to loss of cell 
membrane integrity. In the same conditions SiNP70 showed a 30% increase in 
cell viability at 25-50 µg/ml (Figure 4.9, red bars in a). The similar remarked 
effects were also detected for SiNP20 in CM-0.5% and CM (Figure 4.9, blue 
bars in c, d, e and f).  On the other hand, SiNP70 only caused a dose-
dependent reduction of cell viability and increase of  LDH release when tested 
in CM (Figure 4.9, red bars in e and f), while SMP200 and SMP500 had little 
effect regardless of the test media (Figure 4.9, green and purple bars). These 
results provided evidence that colloidal silica toxicity is size-dependent. 
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Figure 4.9 MTT and LDH assays on HaCaT cells following 24 hours treatment with colloidal 
silica. a, b: cells treated with particles in CM-10%; c, d: cells treated with particles in CM-0.5%; 
e-f: cells treated with particles in CM. Results were expressed as percentage of negative 
control, black line serves as reference for normal activity.Each particle concentration was tested 
in triplicates and the results analysed by one-way ANOVA and Student’s t-test. Statistically 
significant results (p<0.05) are marked with an asterisk (*) on top of the corresponding bar. 
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(b) Effect on morphology. The difference in morphology between control cells 
and those treated with colloidal silica for 24 hours were readily observed using 
phase contrast light microscopy. Control cells maintained in CM-10% showed 
an adherent growth pattern and morphology with rounded nuclei and membrane 
projections as indicated by the arrows in Figure 4.10 (a). This feature of cell 
morphology was associated with active cell growth.  Control cells maintained in 
CM, on the other hand, exhibited an adherent feature with relatively larger 
nuclei (Figure 4.10, f compared with a), which could indicate the blockage of 
cell division. In CM-10%, SiNP20 caused detachment of cells from the culture 
surface in a concentration- dependent manner; the remaining attached cells 
showed irregular shape in CM-10% (Figure 4.10, b compared with a). Cells 
treated with SiNP70 showed very similar morphology as compared with control 
cells but much higher cell density (Figure 4.10, c compared with a), indicative 
of active cell growth. SMP200 also induced a similar morphological change to 
SiNP70, although cell density was much lower (Figure 4.10, d compared with 
c). Cells treated with SMP500 showed a flattened morphology, reflecting the 
impact of the substantial sedimentation of these large particles (Figure 4.10, e 
compared with a).  In CM, SiNP20 again caused detachment of cells from the 
culture surface in a concentration- dependent manner; the remaining attached 
cells displayed much smaller nuclei (Figure 4.10, g compared with f). Cells 
treated with SiNP70 showed lower density with cell morphology resembling to 
cells treated with SiNP20 (Figure 4.10, h compared with g), suggesting a 
comparable mechanism of cytotoxicity.  Cells treated with SMP200 and 
SMP500 showed a flattened morphology, reflecting once again the impact of 
the substantial sedimentation of these large particles (Figure 4.10, i and j 
compared with f). Nonetheless, these cells retained a relatively high density, 
suggesting that treatment with SMP200 and SMP500 had little effect on cell 
viability.    
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Figure 4.10 Phase contrast imaging of HaCaT cells after 24 h treatment with colloidal silica. a, 
f: Untreated cells; b, g: cells treated with SiNP20; c, h: cells treated with SINP70; d, i: cells 
treated with SMP200; e, j: cells treated with SMP500. Arrows in images a, c, d indicate cellular 
proliferation in the corresponding sample. 
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(c) Cellular Uptake and subcellular location.  In order to investigate whether silica 
size-dependent toxicity was associated with cellular uptake of the particles, flow 
cytometry and TEM imaging were performed. Figure 4.11 and Table 4.15 present the 
flow cytometry profiles of cellular florescence intensity and semi quantification of 
fluorescent positive cells after 24 h treatment with fluorescent particles. The shift of 
peaks for cells treated with silica of different size to the right of control cells indicates a 
dose-related increase of cellular uptake of particles. SiNP20 was excluded from this 
assay as it was not FITC-labelled. When tested in CM-10%, cell uptake was detected 
for all particles at 25-200 µg/ml and appeared to be higher for SMPs than SiNP70, 
which was associated with sedimentation of the larger particles in cell culture. When 
tested in CM on the other hand, the uptake increased markedly with 99-100% of cells 
being fluorescent positive with silica at 25 µg/ml. Further increase of concentration to 
200 µg/ml resulted in a decrease of cell count; the effect was more pronounced for 
SiNP70, which could be due to the size-dependent toxicity.  
 
Figure 4.11 Cellular uptake of colloidal silica measured by flow cytometry. HaCaT cells were 
treated with colloidal silica at 25-200 µg/ml for 24 h in CM-10% and CM. Results are expressed 
as number of cells vs. detected fluorescence. The red line separates the left part of the graph, 
which indicates non-fluorescent cells associated with particle-free cells, from the right part of the 
graph, which shows fluorescence positive cells associated with silica particles uptake. 
 
 
 Control  10 µg/ml  25 µg/ml  50 µg/ml  100 µg/ml  200 µg/ml 
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Table 4.15 Flow cytometry quantification of silica nanoparticles’ cellular uptake. The results as 
shown in Figure 4.11 were qualitatively analyzed using BD CSampler software as described in 
the methods section. Each value of the table corresponds to the percentage of fluorescence 
detected by the flow cytometer and previously expressed as cell count vs. fluorescence. 
 SiNP70 SMP200 SMP500 
CM-10% CM CM-10% CM CM-10% CM 
Negative Control N/A N/A N/A N/A N/A N/A 
10 µg/ml 2.6% 84.3% 2.1% 98.7% 52.8% 95.5% 
25 µg/ml 15.7% 99.3% 11.4% 99.8% 48.7% 99.7% 
50 µg/ml 64.9% 99.8% 63.5% 99.9% 76.8% 99.3% 
100 µg/ml 84.2% 99.5% 88.3% 99.9% 96.1% 99.6% 
200 µg/ml 93.6% 99.1% 95% 99.3% 97.9% 99.6% 
 
To confirm cellular uptake of colloidal silica as well as investigate their cellular 
location, HaCaT cells were treated with all particles at 25 µg/ml for 24 hours in 
CM-10% and analyzed by TEM imaging (Figure 4.12). Untreated HaCaT cells 
showed a well-defined cytoplasmic and nuclear ultrastructure, whereas cells 
treated with silica particles showed evidence of particle uptake.  SiNP20 was 
mostly observed in multi-vesicular bodies/merged endosomes.  The lack of a 
defined shape of these nanoparticles is consistent with SEM and TEM 
characterization and can be linked to particle agglomeration. SiNP70, SMP200 
and SMP500, on the other hand, retained their spherical shape and were found 
mostly in intracellular vacuoles (indicated by black arrows in e-g & i- j) and 
also free in cytoplasm (indicated by white arrows in e, h, j). None of the 
particles were found in nuclei. 
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Figure 4.12 Uptake of colloidal silica inside HaCaT cells measured by TEM imaging. HaCaT 
cells were treated with particles at 25 µg/ml for 24 h in CM-10%. a,b: untreated cells; c, d: cells 
treated with SiNP20; e, f: cells treated with SiNP70; g, h: cells treated with SMP200; I, j: 
SMP500. Scale bar: 1µm. Black/white arrows indicate the corresponding particle in each image, 
while N=nucleus. Images taken by Dr. David Dinsdale, MRC Toxicology Unit (Leicester, UK). 
 
(d) Effect on wound healing. The effect observed in phase contrast imaging 
for SiNP70 and SMP200 in CM-10% suggested that silica could have the 
potential to promote cell growth in a size dependent manner. As cell growth 
plays a critical role in wound healing, silica particles were further investigated 
for their effect on wound healing in vitro using HaCaT cells in collaboration with 
Dr. Lino Ferreira and Michela Comune at CNBC (Centre of Neuroscience and 
Cell Biology), Coimbra (Portugal). As observed via light microscopy, cell 
migration to the wound area was relatively low for untreated cells (Figure 4.13, 
a-d), whereas cell migration was promoted by all silica particles (e-t).  A size-, 
concentration- and time-dependent effect in promoting wound closure was 
demonstrated using the AxioVision (Carl Zeiss) software. The maximum effect 
was achieved at 25 µg/ml for all particles at 72 hours (Figure 4.14). For SiNP20 
and SMP200 (Figure 4.14, a and c), further increase in concentration resulted 
in significant toxicity as observed under light microscopy (data not shown). For 
SiNP70 and SMP500 (b and d), the slowdown of wound closure at 50-200 
µg/ml could also be due to cytotoxicity. 
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Figure 4.13 In vitro wound healing assay for HaCaT cells treated with colloidal silica 
(microscopy imaging). Cells were treated 0, 24, 48 and 72 h with colloidal silica 5-200 µg/ml in 
CM-0.5%. Images show effect at 25 µg/ml. a, d: untreated cells; e, h: cells treated with SiNP20; 
I, l: cells treated with SiNP70; m, p: cells treated with SMP200; q, t: cells treated with SMP500. 
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Figure 4.14 In vitro wound healing assay for HaCaT cells treated with colloidal silica. Cells 
were treated 24, 48 and 72 h with colloidal silica 5-200 µg/ml in CM-0.5%. Results are 
expressed as percentage of wound closure in particle-treated samples compared with particle-
free culture.  
 
(e) Expression pattern change of cell death genes in response to SiNP20.  
In order to understand the mechanism of colloidal silica cytotoxicity, cells 
treated with all particles at 10-50 µg/ml for 24 hours were also assessed for 
induction of necrotic and apoptotic cell death by Annexin V/FITC – Propidium 
Iodide (PI) staining and subsequent flow cytometer analysis. More than 90% of 
control cells (cultured in CM-10% and CM without particle treatment) were PI 
and FITC negative (Figure 4.15, a-e). SiNP20 10-50 µg/ml in CM-10% induced 
a concentration-dependent increase in FITC positive and PI/FITC double 
positive cells, indicative of apoptosis (b-d). On the other hand, SiNP70, 
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SMP200 and SMP500 did not induce any forms of cell death when tested in 
CM-10% (data not shown).  In CM, however, all particles caused toxicity as 
indicated by an increase in floating cells observed under the microscope. Owing 
to severe toxicity, not enough cells could be recovered from the samples treated 
with SiNP20 for the assay, while enough cells were recovered after treatment 
with larger particles.  SiNP70, SMP200 and SMP500 appeared to induce size- 
and concentration-dependent increases in PI/FITC double positive cells (Figure 
4.15, f-h, i-k, and l-n), indicative of apoptotic cell death, with SiNP70 being 
most toxic.   
 
 
 126 
 
Figure 4.15 Annexin V/FITC – PI staining of HaCaT cells treated with colloidal silica to detect 
apoptotic cell death. Cells were treated with colloidal silica 10-50 µg/ml; only CM-10% 
measurement is showed for cells treated with SiNP20 (b-d), while CM measurements are shown 
for cells treated with SiNP70, SMP200 and SMP500 (f-n). Following treatment, double staining 
with propidium iodide (PI) and Annexin V/FITC was performed and using BD Accuri C6 flow 
cytometer. For each sample 10.000 events were recorded, and the results expressed as PI 
fluorescence vs. Annexin V/FITC fluorescence. In each quadrant, quantification is reported as 
percentage of detected fluorescence. 
 
Confirmation of apoptotic cell death was obtained by Western Blot analysis, in 
collaboration with Dr. Xiao Ming Sun and Prof. Marion MacFarlane, MRC 
Toxicology Unit, Leicester (UK). HaCaT cells were treated with colloidal silica at 
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10-100 µg/ml in CM-10% to induce a concentration dependent apoptotic cell 
death as detected by flow cytometry (Figure 4.15, b-d). Proteins were then 
extracted and the samples were analyzed for the apoptosis specific cleavage of 
caspase 3. Caspase 3 is part of the caspase family responsible for the caspase-
dependent pathways of apoptosis. It is activated by the apoptosome caspase 
9/APAF-1. In its activated form it cleaves caspase 2, 6, 8, 10 at the cytoplasm, 
thus playing a major role in the initial steps of cell death [136]. The degradation 
of this protein has been associated with apoptosis.  As shown in Figure 4.16, 
no caspase 3 degradation was detected in all samples except for sample 4, 
which was treated with SiNP20 at 50 µg/ml and presented caspase-3 
degradation product p17, suggesting activation of apoptosis. This was in 
accordance with flow cytometry data, as the strongest apoptotic effect was 
detected in the same conditions. Not enough cells could be retrieved for protein 
extraction from sample 5, meaning that the toxic effect of SiNP20 is too high at 
100 µg/ml.  
 
 
Figure 4.16 Western blot analysis of caspase 3 in cells treated with colloidal silica in CM-10% 
for 24 h. Caspase 3 inactive preform is located in the 36 kDa row, while p17 product is located 
in the 16 kDa row. Image taken by Dr. Xiao Ming, MRC Toxicology Unit (Leicester, UK). 
 
To further explore the molecular mechanism by which silica particles initiate 
apoptotic cell death in HaCaT cells, 6x105 cells treated for 24 h with SiNP20 at 
10, 25 and 50 µg/ml in CM-10% were subjected to the Human Cell Death 
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PathwayFinder™ PCR Array assay, which allows to profile the expression of 84 
key genes important for the central mechanisms of cellular death: apoptosis, 
autophagy, and necrosis. The array also includes 5 housekeeping genes, which 
were Actin (ACTB), Beta-2-microglobulin (B2M), Glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH), Hypoxanthine phosphoribosyltransferase 1 (HPRT1), 
Ribosomal protein, large, P0 subunit (RPLP0). This assay involved total RNA 
extraction, cDNA synthesis and quantitative PCR (qPCR).   
RNA purity before cDNA synthesis was assessed using Picodrop Q100, and 
expressed as A260/A280 (purity) and A260/A230 (impurities) (Table 4.16).  The 
A260/A280 ratio of 1.5-2 is required for specific gene expression assay, while 
A260/A230 ratio ≥1.0 indicates cDNA purity. The data shown in Table 4.16 and 
Table 4.17 suggested that all cDNA synthesis products were of sufficient 
quantity and purity for subsequent real-time PCR assay.       
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Table 4.16 Quality of the cDNA synthesis from total RNA extracted from HaCaT cells treated 
with SiNP20 of different concentrations. 
Sample Name cDNA concentration (ng/µl) A260/A280 (Purity) A260/A230 (Impurities) 
A1 (Plate A, Neg. Contr.) 156.7 2.080 1.668 
A2 (Plate A, SiNP20 10 µg/ml) 160.2 1.998 1.641 
A3 (Plate A, SiNP20 25 µg/ml) 163.5 1.911 1.464 
A4 (Plate A, SiNP20 50 µg/ml) 157.2 1.989 1.670 
B1 (Plate B, Neg. Contr.) 140.5 2.032 1.589 
B2 (Plate B, SiNP20 10 µg/ml) 116.7 1.998 0.967 
B3 (Plate B, SiNP20 25 µg/ml) 156.4 2.015 1.335 
B4 (Plate B, SiNP20 50 µg/ml) 123.2 1.971 1.569 
C1 (Plate C, Neg. Contr.) 144.8 2.017 1.204 
C2 (Plate C, SiNP20 10 µg/ml) 151.5 2.025 1.431 
C3 (Plate C, SiNP20 25 µg/ml) 149.9 2.009 1.238 
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Table 4.17 Mean concentrations of cDNA synthetized from total RNA extracted from HaCaT 
cells treated with SiNP20 of different concentrations. For A), B), C) nº replicates = 3, for D) nº 
replicates = 2. SD indicates the standard deviation for each sample. 
Samples cDNA concentration 
Mean ± SD (ng/µl) 
A) Control 147 ±8.4 
B) SiNP20 10 µg/ml 143±23 
C) SiNP20 25 µg/ml 157±6.8 
D) SiNP20 50 µg/ml 135±20 
 
The raw real-time PCR data were analyzed with the QIAGEN Data Analysis 
Web Portal (QIAGEN, UK) and expressed as fold-change for each gene. The 
fold change was derived from the normalized gene expression in the test 
samples divided the normalized gene expression in the control samples. The 
fold change greater or less than two fold was defined as up-regulation or down-
regulation for a given gene. As it can be seen in Figure 4.17, a change of gene 
expression pattern was induced by the SiNP20 treatment at different 
concentrations. At 10 µg/ml, only 5 genes were up-regulated with the rest down 
regulated (a). The up-regulated genes included 3 housekeeping genes, namely 
actin (ACTB), Hypoxanthine phosphoribosyltransferase 1 (HPRT1) and 
ribosomal protein, large, P0 (RPLP0), and two cell death regulator genes, 
ATP6V1G2 and PARP1 (Table 4.18). The 116 KDa protein PARP1 is located in 
the nuclei and activated in cells experiencing stress and/or DNA damage. 
ATP6V1G2, a component of H+ transporting, lysosomal vacuolar ATPase (V-
ATPase), mediates acidification of intracellular compartments, which is 
necessary for protein sorting, zymogen activation, receptor-mediated 
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endocytosis, and synaptic vesicle proton gradient generation [137]. More genes 
were up-regulated by SiNP20 at 25 µg/ml (Figure 4.17, b), while the majority of 
genes were down regulated by further increase the concentration to 50 µg/ml 
(Figure 4.17, c). The different down-regulation at 10 and 50 µg/ml were linked 
with early and late apoptosis respectively as seen Figure 4.15. The full list of 
examined genes and related fold changes are listed in Table 4.18. 
 
 
Figure 4.17 Gene expression scatter plots following HaCaT 24 h treatment with SiNP20 10-50 
µg/ml in CM-10%. Results are expressed as Log10 of normalized expression. a: SiNP20 10 
µg/ml; b: SiNP20 25 µg/ml; c: SiNP20 50 µg/ml. Down-regulated are indicated in green, while 
red indicates up-regulated genes. Black central line indicates unchanged gene expression. The 
dotted lines indicate the selected fold regulation threshold (fold = ± 2). 
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Table 4.18 Effect of SiNP20 on the expression of mRNAs involved in apoptosis regulation. Full 
names of the corresponding genes were given with symbols included in  brackets; values in red 
indicate genes up-regulated ≥ 2 folds; values in green indicates genes down regulated more 
than 2 fold; gene descriptions were obtained through UniProt and GENE bank at National 
Centre for Biotechnology Information (NCBI). 
Gene name / Symbol Description Expression in SiNP20 10 µg/ml 
Expression in SiNP20 25 µg/ml 
Expression in SiNP20 50 µg/ml 
C-abl oncogene 1 (ABL1) Proto-oncogene for a non-receptor tyrosine kinase involved in a variety of cellular processes, including response to stress 
-6.34  -3.08 
V-akt murine thymoma viral oncogene homolog 1 (AKT1) Apoptosis suppressor, phosphorylates and inactivates components of the apoptotic machinery 
-2.81 2.38 -3.07 
Apoptotic peptidase activating factor 1 (APAF1) Its related protein is involved in the initiation of apoptosis 
-2.86 7.50 -2.19 
Amyloid beta (A4) precursor protein (APP) Cell surface receptor and transmembrane precursor protein that is cleaved to form different peptides 
-2.72  -2.07 
Autophagy related 12 homolog (S. cerevisiae) (ATG12) 
Involved in autophagy -2.58   
Autophagy related 16-like 1 (S. cerevisiae) (ATG16L1) Part of a large protein complex that is necessary for autophagy 
-3.34 2.01 -3.31 
Autophagy related 3 homolog (S. cerevisiae) (ATG3) 
Encodes a ubiquitin-like-conjugating enzyme involved in autophagy 
-3.34  -2.10 
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Autophagy related 5 homolog (S. cerevisiae) (ATG5) 
Involved in autophagy -3.80 7.55 -3.79 
ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2 (ATP6V1G2) 
Encodes a component of vacuolar ATPase (V-ATPase), which mediates intracellular acidification of cells 
4.78 23.70  
BCL2-associated X protein (BAX) Forms a heterodimer with BCL2, and functions as an apoptotic activator 
-4.29  -2.35 
B-cell CLL/lymphoma 2 (BCL2) Encodes an integral outer mitochondrial membrane protein that blocks the apoptotic death 
-3.14 7.55 -2.38 
BCL2-related protein A1 (BCL2A1) Reduction of the release of pro-apoptotic cytochrome c from mitochondria and block caspase activation 
-2.53 3.72  
BCL2-like 1 (BCL2L1) Regulation of outer mitochondrial membrane channel (VDAC) opening 
-2.81 2.80 -4.13 
BCL2-like 11 (BCL2L11) Apoptotic activator -2.65 10.36 -2.13 
Beclin 1 (BECN1) Involved in autophagy regulation -2.92 3.34 -2.60 
Baculoviral IAP repeat containing 2 (BIRC2) Apoptosis inhibition by binding to tumor necrosis factor receptor-associated factors TRAF1 and TRAF2 
-2.92 2.55 -2.37 
Bcl2 modifying factor (BMF) Binds BCL2 proteins and functions as an apoptotic activator 
-4.16 5.25 -3.36 
 134 
Chromosome 1 open reading frame 159 (C1orf159) 
Unknown -3.34 48.84 -3.39 
Caspase 1 (CASP1) Induction of apoptosis -2.99 24.25 -2.14 
Caspase 2 (CASP2) Apoptosis-related cysteine peptidase -3.38 15.46 -4.13 
Caspase 3 (CASP3) Apoptosis-related cysteine peptidase, cleaves and activates caspases 6, 7 and 9, and the protein itself is processed by caspases 8, 9 and 10 
-2.95 5.43 -2.75 
Caspase 6 (CASP6) Downstream enzyme in the caspase activation cascade 
-2.55 29.45 -2.77 
Caspase 7 (CASP7) Apoptosis-related cysteine peptidase -2.81  -57.63 
Caspase 9 (CASP9) Apoptosis-related cysteine peptidase -2.72  -20.14 
Coiled-coil domain containing 103 (CCDC103) Protein homodimerization activity 
-2.55 13.55 -4.32 
CD40 molecule (CD40) TNF receptor superfamily member 5, receptor on antigen-presenting cells of the immune system 
-2.79 13.42 -24.09 
CD40 ligand (CD40LG) Protein expressed on the surface of T cells, regulates B cell function by engaging CD40 
 6.48  
CASP8 and FADD-like apoptosis regulator (CFLAR) Regulator of apoptosis structurally similar to caspase-8 
-3.54 10.51 -39.96 
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COMM domain containing 4 (COMMD4) Inhibits nuclear factor kappaB (NF-kappaB), a transcription factor affecting apoptosis 
-2.14 13.90  
Cathepsin B (CTSB) Involved in the proteolytic processing of amyloid precursor protein (APP) 
-4.76 -3.23 -5.73 
Cathepsin S (CTSS) Lysosomal cysteine proteinase -2.47   
Cylindromatosis (CYLD) Turban tumor syndrome; deubiquitinating enzyme 
-2.92  -2.15 
Defensin, beta 1 (DEFB1) Antimicrobial peptide implicated in the resistance of epithelial surfaces to microbial colonization 
-2.76   
DENN/MADD domain containing 4A (DENND4A) C-myc promoter-binding protein -3.15  -3.00 
DNA fragmentation factor, 45kDa, alpha polypeptide (DFFA) 
Substrate for caspase-3; triggers DNA fragmentation during apoptosis 
-3.35 3.01 -2.26 
Dihydropyrimidinase-like 4 (DPYSL4) N/A  8.19 -8.38 
Eukaryotic translation initiation factor 5B (EIF5B) Initiation of translation -3.65 4.30  
Estrogen receptor 1 (ESR1) Ligand-activated transcription factor -3.91 15.63 -4.36 
Fas (FAS) TNF receptor superfamily, member 6; contains a death domain, shown to play a central role in 
-2.32 3.54  
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apoptosis 
Fas ligand (FASLG) Induction of apoptosis by binding to FAS -2.37 28.31 -3.08 
Forkhead box I1 (FOXI1) Transcription factor; specific function unknown 
 13.61 -4.78 
Glucosidase, alpha; acid (GAA) Degradation of glycogen to glucose in lysosomes 
-3.09 2.98 -3.12 
Growth arrest and DNA-damage-inducible, alpha (GADD45A) 
Environmental stress response -11.62 -2.65 -10.44 
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 5 (GALNT5) 
N/A -3.58 2.00 -3.65 
Growth factor receptor-bound protein 2 (GRB2) Involved in the signal transduction pathway -2.29  -3.16 
HSPB (heat shock 27kDa) associated protein 1 (HSPBAP1) 
Encodes a protein that binds toHsp27, which is involved with cell growth and differentiation 
-2.76 -7.82 -2.69 
Huntingtin (HTT) Widely expressed and is required for normal development 
-2.62 5.05 -2.67 
Interferon, gamma (IFNG) Antiviral, immunoregulatory and anti-tumor properties; potent activator of macrophages 
-3.03 9.54 -4.34 
Insulin-like growth factor 1 (somatomedin C) (IGF1) Involved in mediating growth and development 
-2.80 20.97 -2.10 
Insulin-like growth factor 1 Highly overexpressed in malignant tissues -2.94 4.42 -3.86 
 137 
receptor (IGF1R) where it functions as an anti-apoptotic agent by enhancing cell survival 
Insulin (INS) Glucose uptake -3.54 20.49 -3.08 
Immunity-related GTPase family, M (IRGM) Regulation of autophagy -2.94 6.70  
Junctophilin 3 (JPH3) Component of junctional complexes between the plasma membrane and endoplasmic/sarcoplasmic reticulum 
-4.98 6.92 -3.08 
Kv channel interacting protein 1 (KCNIP1) Member of the family of cytosolic voltage-gated potassium (Kv) channel-interacting proteins (KCNIPs) 
-6.83 10.88 -2.41 
Myelin associated glycoprotein (MAG) Involved in the myelination process -2.95 28.25 -3.08 
Microtubule-associated protein 1 light chain 3 alpha (MAP1LC3A) 
Microtubule-associated proteins which mediate the physical interactions between microtubules and components of the cytoskeleton 
-2.73 6.51 -15.77 
Mitogen-activated protein kinase 8 (MAPK8) Activated by tumor-necrosis factor alpha (TNF-alpha) to induce apoptosis 
-2.97 3.34 -52.06 
Myeloid cell leukemia sequence 1 (BCL2-related) (MCL1) 
Anti-apoptotic protein member of the Bcl-2 family 
-3.01  -50.23 
Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (NFKB1) 
Involved in a wide variety of biological functions 
 3.40 -30.42 
Nucleolar protein 3 (NOL3) Anti-apoptotic protein; down-regulates caspase 2, caspase 8 
 9.08 -10.79 
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and tumor protein p53 
Olfactory receptor, family 10, subfamily J, member 3 (OR10J3) 
Recognition and G protein-mediated transduction of odorant signals 
 13.86 -3.21 
Poly (ADP-ribose) polymerase 1 (PARP1) Regulation of differentiation, proliferation, tumor transformation, regulation of cell recovery from DNA damage 
7.75 6.22 -6.55 
Poly (ADP-ribose) polymerase 2 (PARP2) Caralysis of a poly(ADP-ribosyl)ation reaction 
-2.03 2.73 -68.30 
Phosphoinositide-3-kinase, class 3 (PIK3C3) Authophagy-related -2.14 6.41 -38.29 
Poliovirus receptor (PVR) Transmembrane glycoprotein; mediates cell attachment to the extracellular matrix 
-2.88 2.54 -87.65 
RAB25 Member RAS oncogene family; controls the return of internalized membrane-associated moieties to the cell surface 
-3.15  -147.76 
Ribosomal protein S6 kinase, 70kDa, polypeptide 1 (RPS6KB1) 
Signaling to promote protein synthesis, cell growth, and cell proliferation. Activity has been associated with human cancer 
-3.48 2.43 -64.61 
S100 calcium binding protein A7A (S100A7A) Inflammatory response  12.79  
Synuclein, alpha (SNCA) non A4 component of amyloid precursor; involved in signaling and membrane trafficking 
 39.12 -3.36 
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Spermatogenesis associated 2 (SPATA2) Cellular differentiation -3.48 5.51 -45.11 
Sequestosome 1 (SQSTM1) Functions as a scaffolding/adaptor protein in concert with TNF receptor-associated factor 6 to mediate activation of NF-kB in response to upstream signals 
 -2.42  
Synaptonemal complex protein 2 (SYCP2) Part of thesynaptonemal complex, which links homologous chromosomes during the prophase of meiosis 
-156.33 -4.07 -355.10 
Transmembrane protein 57 (TMEM57) Unknown  2.42  
Tumor necrosis factor (TNF) Cytokine involved in a wide spectrum of biological processes including apoptosis 
 13.77  
Tumor necrosis factor receptor superfamily, member 10a (TNFRSF10A) 
Receptor that transduces cell death signal and induces cell apoptosis 
  -2.01 
Tumor necrosis factor receptor superfamily, member 11b (TNFRSF11B) 
Osteoblast-secreted decoy receptor that functions as a negative regulator of bone resorption 
 2.41  
Tumor necrosis factor receptor superfamily, member 1A (TNFRSF1A) 
One of the major receptors for the tumor necrosis factor-alpha; mediates apoptosis and functions as a regulator of inflammation 
-2.58 2.29 -3.25 
Tumor protein p53 (TP53) Tumor suppressor protein responding to cellular stresses, thereby inducing 
 2.19 -362.14 
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apoptosis 
TNF receptor-associated factor 2 (TRAF2) Associates with, and mediates the signal transduction from members of the TNF receptor superfamily 
-3.44 -2.54 -205.61 
Thioredoxin-like 4B (TXNL4B) Mitotic division -3.06 3.35  
Unc-51-like kinase 1 (C. elegans) (ULK1) Serine/threonine-protein kinase involved in autophagy in response to starvation 
-12.60  -15.68 
X-linked inhibitor of apoptosis (XIAP) Member of a family of apoptotic suppressor proteins sharing the conserved baculovirus IAP repeat, necessary for their anti-apoptotic function 
-10.42  -6.61 
Actin, beta (ACTB) Involved in cell motility, structure, and integrity 26.44 4.12 29.61 
Hypoxanthine phosphoribosyltransferase 1 (HPRT1) 
Central role in the generation of purine nucleotides through the purine salvage pathway 
5.77  20.41 
Ribosomal protein, large, P0 (RPLP0) Encodes a ribosomal protein that is a component of the 60S subunit 
29.68  33.70 
 
4.2.3 In vitro toxicity potential in other human skin cells  
To investigate whether the size-dependent toxicity  of silica particles as 
detected  in HaCaT cells  is cell type dependent, the same group of colloidal 
silica particles of different size was assessed for cytotoxicity potential in three 
more human skin cell types including K17 keratinocytes, Human Dermal 
Fibroblasts (HDF) and BJ fibroblasts. 
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Size-dependent toxicity on K17 keratinocytes and Human Dermal 
Fibroblasts (HDF). The cell type dependent effects of the colloidal silica were 
further investigated in additional human keratinocytes and fibroblast cell lines in 
collaboration with Dr. Xavier Vigé and Dr. Sara Vicente in Sanofi Chilli-Mazarin 
(France). Assays of cytotoxicity, namely WST-1, Caspase 3/7 activity and 
Propidium Iodide measurement were conducted using the same cell culture and 
treatment conditions that have been tested for HaCaT cells.    
In K17 keratinocytes, WST-1 assay was used to assess cell viability. After 24 
hours treatment with colloidal silica at 5-200 µg/ml, a clear size- and 
concentration-dependent effect was detected (Figure 4.18). SiNP20 caused a 
50% reduction of cell viability at 25 µg/ml, with the lowest effect concentration of 
10 µg/ml. For SiNP70, a 20% reduction of cells viability was detected at 200 
µg/ml, the highest concentration tested.    For larger silica, on the other hand, 
SMP200 showed up to 20% increase in viability with the effect not following 
dose-dependent pattern, whereas SMP500 showed a reduction of cell at 10-25 
µg/ml and an increase of cell viability at 100-200 µg/ml.    
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Figure 4.18 WST-1 analysis of cell viability in K17 keratinocytes treated with colloidal silica. 
Cells were treated with colloidal silica 10-200 µg/ml for 24 h. Results were expressed as 
percentage of negative control; black line serves as reference for normal activity. Each particle 
concentration was tested in triplicates and the results analyzed by one-way ANOVA and 
Student’s t-test. Statistically significant results (p<0.05) are marked with an asterisk (*) on top of 
the corresponding bar. 
 
The toxicity potential of colloidal silica in K17 cells was further characterized 
using the Propidium Iodide (PI) assay after 24 h treatment with Triton X-100 
0.025% as positive control. Triton X-100 was chosen because it is widely used 
to lyse cells or to permeabilize the membranes of living cells. In this study the 
increase of PI would give indication of cell membrane damage and necrotic cell 
death. As expected, staurosporine induced an 80% increase of PI staining cells.   
As consistent with the effect in cell viability, SiNP20 induced a dose-dependent 
increase of PI, while the other particles had little effect in PI uptake (Figure 
4.19).  
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Figure 4.19 Propidium Iodide measurement of K17 keratinocytes after treatment with colloidal 
silica. Cells were treated with colloidal silica at 10-200 µg/ml for 24 hours, plus Triton X-100 
0.025% for 15 minutes at 37 oC as positive control.  
 
To investigate whether the cytotoxicity of colloidal silica in K17 involved 
apoptotic cell death through activation of the caspase pathway, the cells were 
subjected to the analysis of caspase 3/7 activity (Figure 4.20). For this assay, 
staurosporine 10 µM was also added as positive control. Staurosporine was 
chosen because it is routinely used in apoptosis assays, as it induces apoptotic 
cell death by two different pathways, one caspase-dependent and one caspase 
independent [138]. As expected, the positive control showed a high level (more 
than 5 folds) induction of the caspase 3/7 activity. As consistent with its effect in 
reduction of cell viability, SiNP20 at 10 µg/ml induced an induction of the 
caspase activity, while the inhibitory effect at 100 µg/ml was consistent with the 
loss of cell viability and subsequent loss of total proteases observed in Figure 
4.18 and Figure 4.19.  Little to no effect was detected for the rest of the 
particles, consistent with the lack of toxicity as detected by the WST-1 and PI 
assays.  
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Figure 4.20 Caspase 3/7 assay on K17 keratinocytes treated with colloidal silica. Cells were 
treated with colloidal silica at 10 and 100 µg/ml for 24 hours, plus staurosporine 10 µM as 
positive control, for 6 hours at 37°C. Results were expressed as fold increase of caspase 3/7; 
black line serves as reference for normal activity. Each particle concentration was tested in 
triplicates and the results analysed by one-way ANOVA and Student’s t-test. Statistically 
significant results (p<0.05) are marked with an asterisk (*) on top of the corresponding bar. 
 
To take the advantage of the confocal microscopy technique developed in the 
collaborator’s lab in Sanofi, the mechanism of silica toxicity in relation to particle 
internalization in K17 cells was further investigated.  Cells were treated with 
fluorescent silica particles 70-500 nm at 10 µg/ml, double stained with Hoechst 
33342 and ActinRed™, and then subjected to confocal imaging to establish 
particles internalization and their localization inside cells. SiNP20 was excluded 
from the test as they were not FITC labelled. After 2 hours of treatment, K17 
keratinocytes showed a low level of particles’ internalization, with most of the 
particles being seen outside the cells and only a few clusters located inside 
cells (Figure 4.21, a-c). After 24 hours there was an increased uptake for all 
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particles, which were found clustering around the nuclei in a size-independent 
manner, meaning more uptake was detected for SMP200 and SMP500 than 
SiNP70  (Figure 4.21, d-f). As shown in the Z-stacks, which combine multiple 
images taken at different focus distances in order to achieve a greater depth of 
field (DOF), no particles could be detected inside the nuclei for all three sized 
particles (Figure 4.22).  
 
 
Figure 4.21 Confocal microscopy imaging of K17 keratinocytes treated with colloidal silica. 
Cells were treated with FITC-particles (green) at 10 µg/ml and co-stained with Hoechst 33342 
for nuclei (blue) and actin (red).   
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Figure 4.22 Z-Stacks of K17 keratinocytes treated with colloidal silica. 
2 H 24 H 
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The same assays used on K17 keratinocytes were exploited also to examine 
the toxic effects of colloidal silica on Human Dermal Fibroblasts (HDF). WST-1 
assay showed that after 24 h treatment at 10-200 µl/ml, only SiNP20 induced a 
concentration dependent reduction of cell viability, with 100 µl/ml being the 
lowest effect concentration, whereas SiNP70, SMP200 and SMP500 showed 
little effect (Figure 4.23).  
 
   
 
  
Figure 4.23 WST-1 analysis of HDF fibroblasts treated with colloidal silica. Cells were 
treated with colloidal silica at 10-200 µg/ml for 24 h at 37 °C. Results were expressed 
as percentage of negative control; black line serves as reference for normal activity. 
Each particle concentration was tested in triplicates and the results analysed by one-
way ANOVA and Student’s t-test. Statistically significant results (p<0.05) are marked 
with an asterisk (*) on top of the corresponding bar. 
 
The toxicity potential of the colloidal silica particles in the HDF cells was further 
characterized by the Propidium Iodide (PI) uptake assay. Cells were treated 
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with the particles at 10-200 µg/ml for 24 h, with Triton X-100 0.025% as positive 
control.  Again, Triton X-100 induced a significant increase of PI uptake. Only 
SiNP20 induced a significant increase in PI uptake at the concentrations that 
induced significant reduction of cell viability (Figure 4.24). The other particles, 
on the other hand, showed no detectable effect on cellular uptake of PI.  
 
 
 
Figure 4.24 Propidium Iodide measurement of HDF after treatment with colloidal silica. Cells 
were treated with colloidal silica 10-200 µg/ml for 24 h, with Triton X-100 0.025% positive 
control. 
 
Whether apoptotic cell death was involved in the toxicity of the colloidal silica 
particles in HDF cells was also investigated by the caspase 3/7 activity assay. 
As shown in Figure 4.25, it appeared that only treatment for 24 h with SiNP20 
at 10 µg/ml induced an increase of caspase 3/7 activity, while an inhibition was 
detected for SiNP20 at 100 µg/ml, which is co-occurrence with the substantial 
reduction of cell viability.  Treatment with other particles, on the other hand, was 
not associated with the induction of the caspase 3/7 activity (Figure 4.25).  
0
20
40
60
80
100
120
10 µg/ml 25 µg/ml 50 µg/ml 100 µg/ml 200 µg/ml Positive Negative
% P
I-la
bele
d C
ells
 
Silica NPs Concentration (µg/ml)
 149 
Positive control staurosporine was tested at different concentrations (1, 10, 100 
µM); however, no effect could be detected of HDF. As positive control showed a 
negative effect, more experiments need to be performed to establish the 
whether the colloidal particles can induce toxicity in the HDF cells through 
activation of caspase 3/7.  
 
 
 
Figure 4.25 Caspase 3/7 assay on HDF treated with colloidal silica. Cells were treated with 
colloidal silica at 10-100 µg/ml for 24 h at 3°C, with staurosporine 10 µM as positive control. 
Results were expressed as fold increase of caspase 3/7; black line serves as reference for 
normal activity. Each particle concentration was tested in triplicates and the results analyzed by 
one-way ANOVA and Student’s t-test. Statistically significant results (p<0.05) are marked with 
an asterisk (*) on top of the corresponding bar. 
 
The cellular uptake and subcellular location of colloidal silica in HDF cells was 
also investigated by confocal imaging. As seen in K17 keratinocytes, cellular 
uptake of the silica particles observed after 2 h incubation (Figure 4.26 a-c) 
showed no internalization, with particles located outside the cells. After 24 hours 
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treatment (Figure 4.26 d-f), active uptake could be observed for all particles, 
but no specific localization could be detected, as NPs appeared to be free in the 
cytoplasm (Figure 4.27). 
 
 
Figure 4.26 Confocal microscopy imaging of HDF fibroblasts. Cells were treated with FITC-particles 
(green) at 10 µg/ml for 24 h. Cells were co-stained with Hoechst 33342 for nuclei (blue) and actin (red). No 
specific localization could be detected, as particles appeared to be free in the cytoplasm. 
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Figure 4.27 Z-Stacks of HDF treated with colloidal silica. Laser scanning of cells previously 
treated with FITC-labelled silica particles and double stained with Hoechst 33342 for nuclei 
(blue) and actin (red) revealed that particles are mostly free inside the cytoplasm, making exact 
localization difficult; none reached the nuclei. 
2 H 24 H 
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Size-dependent toxicity of silica in BJ fibroblasts. The toxicity of colloidal 
silica of different size was assessed by MTT and LDH assays after treatment of 
BJ fibroblasts for 24 h of treatment at 25-100 µg/ml. Like in HaCaT cells, 
colloidal silica particles were tested in CM-10%, CM-0.5 and CM.  As assessed 
by MTT and LDH assays, no effects were detected for all the particles when 
tested in CM-10%, while some dose-dependent effects were detected for 
SiNP20 in CM-0.5% and for both SiNP20 and SiNP70 in CM (Figure 4.28).  
The discrepancy between the results of MTT and LDH could be due to the low 
metabolism of cells maintained in CM.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 153 
 
    
    
    
  
  
Figure 4.28 MTT and LDH assay of BJ fibroblasts after treatment with colloidal silica. Cells 
were treated with particles at 25-100 µg/ml for 24 h in CM-10%, CM-0.5% and CM. a, b: 
treatment in CM-10%; c, d: treatment in CM-0.5%; e, f: treatment with CM. Results were 
expressed as percentage of negative control; black line serves as reference for normal activity. 
Each particle concentration was tested in triplicates and the results analysed by one-way 
ANOVA and Student’s t-test. Statistically significant results (p<0.05) are marked with an asterisk 
(*) on top of the corresponding bar. 
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The effect of colloidal silica was also examined using phase contrast imaging. 
BJ Fibroblasts treated with SiNP20-70 at 50 µg/ml in CM-10% and CM for 24 
hours were assessed for shape and density variations. As shown in Figure 
4.29, cells maintained in CM-10% exhibited a density of around 70% confluence 
and signs of active growth features that have been seen in HaCaT cells (Figure 
4.10, a compared with Figure 4.29, a), while cells maintained in CM showed a 
much lower density (Figure 4.29, d compared with a), suggesting a low level 
of metabolism/growth potential. Particle-treated samples showed notable shape 
variations, especially cells treated with SiNP20, where a significant loss of 
shape could be detected both in CM-10% and CM (Figure 4.29, a compared 
with b and e compared with d). These morphological changes were not 
associated with the loss of cell viability and membrane damage as seen in 
Figure 4.28.  For SiNP70 a much lower cell density as compared with control 
cells was observed (Figure 4.29, c compared with a), which was inconsistent 
with the result in the MTT assay (Figure 4.28, a), indicating the low sensitivity of 
the MTT assay. Based on the results from the LDH and phase contrast 
microscopy assays, it was evident that the toxicity of the colloidal silica in BJ 
fibroblast was size- dependent and the effects were not detectable in the 
presence of FBS.   
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Figure 4.29 Phase contrast imaging of BJ fibroblasts cells treated with SiNP20-70. Cells were 
treated with particles at 50 µg/ml for 24 h in CM-10% and CM. Arrows in image a indicate 
cellular proliferation in the corresponding sample. 
 
Based on the study of the colloidal silica particles in human keratinocyte and 
fibroblast cells, it appeared that the order of the toxicity follows is 
SiNP20>SiNP70>SMP200 >SMP500. 
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5 DISCUSSION 
5.1 Silica particles dispersion properties in biological media depend on size, media composition and temperature 
As in vivo and in vitro toxicology studies involve delivery of testing materials in 
aqueous biological media, size, as well as aggregation/agglomeration state of 
the materials under physiological conditions are fundamental parameters to be 
determined prior to toxicological studies [139].  The terms ‘‘agglomerate’’ and 
‘‘aggregate’’ are widely used to describe the status of NMs in liquid 
suspensions. Despite the fact that each term has its own specific meaning, they 
are frequently interchanged at will, which results in conflicting definitions in 
national and international standards, thus creating problems with 
communication of results in reports and research papers. To avoid such 
confusion, in this study “agglomeration” will be defined as an assemblage of 
particles which are firmly bound and therefore not readily dispersed, whereas 
“aggregation” will be defined as an assemblage of particles loosely attached by 
contact at their corners and edges, thus easy to re-disperse [140]. The 
aggregation/agglomeration and subsequent sedimentation of nanoparticles 
raises concerns when considering size-, time-, and dose-dependent toxicity 
[141]. Experimental determination of NPs aggregation/agglomeration state is 
possible thanks to techniques such as Dynamic Light Scattering (DLS).   
The determination of particles surface charge when introduced into aqueous 
solutions is also of the uttermost importance, as almost all mode of exposure in 
toxicology studies involve particles interaction with aqueous biological fluids, 
whose characteristics, such as ionic strength, pH and composition, contribute to 
the modification of particle behaviour in suspension. Measuring zeta potential 
often provides insight both on dispersion stability of the particle in suspension 
as well as information about their aggregation/agglomeration behaviour [142, 
143]. Zeta potential is a measure of the magnitude of the electrostatic or charge 
repulsion/attraction between particles. If all the particles in suspension have 
large negative or positive ZP they will repel each other, thus preventing any 
agglomeration/aggregation. However, if ZP levels are low, no force will be able 
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to prevent the particles from coming together and aggregate [98]. Beside DLS 
and ZP, high resolution imaging techniques such as Scanning electron 
microscopy (SEM) and/or transmission electron microscopy (TEM) are 
considered as gold standard to assess particles shape, morphology, size range, 
agglomeration state, surface morphology [46].  
A key factor to take into consideration when characterizing NMs in biological 
media is the potential interaction with proteins as this leads to formation of a 
protein corona (PC), thus altering their surface properties and reactivity. The 
majority of in vitro tests of NPs are performed using bovine serum, mainly 
because of its availability and traditional use in many assays, as well as for 
economic reasons. Another fact to consider is the culture medium 
characteristics, such as ionic strength, pH and composition, as they contribute 
to the modification of particle behaviour in suspension, and therefore the nature 
of their interaction with cells [144].  
In this study, all the silica materials tested were characterized in different cell 
culture media with different bovine serum concentrations to gain information on 
average size, aggregation/agglomeration state, colloidal stability, shape, as well 
as the effect that serum and media composition had on particle stability.  The 
selection of manufactured fumed silica and colloidal silica particles of different 
size allowed the differentiation of silica particles form- and size-dependent 
effects.  
When analysed by DLS, SiNP7 and SiNP14 showed aggregation in CM, while 
in CM-10% their size and PDI increased compared to their given size. Such 
effect could be the result of protein corona formation, thus suggesting the role of 
FBS in improving colloidal stability for these particles. TEM imaging in deionised 
water showed chain-like structure compatible with aggregation as well. Such 
findings were previously described [145, 146]; Irfan et al. (2014) [145], having 
tested the same particles in medium by assays of DLS, TEM and ZP, found that 
while fumed silica 7 and 14  dispersed well in culture medium, they also had the 
tendency to form aggregates very quickly. They linked this effect to low zeta 
potential, which was measured to be around -9. A similar effect was described 
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by Sun et al. (2015) [146]; they used pristine, calcinated, rehydrated and doped 
fumed silica to assemble a library of fumed silica nanoparticles in order to study 
the relationship of surface silanol display to pro-inflammatory responses in 
macrophages and murine lung. Regarding pristine fumed silica, they tested 
them in a) water, b) a mixture of PBS +  Bovine Serum Albumin (BSA) + 1,2-
Dipalmitoyllecithin (DPPC), c) RPMI 1640 medium +10% serum. They found 
that fumed silica were better dispersed in medium rather than water and 
PBS/BSA mixture, which was linked to protein corona formation actually 
improving fumed silica colloidal stability. TEM characterization also showed a 
‘string of pearl-like structures’, compatible with particle aggregation.  
Regarding colloidal silica, in CM the size of all particles was consistent with their 
given size. However, when dispersed in CM-10% at concentrations above 50 
µg/ml, all the particles with the exception of SMP500 were measured larger than 
their known size. The same increase in particle size could also be detected for 
all particles suspended in CM-0.5% and Medium 106. The ratio of size 
difference as measured in CM-10%, CM-0.5% and Medium 106 vs CM was in 
the order SiNP20>SiNP70>SMP200>SMP500. SiNP20 had the biggest size 
alteration, compatible with particle agglomeration, which was not associated 
with a change in zeta potential, suggesting that non-electrostatic protein 
adsorption could be the cause for size change. For SiNP70 and SMP200, on 
the other hand, the slight size increase could be due to the formation of protein 
corona. In the last few years, protein corona formation has gained so much 
importance that in the future it may be used for NPs classification [147, 148]. 
Despite the increasing interest, only very recent contributions have addressed 
the question of how NPs-protein coronas form, evolve with time and affect 
colloidal stability [149, 150]. Until recently, the main reason for colloidal 
instability of nanoparticles has been assumed to be cell culture medium, in 
particular its high ionic strength, capable of reducing particles’ surface 
potentials. On the other hand, proteins had been generally assumed to enhance 
the dispersion of NPs in culture medium [151]. Nevertheless, in the last decade 
studies demonstrated size-dependent protein absorption. Roach et al. (2006) 
[152] used 15-165 nm silica spheres treated with bovine serum albumin (BSA) 
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and bovine fibrinogen (Fg) to assess protein-NP surface interactions and 
protein binding affinity, with focus on NPs surface curvature variations. They 
found that while binding affinity and saturation values were similar for both 
proteins, a size-dependent difference in orientation/conformation was detected, 
with albumin increasingly less ordered on larger particles, while fibrinogen 
became more denatured upon binding to smaller particles, suggesting that 
smaller particles cause protein alteration when PC is forming. Orts-Gil et al. 
(2013) [153] scrutinized the short and long term colloidal stability of silica 
nanoparticles (SNPs) and silica–poly(ethylene glycol) nanohybrids (Sil–PEG) in 
a protein model system using Bovine Serum Albumin (BSA) dispersed in PBS. 
Using such method, they showed that pristine silica nanoparticles formed small 
clusters with BSA after some minute’s incubation in BSA/PBS solution, while 
after several hours the formation of large agglomerates was observed. In 
contrast, Sil–PEG hybrid nanoparticles were able to resist BSA adsorption and 
persisted as single NPs in a BSA–PBS suspension even after 48 h incubation. 
They explained such results as BSA acting as a ‘bridge’ between particles, as 
uncoated particles showed a stronger tendency to agglomerate. The data 
obtained in CM-10%, CM-0.5%, CM and Medium 106 were all in agreement 
with such studies [152, 153], as a size-dependent surface adsorption could be 
observed.  
About SMP200 and SMP500 protein binding properties in different media, a 
previous study by Puddu et al. (2013) [154] demonstrated a shift of the 
dominant binding mechanism toward electrostatic interactions on larger silica 
particles. Using silica particles of 28, 82, 210 and 500 nm, they investigated the 
adsorption capability of each particle towards three different types of peptides. 
They found size-dependent protein adsorption, with binding mechanism for 
larger particles based on hydrogen-bonding interactions. This current study 
seemed consistent with this observation, as zeta potential for larger particles 
was reduced in CM-10%, suggesting the occurrence of electrostatic interaction 
between the particles and biomolecules. The sedimentation observed for 
SiNP20 and SiNP70 in EpiLife™ medium can be linked to the difference in 
composition compared with other media, as shown in the increased average 
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size measured for particle-free EpiLife™ medium by DLS. Such assertion is 
corroborated by direct comparison of DMEM/F-12 and EpiLife™ medium 
composition. The amount as well as the composition of inorganic salts is 
different, with EpiLife™ medium containing higher amounts as well as being 
characterized by different inorganic salts, such as magnesium chloride (MgCl2 x 
6H2O), potassium chloride (KCl), sodium meta silicate (Na2SiO3 x 9H2O) and 
sodium phosphate dibasic (Na2HPO4 x 7H2O). Such differences have a direct 
influence on the ionic strength of the medium, thus affecting particle behaviour 
once dispersed. Inorganic ions play an important role in determining the 
aggregation and electro-kinetic behaviour of NPs. Ions with charge opposite to 
that of the NPs surface charge (counter ions) can attenuate the effect of 
repulsion by neutralizing the particle surface charge. Increase in the counter ion 
concentration normally causes an increase in zeta-potential values towards 
zero, thus facilitating particle aggregation. Ions charged similarly to the surface 
charge of NPs (co-ions) can also play important role in affecting the charge and 
aggregation behaviour of NPs. Approach of co-ions close to the surface of the 
particles causes an increase of the electro kinetic potential, thus imparting 
surface charges (more negative or more positive) by preferential adsorption 
[155].  
Another important factor often overlooked during particle characterization is 
temperature. Temperature can influence protein corona composition, as 
evidenced that the composition of the protein corona formed upon NP exposure 
to heat-inactivated proteins (preheating at 56 °C) and non-heat-inactivated 
proteins is different [156]. However, effects on the protein corona when 
temperature is close to physiological temperature have not yet been studied in 
detail. Studying such effects may be relevant for NPs in vivo applications, as 
human body temperature can vary significantly. Normally human body 
temperature ranges from 35.8 to 37.2 °C depending on different parts of the 
body [157]. If protein adsorption onto the surface of NPs depends on the body 
temperature, it may also result in a significant effect on the cellular uptake of 
NPs in vivo. Therefore, in this study a DLS measurement of colloidal silica 
following incubation in medium at 37 °C was included, in order to mimic the in 
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vitro conditions used for cell-based assays as well as to mimic the mean human 
body temperature. While no difference could be detected for particles in CM as 
compared with their given size, particles in CM-10% showed an increase in 
average size that was associated with protein adsorption on the particle surface 
which was temperature dependent as the changes was only detected at 37oC 
but not 4oC. Such effect was previously demonstrated with different NPs [158, 
159]. Mahmoudi et al. (2013) tested the effect of temperature on protein 
composition on 3-20 nm FePt NPs following treatment with Human Serum 
Albumin (HSA) and apo-transferrin (apo-Tf) at 9, 22, and 43°C; they also 
incubated larger FeOx NPs with positive, negative charge and neutral surfaces 
in foetal bovine serum (FBS) at 10-50°C [158]. They found that the increase of 
temperature resulted in an increase of protein affinity for binding to the surface 
of particles, thus leading to an increase in protein corona thickness. The amount 
of proteins in the corona was highest around 40 °C. In contrast, Mu et al. (2012) 
analysed amorphous silica Ludox SM-30 (20 nm) at 37°C in both water and 
DMEM medium with 10% FBS [159]. They found that while in water the 
particles were monodispersed with an average size around 14 nm, in DMEM 
the NPs suspension showed an average size of approximately 500 nm, 
indicating particle agglomeration which was consistent with the results from the 
current study. 
SEM and TEM imaging confirmed the spherical shape and size of SiNP70, 
SMP200 and SMP500 as reported previously by Al-Rawi et al. (2011) [160]. For 
SiNP20, the elongated shape as well as the agglomeration detected was also 
previously reported by Mu et al. (2012) [159]. 
The fact that fumed SiNP7 and SiNP14 could disperse well in CM-10% but 
colloidal SiNP20 showed agglomeration could be linked to the original physical 
state and characteristics of the particles before dispersion in media. SiNP7 and 
SiNP14 are both ultrafine nanopowders with desiccant properties, which cause 
them to swell inside aqueous solutions [161]. SiNP20, on the other hand, was a 
clear aqueous solution containing Na+ as a counter-ion to increase particle 
stability due to the high surface reactivity of the particles. While re-suspension 
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of SiNP7 and SiNP14 would have caused swelling, thus affecting their size and 
surface reactivity, re-suspension of SiNP20 in media without its counter-ions 
would have caused an imbalance in particle stability, which resulted in 
aggregation/agglomeration. 
 
5.2 Silica particles uptake into HaCaT cells is endocytosis-related 
Cellular uptake of NMs is of paramount importance, as the targets for many 
therapeutic compounds are localized in the subcellular compartments [162, 
163]. However, to achieve entrance inside the cells, NMs must be capable of 
efficient translocation across the plasma membrane, since the function of the 
barrier is to regulate which compounds enter into the cells. As efficient uptake of 
NMs is of central importance to nanomedicine applications, a deeper 
understanding of the biological pathways for cellular internalization of nutrients 
and solutes can facilitate the development of nanomaterials with precise 
intracellular targeting and enhanced therapeutic outcomes [162, 164]. 
In this study, cellular uptake in HaCaT cells occurred for both fumed and 
colloidal silica in a concentration-dependent manner. While fumed silica uptake 
was relatively low at concentrations ≤100 µg/ml, colloidal silica was readily 
taken up by HaCaT cells at ≥25 µg/ml. Such effect was previously described by 
Zhang et al (2012) [62], who addressed the fate of both fumed silica and Stöber 
silica nanoparticles tested at 25 µg/ml in BEAS-2B lung epithelial cells and 
THP-1 monocytes. They observed relatively low uptake for fumed silica, while 
Stöber silica were readily taken up by both cell types. In this study such effect 
was further investigated by assessing the intracellular location of both fumed 
and colloidal silica. While TEM imaging of SiNP7 showed that cells were devoid 
of particles, SiNP20 were mostly observed as clusters in multi-vesicular bodies, 
while SiNP70, SMP200 and SMP500 were more often isolated in small 
vacuoles. Most of colloidal silica were observed in membrane-bound organelles 
regardless of size but some were free in cytoplasm.  
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This difference in cellular localization was observed as well by Zhang et al. 
(2012) [62]. Using TEM imaging, they demonstrated that fumed silica NPs in 
BEAS-2B and THP-1 cells were mostly associated with the external cell surface 
membrane, with few fumed silica nanoparticles inside the cells. Stöber silica 
NPs, on the other hand, were readily internalized and did not collect on the 
outer surface. The lack of membrane-bound fumed silica in this study can be 
linked to cell type difference, as BEAS-2B are lung epithelial cells and THP-1 
are monocytes. The difference might also be linked to different culture 
conditions, such as the use of Foetal Bovine serum (FBS). In this current study 
FBS appeared to partially prevent the uptake, as the uptake was more 
pronounced in CM rather than CM-10%. This effect might be due to the fact 
that, when placed in a complex biological environment, nanoparticles interaction 
with the proteins in the medium and the formation of a protein corona can 
‘screen’ the functional groups on the surface of nanoparticles, thus preventing 
non-selective cellular uptake of nanoparticles [165].  Nowak et al. (2013) [166] 
reported on the effect of serum proteins on the uptake of 20 nm monodispersed 
nanoparticles. Uptake rate of the particles was demonstrated to be lower in the 
presence of serum proteins compared to serum free conditions. The presence 
of colloidal particles free in the cytoplasm might be due to insufficient 
degradation of particles inside the lysosomal environment, where they could 
remain through late stage lysosomal digestion until release into the cytoplasm.  
The considerations regarding the location of colloidal silica is further 
corroborated by previous studies, which showed that silica particles and some 
other types of nanoparticles were often observed in lysosomes [167] and in 
some cases were also found free in the cytoplasm [168]. Ye et al. (2013) [167] 
selected three industrially made SiO2 particles of 50 nm, 100 nm and 200 nm to 
investigate their ability of nanoparticles to access and transport across the 
blood brain barrier (BBB). To do so they used the particles to treat in vitro 
endothelial hCMEC/D3 cells, and then examine them by extensive TEM 
imaging. They found that all tested nanomaterials entered the endothelial cell 
monolayer and accumulated along the endo–lysosomal pathway. Herd et al. 
(2011) [168] used three types of amine-terminated Stöber silica nanomaterials 
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of different shapes, namely spheres (178 nm), worms (232 nm × 1348 nm) and 
cylinders (214 nm × 428 nm) to study in vitro the influence of geometry of silica 
nanomaterials on cellular uptake and toxicity on epithelial A549 cells and 
phagocytic RAW264.7 murine macrophages. They found that geometry did not 
play a dominant role in the modes of toxicity and uptake of these particles, while 
a concentration- and cell-type dependent toxicity of all particle types could be 
observed. The presence of particles either free in the cytoplasm or co-localized 
within highly acidic lysosomal compartments suggests lysosomal escape or an 
indication of different stages of lysosome maturation. 
The uptake of non-functionalized silica particles and their location in both the 
lysosomal compartment and free in the cytoplasm suggests that non-specific 
endocytosis could be the mechanism of uptake for these particles. Such 
affirmation is due to inconclusive assessment of uptake mechanisms using 
pathway-specific inhibitors. Use of Cytochalasin D, Dynasore, Nocodazole, 
Filipin and Polyinosinic acid did not provide any type of information regarding 
specific preferential pathways, such as cavaeolae-mediated or clathrin-
mediated endocytosis. These observations are further corroborated by previous 
studies [31, 32]. Huang et al. (2010) [169] used three different shaped 
monodisperse mesoporous silica nanoparticles of 100, 240 and 540 nm to study 
the effects of particle shape on cellular uptake and behaviour using A375 
human melanoma cells. They found that smaller particles had a greater impact 
on different aspects of cellular function including cell proliferation, apoptosis, 
cytoskeleton formation, adhesion and migration. They also found that particles 
were readily taken up by A375 cells and encapsulated into vesicular or cytosolic 
compartments. From the TEM images, they concluded that MSNs were first 
internalized in A375 cells by non-specific cellular uptake and merged with 
endosomes. Subsequently the MSN particles escaped from the endosomes and 
entered the cytoplasm. Chu et al. (2011) [170] used 50 nm and 400 nm Stöber 
silica NPs plus 10 and 20 nm industrially made silica NPs to study in vitro the 
interaction of silica nanoparticles (NPs) with human cell lines H1299 human 
lung carcinoma cell, HONE1 human nasopharyngeal carcinoma cell, NE083 
human oesophageal epithelial cell, NL20 human bronchial epithelial cell and 
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HEK293 human embryonic kidney cell. Using three time-points (3 hours, 10 
hours, 48 hours) they assessed particle uptake to determine the mechanism for 
both pathways. For all particles and cell type tested most of the NPs were found 
in mono-dispersed form in endolysosomes or cytoplasm  after 3 hours 
incubation; after 10 hours and further to 48 hours, more and more clustering of 
multiple NPs appeared in the endo-lysosomes, while very few single particles 
were found in the cytoplasm. The observation of a large amount of membrane 
bounded NPs inside the cells, together with the fact that no specific coating was 
deposited on the NP surface, suggested nonspecific endocytosis as the major 
mechanism for the cellular uptake of the nanoparticles. They also studied the 
excretion pathway by incubating with particle-free medium for 1 hour after the 
maximum uptake period (48 + 1 hour). Taking into consideration the dynamic 
nature of endocytosis and exocytosis, they observed a notable difference 
between the amount of silica nanoparticles inside and outside the cells, with 
most of the NP aggregates in the organelles disappearing but with some single 
NP left in the cytoplasm. Based on these observations they concluded that NP 
clusters in lysosomes were more easily excreted by the cells when compared to 
the single NP in cytoplasm.  
Taken together, existing data suggest that the cellular uptake of silica particles 
could be cell type-dependent via non-specific endolysosomal pathways that 
have a broad range of shape and size selections. Different locations between 
SiNP20 and SiNP70, SMP200, SMP500 also suggest the role of particle size in 
the internalization pathway. Further study will be needed to firmly establish 
cellular uptake pathways of silica particles in both CM-10% and CM, as well as 
assess their fate post-uptake. 
 
5.3 Modulation of silica size dependent toxicity by FBS  
Due to the many different forms of NPs produced in a wide variety of 
applications, study of the effects of nanomaterial exposure to the human body is 
of paramount importance. Studies using in vitro and in vivo models to delineate 
size-dependent effects of silica particles have been increasingly documented. 
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However, the relevance of particle size in toxicity has not been established, 
which was partially due to the variations in physico-chemical properties of 
particles used by different groups.  
When studying in vitro the potential toxicity of NPs, assays assessing cell 
viability and cellular membrane damage were often employed in combination to 
gain initial assessment of toxicity potential of the testing materials [171, 172].  
More assays were needed to gain insights into the mechanisms of the toxicity.  
In this study, silica particles were initially assessed by MTT/WST-1 and LDH/PI 
staining for their effects on cell viability and membrane damage respectively.   
HaCaT cells were used as a model to assess the effect of fumed and colloidal 
silica previously characterized in culture medium, thus allowing the correlation 
of cytotoxicity to their size as well as the presence or absence of FBS. The 
study clearly demonstrated size- and dose-dependent toxicity of colloidal silica 
in the order SiNP20≥SiNP70≥SMP200≥SMP500 respectively. For both forms of 
silica particles, cytotoxicity was detected in the absence of FBS, while in CM-
10% the toxicity was detected for colloidal SiNPs but was absent for fumed 
SiNPs, thus providing evidence that serum modulates silica toxicity which is 
silica-type dependent.  
Although many studies indicate that nanoparticles are more toxic than their 
larger counterparts, the size-dependent mode of action is still elusive. Size-
selective cellular internalization is one of the speculations for the toxicity of 
nanoparticles. Zhu et al. (2013) [173], for example, investigated the cellular 
uptake efficiency, mechanism and cytotoxicity of silica nanoparticles (SNPs) 
with different sizes (55.6, 167.8, 306.7 nm) in HeLa cells. They found that 
cellular uptake efficiency was size-dependent, in the order 55.6 ≥ 167.8 ≥ 307.6 
nm; however, no toxicity could be detected after 48 hours. While providing 
evidence for size-dependent uptake of particles, the lack of toxicity is in contrast 
with other reports on size-dependent toxicity of silica particles of similar size, 
thus suggesting a different size-related mode of action. Li et al. (2011) [174] 
compared the potential cytotoxicity induced by amorphous silica particles of 19, 
43, 68 and 498 nm in vitro using HepG2 human hepatoma cells. Investigation of 
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cell viability found that cytotoxicity generated by silica particles strongly 
depended on particle size and administered dose, with smaller silica particle 
producing higher toxic effect. Lu et al. (2011) [175] investigated the cytotoxicity 
of 7–50 nm silica nanoparticles in human HepG2 hepatoma cells, using normal 
human L-02 hepatocytes as a control. They found that silica nanoparticles were 
also cytotoxic in a dose- and time-dependent manner. Dose-dependent toxicity 
has also been observed in previous studies. Ahmad et al. (2011) [176] used 14 
nm silica nanoparticles to assess reactive oxygen species (ROS) mediated 
apoptosis in human liver cell line HepG2. They found that treatment 5–200 
μg/ml caused cytotoxicity and oxidative stress above 25 µg/ml, suggesting 
dose-dependent toxicity.  
The influence of FBS on particle cellular uptake and toxicity has been previously 
discussed. For fumed SiNPs, the toxicity and cellular uptake were only 
significant in the absence of FBS. For colloidal silica, on the other hand, it 
seemed that it was the toxicity but not cellular uptake was size-dependent. Such 
difference might be due to the desiccant capability of fumed silica, which may 
be able to adsorb proteins on their surface in a different fashion compared to 
colloidal silica.  It is likely that, after cellular internalization and digestion of 
corona proteins, colloidal silica particles regain their primary size so that the 
smaller particles can access the binding side of intracellular 
structures/molecules, and interfere with cell survival programme, leading to cell 
death. The agglomeration/aggregation of SiNP7, SiNP14, SiNP20 and SiNP70 
in culture medium, as well as the sedimentation of SMP200 and SMP500 on the 
surface of cells in culture suggests that they may cause toxicity via strong 
physical contact with cells, triggering cell death signals.  As the characteristics 
of NPs may be affected by the chemistry of their surroundings, caution needs to 
be taken in interpreting in vitro studies. The composition of inorganic and 
biological moieties of FBS used in in vitro culture is different from human serum, 
and thus could have a different effect on the toxicity of silica particles [94]. 
Size-dependent toxicity of silica particles was also proved true in many different 
in vivo models.  Several studies showed that silica nanoparticles particles 
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elicited higher toxicity than their larger counterparts. Nemmar et al. (2014) [177] 
used amorphous silica particles 50 nm and 500 nm at 0.5 mg/kg to demonstrate 
induction of systemic inflammation and coagulation events in mice through 
intraperitoneal injection. They linked size-dependent effects to internalization in 
platelets, oxidative stress and cytolysis.  Brown et al. (2014) [178] used rats as 
model to perform the pulmonary instillation of silica particles 50 nm and 200 nm, 
which caused an acute inflammatory response. However, the magnitude of the 
response was influenced by the media used for particles dispersion, suggesting 
that silica particles should be dispersed in media more compatible with body 
fluids, for example using human serum instead of FBS. Hassankhani et al. 
(2014) [179] demonstrated that silica particles of 10-15 nm caused toxicity in 
mice to various tissues including liver, kidney, lung, and testis through oral 
route, although larger particles were not included for comparison. It was also 
interesting to note that when intra-peritoneally administered in mice, 
mesoporous silica nanoparticles caused more damage to systemic immunity 
than colloidal silica particles of similar size [180]. All the particles tested in this 
current study also appeared to cause cytotoxicity through induction of 
apoptosis. 
 
5.4 Silica induction of apoptotic cell death is size- and dose-dependent 
The internalization and accumulation of particles could ultimately lead to the 
loss of cell viability, which could be the outcome of cell death via different 
mechanisms, such as necrosis and apoptosis.  Necrosis is a form of traumatic 
cell death that results from acute cellular injury. Apoptosis, also known as 
‘programmed cell death’, on the other hand, consists of a series of biochemical 
events that lead to characteristic morphology and intracellular changes, 
followed by cell death [181]. Such changes include membrane blebbing, cell 
shrinkage, nuclear fragmentation, chromatin condensation, chromosomal DNA 
fragmentation, and global mRNA decay. While apoptosis is highly regulated and 
controlled process during an organism's lifecycle, necrosis is caused by factors 
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external to the cell or tissue, such as infection, toxins, or trauma, which result in 
the unregulated digestion of cell components [182]. Both pathways can be 
triggered by the interaction between cells and nanomaterials. Although the 
importance of understanding such cellular and molecular pathways in relation to 
nanoparticle exposure has been recognized, only few studies in recent years 
have started to shed light on such mechanisms [183]. 
In this study, the mechanism silica cytotoxicity was preliminarily assessed by 
detection of necrosis and apoptosis. Using the optical microscopy technique of 
phase contrast imaging to assess morphology changes of cells following silica 
treatment proved useful in obtaining real time information on cellular response 
to the treatment.  Although the technique does not have the resolution to see 
individual nanoparticles, it has been widely applied to image morphology 
changes of the cells and tissues for any sign of pathology [184, 185]. The size- 
and dose-dependent cellular effect of silica in CM and CM-10% detected by 
phase contrast imaging was very much comparable with the cytotoxicity 
detected by the MTT and LDH. The effects observed on cells treated with 
SiNP20 and SiNP70, such as cell shrinkage and becoming rounded, were 
associated with apoptosis. The induction of apoptotic cell death was previously 
reported in the literature for different types of nanoparticles [48, 49]. Lee et al. 
(2014) [186] investigated the effects of silver nanoparticles (AgNPs) on NIH/3T3 
mouse embryonic fibroblasts to explore the potential application of these 
nanoparticles in consumer products. After 24 hours of AgNPs treatment, the 
changes in cell morphology were examined using phase-contrast microscopy. 
They found significant morphological changes characteristic of apoptotic cell 
death in NIH 3T3 cells exposed to AgNPs, including cell shrinkage, few cellular 
extensions and increased floating cells. Alarifi et al. (2013) [187] investigated 
the cytotoxicity, oxidative stress, and apoptosis caused by ZnO nanoparticles in 
human skin melanoma (A375) cells. They found that after 24 and 48 hours 
treatment, cells treated with different concentrations of ZnO NPs changed into a 
spherical shape and detached from the surface, which was associated with 
induction of apoptosis in A375 cells. 
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To validate the induction of apoptosis as detected by phase contrast imaging, 
double staining with Annexin V and Propidium Iodide for flow cytometry was 
performed. Annexin V has high affinity to phosphatidylserine, which translocates 
from the inner layer to the outer layer of cell membrane during apoptosis, while 
Propidium iodide (PI) is a DNA intercalating agent that penetrates cells only with 
a damaged cell membrane, normally associated with necrosis. In late apoptosis, 
cells become positive for both Annexin and PI staining due to the plasma 
membrane becoming permeabilized as a direct consequence of 
phosphatidylserine (PS) on the cell surface [188]. 
In this study, a dose-dependent toxicity was demonstrated for both fumed and 
colloidal silica, in the order SiNP7 ≥ SiNP14 and SiNP20 ≥ SiNP70 ≥ SMP200 ≥ 
SMP500. For both particle types, the occurrence of late apoptosis, as indicated 
by double positive Annexin V/PI-stained, was more accentuated in CM, thus 
providing further evidence of the role of serum in attenuating toxicity. Detection 
of apoptosis induced by nanoparticles has also been reported previously [51, 
52]. Jia et al. (2013) [189] used paclitaxel (PTX)-loaded mesoporous silica 
(MSNs) to treat MCF-7 breast cancer cells and found a dose-dependent 
increase of late apoptosis,  which was associated with critical particle pore size. 
Laha et al. (2014) [190] used 30 nm CuO NPs to investigate apoptosis in MCF7 
breast cancer cells. They found that after 24 hours treatment, the majority of 
cells were in a late apoptosis; such effect was linked to the cleavage of Poly 
(ADP-ribose) polymerase (PARP), a nuclear protein activated in cells 
experiencing stress and/or DNA damage, de-phosphorylation of Bcl-2-
associated death promoter (BAD) (which has a role in apoptosis activation), and 
increased cleavage product of caspase 3. 
Although the mechanisms and morphologies of apoptosis and necrosis differ, 
there is overlap between these two processes. Necrosis and apoptosis 
represent morphologic expressions of a shared biochemical network. Whether a 
cell dies by necrosis or apoptosis depends in part on the nature of the cell death 
signal, the tissue type, the developmental stage of the tissue and the 
physiologic milieu [191, 192]. Two factors that will convert an ongoing apoptotic 
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process into a necrotic process include a decrease in the availability of 
caspases and intracellular ATP [191, 193]. The mechanisms of apoptosis are 
highly complex and sophisticated, involving two energy-dependent apoptotic 
pathways: the extrinsic or death receptor pathway and the intrinsic or 
mitochondrial pathway. The two pathways are linked, and molecules in one 
pathway can influence the other [189, 194]; both converge on the same 
execution pathway initiated by the cleavage of caspase 3. Caspase 3, caspase 
6 and caspase 7 function as effector caspases, cleaving various substrates that 
ultimately cause the morphological and biochemical changes seen in apoptotic 
cells [189]. Caspase 3 is considered the most important of the execution 
pathway caspases; activated by initiator caspases (caspase 8, caspase 9, or 
caspase 10), it activates CAD, an endonuclease responsible for chromosomal 
DNA degradation and chromatin condensation within the nuclei. Caspase 3 also 
induces cytoskeletal reorganization and disintegration of the cell into apoptotic 
bodies [192]. In this study, discrimination between apoptosis and necrosis as 
well as definition of apoptosis pathway has been assessed by Western Blot and 
gene expression analysis. The size- and dose-dependent detection of activated 
caspase 3 in HaCaT cells treated with colloidal silica was consistent with both 
phase-contrast imaging and Annexin V/PI staining, thus giving confirmation 
about induction of apoptotic cell death as primary toxicity mechanism in HaCaT 
cells. Constantini et al. (2011) [195] previously reported a similar effect, which 
compared the uptake and toxicity of amorphous and crystalline silica in vitro 
using MH-S mouse alveolar macrophages. By assay of Western blot after 4 and 
8 hours treatment, they found that both crystalline and amorphous silica 
induced high amounts of cell death in MH-S cells, with a high ratio of cleaved 
(active) caspase 3, suggesting a similar toxicity mechanism between the two 
particles. Sun et al. (2011) [196] investigated the cytotoxicity and mitochondrial 
damage of amorphous silica nanoparticles 43 nm following treatment in HepG2 
hepatocellular carcinoma cell line for 24 hours. Detection of caspase 3 by 
Western blot showed dose-dependent increase in protein levels, which, paired 
with the released cytochrome c and decreased membrane potential, was linked 
to apoptosis through mitochondrial pathway. 
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Further information regarding the molecular pathway to silica-induced apoptotic 
cell death was obtained by gene expression assay of cells treated with SiNP20 
in CM-10%, which revealed a dose-dependent up-regulation/down-regulation of 
several pro-apoptotic and anti-apoptotic genes, suggesting a dynamic process 
of apoptosis. The slight change of the gene expression profile induced by 10 
µl/ml of SiNP20 treatment was consistent with the lack of toxicity. While majority 
genes appeared down regulated, only 5 genes were up-regulated, including 
ATP6V1G2, PARP1, ACTB, HPRT1 and RPLPO.  With the increase of SiNP20 
concentration to 25 µg/ml, the majority of cell death genes were up regulated, 
suggesting that cells were actively engaged in the process of cell death. Among 
these genes, the well-known pro-apoptotic CASP gene family and FASLG were 
predominantly up regulated as compared with the anti-apoptotic BCL2 gene 
family and the autophagy ATG gene family. This gene expression profile 
coincided with induction of apoptosis, providing insights into the dominant 
molecular mechanism of SiNP20 toxicity in HaCaT cells.  
The pro-apoptosis genes that were up regulated could be linked to both the 
extrinsic and intrinsic pathway of apoptosis, as well as the execution pathway 
(Table 5.1). The up-regulation of autophagy regulator genes (ATG5, ATG12, 
IRGM, ULK1, P53) also suggested a role of autophagy in the toxicity 
mechanism induced by SiNP20. Autophagy can be defined as a catabolic 
mechanism that involves cell degradation of unnecessary or dysfunctional 
cellular components through the actions of lysosomes, thus allowing 
degradation and recycling of cellular components [197]. A similar effect was 
previously reported by Hussain et al. (2012) [198]; using CeO2 NPs to treat 
CD14+ monocytes, they demonstrated a notable increase in toxicity after 20-40 
hours exposure, which was associated with both induction of apoptosis and 
autophagy. While apoptosis was linked to mitochondrial damage and 
expression of apoptosis-inducing factor (AIF), autophagy was linked to the 
modulation of transcription factor p53. While the exact mechanism was not 
clear, it was suggested that the accumulation of CeO2 NPs in endosomes and 
lysosomes could cause overexpression of genes for vesicle formation or 
identification of NPs as foreign endosomal pathogens. 
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Table 5.1 The main upregulated genes in this study and their related pathways. 
Extrinsic Pathway Intrinsic Pathway Execution Pathway 
FAS APAF-1 Caspase 3 
FASLG BCL2 Caspase 2 
TNF BAX Caspase 6 
TNFRSF11B BCL2L1, BCL2L11 PARP1 
TNFRSF1A XIAP PARP2 
 
Further increase of SiNP20 to 50 µg/ml resulted in a down-regulation of majority 
genes, which coincided with the onset of late apoptosis.  It was interesting to 
note that the housekeeping genes ACTB, HPRT1 and PRLP0 were persistently 
up regulated regardless of the SiNP20 concentration, suggesting that these 
housekeeping genes play an important role in providing structure support 
against necrotic cell death.       
Gene expression profiles after exposure to amorphous silica particles have 
been reported in previous studies. Ahamed et al. (2013) [199] investigated the 
induction of cytotoxicity, oxidative stress and apoptosis by 15 nm SiO2 NPs 
following 72 hours exposure in A431 human skin epithelial cells and A549 
human lung epithelial cells. Analysis of mRNA expression of apoptotic genes 
caspase 3 and caspase 9 showed that SiO2 NPs up-regulated mRNA levels of 
these genes, which was also linked to increased activity for the corresponding 
proteins. This, together with increased levels of ROS, was linked to stress-
induced apoptosis. Okoturo-Evans et al. (2013) [200] used 20 nm colloidal silica 
to assess in vitro the consequences of exposure of lung to nanoparticles. 
Following treatment in A549 human lung cancer cells, assessment of protein 
expression showed that while exposure to NPs was tolerated up to 4 hours, 
after that specific time notable changes could be detected for apoptosis gene 
regulation, structural reorganisation and regulation of actin cytoskeleton, 
unfolded protein response, and proteins involved in protein synthesis (e.g. 
 174 
ribosomal proteins). Treatment in serum-free medium resulted in a rapid 
deterioration of the cells, suggesting interaction of serum components with the 
nanoparticles. Fede et al. (2014) [201] analyzed the effects of Ludox® SM30 
and AS30 nanoparticles on gene transcription of A549 cells using microarray 
analysis. After establishing the non-toxic critical dose at 0.02 mg/ml, they 
treated cells with said concentration. They found that genes up-regulated in 
response to Ludox® NPs showed notable impact on vesicle transport, regulation 
of apoptosis and regulation of transcription from RNA polymerase II promoter. 
They also showed activation of both intrinsic and extrinsic apoptosis pathway, 
as well as execution pathway, suggesting transcriptional alterations at a dose of 
exposure considered non-cytotoxic.  
While this study proved that amorphous silica induced the size- and dose-
dependent induction of apoptosis, as well as shedding light on the involved 
mechanisms in HaCaT cells, more work will need to be done to further elucidate 
the fate of silica particles  inside cells, as well as assess different cell lines with 
similar high-throughput assays to establish any kind of cell-type dependent 
mechanism of silica toxicity. 
 
5.5 Silica particles enhance wound healing in vitro in the HaCaT model system 
Keratinocyte proliferation and migration are essential for epidermal repair after 
injury.  In vivo, wound repair requires proliferation and migration of both 
fibroblasts and keratinocytes to re-establish the normal cellular and extracellular 
matrix composition of skin, as well as the growth of vascular endothelial cells 
(VECs) to form new blood vessels to supply nutrients to the skin cells [202]. 
In vitro, normal cell growth relies on growth factors. The optimal cell growth is 
usually achieved by supplementing culture medium with 10% FBS. When FBS 
concentration is too low, cells cannot achieve optimal growth. For this reason, in 
vitro wound healing assessment through scratch assay is often carried out in 
culture medium containing 0.5% FBS, which is also referred to as starvation 
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medium, to minimize cell proliferation, but just sufficient to prevent apoptosis 
and/or cell detachment. That way it is possible to assess induction of cell growth 
and migration of the tested materials [203].  
Active proliferation of HaCaT keratinocytes was detected by phase contrast 
imaging in untreated cells as well as those treated with SiNP70 and SMP200. 
The same morphology of cell growth were detected by Nickoloff et al. (2005) 
[204], where melanocytes were compared with different melanoma cell lines 
derived from patient. Rounded structures compatible with cell growth, as well as 
an enhanced proliferation compared with normal cells could be detected. As it is 
already known that HaCaT cells are characterized by faster growth compared 
with other normal phenotype cell lines, the increase in cell number detected in 
cells treated with SiNP70 and SMP200 was linked to enhanced cellular growth. 
As shown in the in vitro scratch assay, HaCaT cells in CM-0.5% (starvation 
medium) underwent a slow process of wound closure, which was augmented by 
all colloidal silica in a dose-dependent manner ≤25 µg/ml. Such observation, 
compared with previously reported toxicity ≥ 25 µg/ml, suggests a threshold 
between promotion of wound healing and induction of toxicity. As the wounds 
were created after particles incubation and removal from the culture medium, 
the effect could only be initiated by colloidal silica internalization inside HaCaT 
cells. Although all the tested particles showed an ability to promote wound 
healing in vitro, they did not share the same dose- and time-response pattern. 
Such difference could be related to the different size of the particles, as well as 
the nature of serum proteins that were carried over by the different particles. 
The adsorption of proteins by particles can be directed by positively charged 
areas on the protein surface towards the negatively charged silica surface at 
conditions allowing specific binding. Consequently, even small variations of 
characteristics in silica particles could lead to a drastic change in protein 
adsorbing properties, in selective protein binding and in delivery by silica 
particles, thus reflecting a different impact on their biological behaviour [205].   
Studies on tissue regeneration properties of amorphous silica are scarce. Feng 
et al. (2007) [206] used silica nanospheres 30-80 nm to assess their potential in 
 176 
bone regeneration. Using the nanospheres to treat osteoblast-like cells, by 
assay of MTT and alkaline phosphatase (ALP) they found that cells treated with 
the nanospheres had higher cell viability as well as higher ALP activity 
compared to the control, thus suggesting enhanced proliferation. Meddahi-Pellé 
et al. (2014) [207] used 50 nm Stöber silica to assess their ability to achieve 
rapid and strong closure and healing of deep wounds in rats skin and liver. They 
reported a beneficial effect of colloidal silica in skin and liver repair, which could 
be attributable to the adhesion and haemostasis activity of silica nanoparticles. 
While the present study using HaCaT cells as model provided further evidence 
that treatment with colloidal silica could be beneficial for tissue repair, the 
effects of the particles in promoting cell proliferation and migration warrant 
further in vitro and in vivo assessment before exploitation for applications in 
regenerative medicine could be considered. 
 
5.6 Cell-type related toxicological effects of colloidal silica 
In order to identify sensitive cells/organs to nanotoxicity, there has been 
considerable effort on investigating the potential toxicity of nanoparticles using 
different cell models [208]. Despite the amount of available studies, inconsistent 
or conflicting observations have hindered the establishment of cell-type specific 
mechanism of nanoparticle cytotoxicity [209, 210].  
In this study, three additional human skin cell lines were chosen to determine 
whether the size-dependent toxicity of the chosen colloidal silica particles is cell 
type specific. These cells were assessed for cell viability, particle uptake and 
activation of apoptotic pathway after colloidal silica treatment. Although the 
chosen assays were different from that used for HaCaT study due to the 
preference of different labs, the results provided insights into the toxicity 
potential and mechanisms of the same group particles in different cell lines. 
While K17 keratinocytes was chosen to present a different cell line but with 
same tissue origin as HaCaT cells, BJ fibroblasts and Human Dermal 
Fibroblasts (HDF) were chosen to present morphologically different cell types 
originated from different skin layers as keratinocytes. Fibroblasts are associated 
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with the dermis, and promote the formation of the connective tissue, which 
unites the different cell layers. Keratinocytes, on the other hand, occupy the 
upper layer of skin, the epidermis, therefore are the first to come to contact with 
any external agent, including nanoparticles. 
In this study, the cell-type dependent response to colloidal silica of different size 
was demonstrated. The particles induced a size- and dose-dependent decrease 
of cell viability in both K17 and HaCaT keratinocytes with the former more 
sensitive than the latter. In contrast, in HDF, cytotoxicity was only induced by 
SiNP20 but not by the larger particles under the different tested conditions. BJ 
fibroblasts were shown to induce cytotoxicity for both SiNP20 and SiNP70, 
although at a lower level compared to HaCaT and K17 keratinocytes. The 
sensitivity difference between cell lines to toxins was previously described by 
Olschläger et al. (2009) [211] using primary fibroblasts NHDF (Normal Human 
Dermal Fibroblasts), primary keratinocytes NHEK (Normal Human Epidermal 
Keratinocytes), 3T3 mouse fibroblasts and HaCaT. While both fibroblast cell 
lines showed similar sensitivities towards sodium dodecyl sulphate (SDS), 
primary keratinocytes died at SDS concentrations about three times lower than 
the toxic concentration derived from the immortal HaCaT cells. The different 
sensitivity between the cell types used in this study might be due to different 
levels of paracrine factors, proteins synthesized in response endocrine factors 
(hormones) to induce changes in neighbouring cells [212]. These factors are 
important for growth and differentiation both in vivo and in vitro [213, 214], and 
low levels of such proteins could lead to lower differentiation and reduced 
sensitivity [215]. This consideration is further corroborated by the previously 
discussed wound healing data. In the wound healing experiment, coating wells 
with fibronectin, a glycoprotein of the extracellular matrix, and prior to HaCaT 
cell seeding was required for cell adhesion, growth, migration, and 
differentiation. While no such assay has been performed on fibroblasts, the 
slower growth, as well as the higher degree of cell differentiation observed in 
the other assays as well as previously reported in the literature [216, 217, 218] 
are two key characteristics. Such characteristics distinguish fibroblasts from 
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keratinocytes and further corroborate the importance of growth and 
differentiation factors in cellular sensitivity to nanoparticle-induced cytotoxicity. 
Another interesting difference between the cell lines is the mechanisms of cell 
death induced by colloidal silica. While in HaCaT cells this mechanism was 
associated with apoptosis, in both K17 and HDF the same mechanism was 
instead associated with necrosis. Such difference could be due to the difference 
of subcellular locations as detected by confocal imaging. In K17 keratinocytes, 
the   particles were located all around the nuclei, while they were found in the 
cytoplasm in HDF. The influence of cell-type related particle localization on 
apoptosis has been previously described [219, 220]. Blechinger et al. (2013) 
[219] investigated the cell-type dependent cytotoxic response of cells and 
uptake kinetics of 304 and 310 nm silica nanoparticles. By 24 hours treatment 
of HUVEC human vascular endothelial and HeLa cervix carcinoma cancer cells 
they found that cellular destination of SiO2 particles was cell-type dependent, as 
particles were found inside the cytoplasm in HUVEC cells and associated with 
the plasma membrane in HeLa cells. This difference in cellular location was 
directly linked to cell death results, as treatment with SiO2 NPs was associated 
with cell death for HUVEC, whereas no effect could be detected on the viability 
of HeLa cells. A previous study (2011) [221] by the same group demonstrated 
that cell death in HUVEC could be linked to induction of necrosis. Wu et al. 
(2015) [220] investigated the cytotoxic effects of 20 nm silica nanoparticles 
(SNPs) on MGC80–3 human gastric cancer cells and HeLa cells. After up to 24 
hours exposure, they observed significant intake of SNPs in both MGC80–3 and 
HeLa cells in similar locations. The higher uptake efficiency they observed for 
MGC80–3 cells was correlated to the higher levels of apoptotic cell death 
induction, suggesting that particle uptake efficiency also plays an important role 
in cytotoxicity and in the definition of cell-type toxicological behaviour. Despite 
the light this study shed on the difference in cell type behaviour after treatment 
with colloidal silica, more work will need to be done on the issue, especially in 
the determination of cell death induction mechanism, as well as uptake 
efficiency and subcellular location. 
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6 CONCLUSIONS 
The increased emphasis on nanotechnology and its potential widespread 
commercial applications over the last two decades has sparked great interest in 
the potential human health and environmental effects of nanomaterials, most of 
which is directed towards nanoparticles. If uncontrolled and unregulated, there 
is some potential that such particles might pose a human health hazard and/or 
environmental damage. Nanotoxicology research has shown that the 
interactions between nanoparticles (NPs), submicroparticles (SMPs) and cells 
are remarkably complex; however, many of the reported results are in 
contradiction between themselves, therefore there is still considerable debate 
about the regulation of nanomaterials. The potential key reasons for these 
conflicts lie in some matters often ignored or barely acknowledged in 
toxicological studies. Such matters include a) the sedimentation of particles and 
the absorption of proteins and other essential biomolecules onto their surface; 
b) the study of toxicity mechanisms taking into consideration of the changeable 
behaviour of particles in different biological media; c) cell type related toxicity. 
Addressing the reasons behind the conflicting results of nanotoxicity offers the 
opportunity to understand better cell-particles interactions, thus decreasing the 
number of conflicting reports and paving the way for better regulation towards 
nanomaterials. 
Consequently, this study aimed to assess the toxic potential of silica 
nanoparticles and submicroparticles in relation to their physico-chemical 
properties. The choice has fallen on amorphous silica particles because despite 
being one of the most abundant materials on earth with a wide range of 
industrial applications, including nanoformulations for drug delivery, their toxicity 
is not well understood and, most importantly, regulated. No specific information 
is available regarding the effect of surface groups and, most importantly, about 
the optimal size range to achieve non-toxicity.  
For this study, the focus has been on the importance of size in relation to 
amorphous silica cytotoxic potential. Sedimentation and protein adsorption have 
also been investigated to provide further evidence on silica stability in 
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suspension as well as to get insight on their interaction with cells. Consequently 
amorphous fumed and colloidal silica nanoparticles of different size were 
sourced from commercial suppliers without further treatment and characterized, 
in order to make the results more reproducible and easy for comparison across 
different laboratories. The main cell line used for this study, HaCaT 
keratinocytes, has been chosen because of its well-characterized behavior, as 
proven by the several studies in which it was used through the years, as well as 
for its characteristics, such as rapid growth and immortalized phenotype without 
tumorigenic activity. The other cell lines chosen for this study provided 
additional information, especially in regards to cell type related cellular response 
to silica particle treatment.  This study has made the following important 
findings:  
1. Fumed and colloidal SiNPs exhibited different dispersity in cell culture 
media, as fumed silica showed aggregation in serum-free medium while 
colloidal silica in the same conditions showed relatively good stability;  
2. Fumed SiNPs showed cytotoxicity only in the absence FBS, whereas 
colloidal SiNPs could induce cytotoxicity also in the presence of FBS;  
3. Silica particles exerted toxicity in a size-dependent manner in four human 
skin cell lines including two cell types; 
4. While silica particles toxicity was evidenced to be associated with the 
induction of apoptotic cell death, sedimentation of larger particle could 
also have impact on cytotoxicity; 
5. Cellular uptake appeared not to be size dependent;  
6. Colloidal silica particles could either induce toxicity or promote wound 
healing in a dose-dependent manner. 
This in vitro study suggests that 1) SiNP7, SiNP14, SiNP20 may not suitable for 
biomedical applications due to their instability in biological media and toxicity 
induction respectively; 2) the potential of silica toxicity could be different in vivo 
as components of FBS used in vitro are different from that of human serum; 3) 
there seems to be dose thresholds for colloidal silica to interfere with different 
cellular processes such as toxicity and wound healing.  
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Although this project aimed to assess the toxicity silica particles for drug 
delivery, this study provided information on a provisional size range suitable for 
biomedical application of amorphous silica, thus providing new scientific 
evidence supporting development of new regulations specific for nanomaterials.  
Modelling the size-dependent effect of silica particles in vitro also provided new 
insights into the size-dependent mode of action, which is of significance for 
predicting the possible outcome of amorphous silica particles exposure in vivo. 
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7 FUTURE PERSPECTIVES 
Despite the new insights provided in this study, more work will need to be done 
in order to understand the cellular and molecular mechanisms of silica uptake 
and toxicity in relation to particle size- and cell-type specificity. Further 
assessment also needs to consider the long-term fate and effect of silica 
particles after cellular internalization. To achieve this, assays could include: 
 Gene and protein expression in different cells in response to cellular 
uptake of silica particles; 
 Detection of exocytosis of silica particles in relationship to their size.  
Future work should also focus more on the effect silica particles on cellular 
proliferation and migration, as these are important cellular processes in wound 
healing. Therefore, the evidence generated could support the development of 
advanced silica nanomaterials for tissue regeneration.  
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APPENDICES 
Appendix A Collaboration Work 
A.1 Preliminary analysis of lipid nanoparticles for drug delivery of Dacarbazine 
Lipid-based nanocarriers are generally composed of lipid components such as 
phospholipids, cholesterol and triglycerides. These materials are mostly from 
natural sources and have good in vivo biocompatibility, as well as being 
biodegradable. Many of these lipid excipients have been used in FDA approved 
pharmaceutical products and have well-established safety proﬁles and 
toxicological data [222]. 
The first lipid-nanocarriers to be produced and studied were liposomes, which 
were composed of a closed bilayer of phospholipids offering a hydrophobic 
compartment (lipid layer) as well as a hydrophilic compartment (inner volume of 
the liposome) for drug encapsulation. However, phospholipids are expensive, 
thus hindering the possibility of meaningful scale-up processes. In the early 
Nineties Solid Lipid Nanoparticles (SLNs) were introduced as drug carriers in 
the pharmaceutical field.  In general SLNs can be defined as a colloidal carrier 
system for controlled drug delivery composed of high melting point lipids 
(glycerides and waxes) solid at room temperature [223, 224].  They are 
characterized by a better physical stability, and synthesis doesn’t require the 
use of phospholipids and organic solvents, making scale-up processes much 
easier to perform. However, they present some disadvantages, especially in 
terms of drug-loading capability. For this reason, a new generation of lipid NPs, 
called Nanostructured Lipid Carriers (NLCs) was designed in order to overcome 
such limitations related to old generation SLNs.  NLCs are composed of a solid 
lipid matrix with a certain content of liquid lipid. Because of this modification, the 
drug is located in the liquid lipid, which in turn is surrounded by the solid lipid. 
This provides some degree of mobility to the drug, which contributes to the 
overall carrier stability [225]. The incorporation of a liquid lipid into solid lipid 
matrix leads to great imperfections in the crystal lattice of the nanocarriers, thus 
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leading to improved drug loading capacity and reduced drug expulsion during 
storage. Because of these improved characteristics, as well as for the ease of 
scaling up, NLCs have been investigated for drug delivery through different 
routes, including oral, ocular and dermal.  This preliminary study has been 
conducted in order to characterize a first batch of NLCs synthesized by our 
group, as well as to give a preliminary analysis of the potential toxicological 
effects these particles have in vitro on HaCaT keratinocytes. The data acquired 
through this analysis have proven useful to correct particle formulation, 
providing the basis for further work on drug encapsulation, drug loading 
capacity studies and in vitro drug release.  
In order to assess size, solubility, structure and behaviour in culture medium, 
anionic NLC (NLC-) and cationic NLC (NLC+) at 25-100 µg/ml were analysed by 
Dynamic Light Scattering (DLS) at 0 and 24 hours. Medium with 0% FBS (CM) 
(Table A.1) was used as background control. Compared with the negative 
control, DLS of NLC- and NLC+ in CM (Table A.2) showed different behaviour. 
Whereas NLC- showed average around 200 nm and PDI levels 0.3-0.4 at all 
tested concentrations and time points, NLC+ showed high average, above 2 
µm, and varying PDI levels, between 0.4 and 1.0, suggesting that either 
synthesis was not efficient or positive particles were highly unstable and 
aggregating in CM. 
 
Table A.1 DLS assay of CM as background control. 
Neg. Contr. 0 h 24 h 
Average PDI Average PDI 
 CM 4.4 0.3 9.3 0.5 
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Table A.2 DLS assay of NLC+ and NLC- in CM at 0 and 24 h after incubation at 4oC (storage 
conditions). 
NPs 
 
25 µg/ml 50 µg/ml 100 µg/ml 
0H 24H 0H 24H 0H 24H 
Ave. PDI Ave. PDI Ave. PDI Ave. PDI Ave. PDI Ave. PDI 
NLC- 187 0.4 185 0.4 184 0.5 187 0.4 194.2 0.5 261 0.5 
NLC+ 4373 0.5 3281 0.6 2977 1.0 2831 0.6 2177 0.6 2944 0.4 
 
Considering characterization data, cytotoxicity potential was assessed by assay 
of cell viability in HaCaT cells using MTT test. Two new sets of particles, neutral 
NLC (NLC) and anionic NLC conjugated with Ludox Silica (NLC/Ludox) were 
added for further reference. Particles were tested at concentrations 25-100 
µg/ml at 4 and 24 hours in CM (Figure A.1). At 4 hours a particle-dependent 
increase in cell viability was detected, with NLC/Ludox composites giving the 
most prominent effect; at 24 hours, on the other hand, no toxicity was detected 
in any of the samples, suggesting that the whole set of samples had little to no 
toxicity. 
  
 
Figure A.1 MTT assay for NLCs particles. HaCaT cells were treated 24 h with NLCs 25-100 
µg/ml, then analysed for mitochondrial activity. 
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One of the concentrations chosen for MTT (50 µg/ml) was also used to assess 
morphology changes in HaCaT cells by phase contrast microscopy imaging. 
Cells were assessed after treatment with CM at 24 hours (Figure A.2). While 
NLC+ and NLC- treated cells showed shape loss and reduced viability, NLC 
and NLC/Ludox treated cells showed little to no effect, suggesting a role of 
surface charge on the toxicity of these particles. 
 
 
Figure A.2 Phase contrast imaging of HaCaT cells following treatment with NLCs. Cells were 
treated with NLC, NLC+, NLC- and NLC/Ludox at 50 µg/ml for 24 hours at 37oC. 
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The results here reported have been used for further development of NLCs 
synthesis; as NLC+, based on the data acquired, were deemed too unstable to 
get suitable carriers, further work has been done on optimizing synthesis for the 
other three types, as well as encapsulation of Dacarbazine in the final product. 
For further reference, see Appendix C. 
 
A.2 Collaboration with Queen Mary University of London (QMUL) for toxicological assessment of polyacrylamide nanoparticles 
As introduced before, in the last 20 years nanomaterials and their potential 
applications as drug delivery systems have attracted significant interest, with 
micelles, lysosomes and solid-lipid nanoparticles being among the most 
interesting because of their unique physico-chemical properties. These types of 
nanomaterials are self-assembled systems, and present several advantages, 
such as increasing bioavailability of drugs, increasing drug deposition in 
diseased tissues and reducing side effects associated with the drug. However, 
a number of issues, including instability in certain solvent systems and ability to 
deliver a drug mainly through diffusion remained unsolved, therefore limiting 
their applications as drug delivery vehicles [226, 227]. Polymeric nanomaterials, 
in contrast, are normally characterized by high stability, as a direct result of the 
presence of a strong network of covalent bonds. Among these, nanogels stand 
out as interesting nanomaterials for biomedical applications, given their ability to 
support stable colloidal solutions [228]. Nanogels are polymeric cross-linked 
particles forming a 3-dimensional network; their ability to cross-link gives them a 
significant advantage over simple block co-polymers, as a) they don’t need to 
rely on self-assembly; b) their stability is higher and c) they have increased 
polymer density [229, 230]. The selection of components used for nanogel 
preparation is responsible for its characteristics: the use of monomers with a 
high degree of hydrophilicity, such as acrylic acid, will result in the production of 
a nanogel with a high affinity for water. This type of particle will provide an ideal 
vehicle for drug delivery, as the high hydrophilicity of the carrier will facilitate the 
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administration of otherwise insoluble drugs [231]. Another important 
requirement for the preparation of the nanogels is the cross-linker, which must 
have a similar chemical structure compared to the monomer in order to achieve 
successful polymerization. Among different type of polymeric nanogels, 
polyacrylamide nanogels have demonstrated an interesting potential as a 
delivery system [232]. Acrylamide is a compound capable of forming polymers 
with good solubility in water. It’s also characterized by amide bonds, which have 
a relatively good affinity to water thanks to hydrogen bonding and which are 
also abundant in the human body as the result of peptide bonds.  As part of the 
same NANODRUG Network, assessment of two polyacrylamide nanogels, JR-
P2-34 and JR-P2-35 (Table A.3 and A.4), for behaviour in culture medium, as 
well as cytotoxic potential and uptake in HaCaT cells has been performed in 
collaboration with Prof. Marina Resmini group at Queen Mary University of 
London (QMUL).  
 
JR-P2-34  
Table A.3 Composition of JR-P2-34. 
Component Structure Percentage In Formulation 
7-trifluoromethyl coumarin 
acrylamide 
 
2.5% 
Acrylic Acid 
 
10% 
Acrylamide 
 
67.5% 
Methylene bisacrylamide 
 
20% 
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JR-P2-35 
Table A.4 Composition of JR-P2-35. 
Component Structure Percentage In 
Formulation 
7-trifluoromethyl coumarin 
acrylamide 
 
5% 
Acrylic Acid 
 
10% 
Acrylamide 
 
65% 
Methylene bisacrylamide 
 
20% 
 
In order to gain information about particle behavior in culture medium, both JR-
P2-34 and Jr-P2-35 were dispersed in CM-10% at 10-200 µg/ml and assessed 
by DLS analysis. Particle-free medium was employed as background control. 
The data obtained is reported in Table A.6. Particles size was 14.9/20.8 nm, 
much smaller compared to the size previously measured by QMUL in water 
(Table A.5), suggesting particle sedimentation in culture medium. 
 
Table A.5 JR-P2-34 and JR-P2-35 specifications. 
 JR-P2-34 Jr-P2-35 
Particle size in water 171 nm 123 nm 
Solubility (mg/ml) 1 mg/ml  1 mg/ml 
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Table A.6 DLS assay of JR-P2-34 and JR-P2-35. 
 10 µg/ml 200 µg/ml 
0H 24H 0H 24H 
Ave. PDI Ave. PDI Ave. PDI Ave. PDI 
JR-P2-34 14.9 0.4 17.4 0.4 15.6 0.4 18.5 0.4 
JR-P2-35 14.8 0.4 18.3 0.4 20.8 0.6 20.2 0.4 
 
Unfortunately, due to the limited amount of available sample, no confirmation of 
size, solubility and shape could be obtained by SEM or TEM. Instead, 
assessment on cytotoxic potential was performed by MTT assay in HaCaT cells 
for concentrations 10- 200 µg/ml at 24 h in CM-10% and CM (Figure A.3). In 
CM-10% a notable increase in cell viability could be detected for both particles 
at 25 and 50 µg/ml, while a decrease could be detected at 10 µg/ml. In CM, on 
the other hand, no reduction of cell viability could be detected; on the other 
hand, a 10-20% increase in cell viability could be detected for both particles at 
all concentrations tested. 
 
  
 
Figure A.3 Cytotoxicity assessment in HaCaT cells. JR-P2-34 and JR-P2-35 at 10-200 µg/ml 
were used to treat cells for 24 h at 37oC. 
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To verify uptake inside HaCaT cells, flow cytometry analysis in CM-10% at 24 
hours using the same concentrations as MTT assay; unfortunately, the results 
were inconclusive, as the wavelength of the particle fluorophore could not 
properly be detected by the instrument (data not shown). In conclusion, even 
though the characterization and viability data proved quite interesting, no further 
analysis could be performed due to lack of sample availability as well as time 
constraints and technical issues. Further work has been done by Prof. 
Resmini’s group to test the particles toxicity in vivo, using Casper zebrafish 
embryos as model. 
 
A.3 Collaboration with Universite’ Catholique de Louvain (UCL) on PLGA nanoparticles 
Wound treatment and its medical complications remain one of the most 
prevalent and economically challenging healthcare issues in the world. One of 
the simplest and pragmatic solutions to faster wound healing process is the 
application of exogenous lactate, which accelerates angiogenesis, activation of 
procollagen factors and recruitment of endothelial progenitor cells in wounds. 
Utilization of poly (lactic-co-glycolic acid) (PLGA) is one of the strategies to 
supply lactate sustainably; using it as a drug delivery system would perform the 
dual role of wound healing agent itself as well as system to release loaded 
drugs to the wound. As part of the NANODRUG Network, in collaboration with 
Prof. Veronique Préat at Université Catholique de Louvain (UCL, Belgium), in 
vitro toxicological assessment of PLGA nanoparticles loaded with human host 
defense peptide LL37 was performed in HaCaT keratinocytes and BJ 
fibroblasts; further details regarding this study can be found in Appendix C. 
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Appendix B Particles Specification Sheets 
SiNP7 (S5130) – SiNP14 (S5505) 
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SiNP20 (Ludox Silica) 
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SiNP70, SMP200, SMP500 
 Z-PS-SIL-GFP-0,07 Z-PS-SIL-GFP-0,2 Z-PS-SIL-GFP-0,5 
Surface Plain Plain Plain 
Diameter 70 nm 200 nm 500 nm 
Concentration 25 mg/ml 50 mg/ml 50 mg/ml 
Quantity 10 ml 10 ml 10 ml 
Polydispersity Index < 0.2 < 0.2 < 0.2 
Shape Spherical Spherical Spherical 
Density 2.0 g/ccm 2.0 g/ccm 2.0 g/ccm 
Porosity Non Porous Non Porous Non Porous 
Stable in Acqueous Solutions 
and Organic Solvents 
Acqueous Solutions 
and Organic Solvents 
Acqueous Solutions 
and Organic Solvents 
Unstable in Acid and Strong 
Bases 
Acid and Strong 
Bases 
Acid and Strong 
Bases 
Product Form Acqueous 
Suspension 
Acqueous 
Suspension 
Acqueous 
Suspension 
Particle per ml 7.0x1013 6.0x1012 3.8x1011 
Particle pro mg 2.8x1012 1.2x1011 7.6x1010 
Optical 
Characteristics 
Green Fluorescence Green Fluorescence Green Fluorescence 
Colour Yellow Yellow Yellow 
Excitation 485 nm 485 nm 485 nm 
Emission 510 nm 510 nm 510 nm 
Other Comments Store at room 
temperature, do not 
freeze 
Store at room 
temperature, do not 
freeze 
Store at room 
temperature, do not 
freeze 
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Appendix C Awards and Publications 
C.1 Awards 
Best Poster Presentation British Toxicology Society (BTS) Spring Meeting 2014 
– Title: Internalization and Toxicity of Amorphous Silica Nanoparticles And 
Submicroparticles In Human Skin HaCaT Cells. 
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